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ABSTRACT 
Brian Vesci: The Effects of Hip Musculature on Knee Valgus During a Squat Task With and 
Without a 2-inch Heel Block 
(Under the direction of Dr. Darin A. Padua) 
 
Objective: To compare hip ROM, strength, muscle activity, and ankle dorsiflexion ROM 
between groups that demonstrate knee valgus during a squat task and those that do not 
(control).  Also, determine if muscle activity changes after knee valgus is corrected by a two-
inch heel block.  Design: A single-session experimental research design was used to compare 
the control group and the valgus group.  Participants: Seventeen (10 Females, 7 Males) 
control subjects (age[yr] = 23.82 ± 5.76, height[cm] = 166.12 ± 31.13, weight[kg] = 69.59 ± 
15.37) and fourteen (12 Female, 2 Male) valgus subjects (age[yr] = 22.36 ± 3.08, height[cm] 
= 167.21 ± 9.3, weight[kg] = 65.93 ± 9.9) without lower extremity injury.  Dependent 
Variables: Supine hip abduction and external rotation ROM.  Ankle dorsiflexion ROM 
(straight and bent knee).  Hip internal rotation, external rotation, extension, and abduction 
eccentric and concentric peak torque and time to peak torque.  EMG mean amplitude of the 
gluteus maximus, gluteus medius and adductor complex during a squat with and without a 
two inch heel block.  Data Analysis: Mixed model analysis of variance tested for difference 
both between and within groups.  Results: A significant group by phase interaction effect (p 
= 0.02) existed for mean adductor amplitude between the valgus and the control group.  A 
significant difference (p < .001) in straight knee ankle dorsiflexion ROM existed between the 
control and the valgus group.  A significant difference (p = 0.034) existed between the 
internal rotation concentric time to peak torque between the two groups.  Conclusion:  The 
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adductor complex plays a significant role in hip extension.  Increased activity of the adductor 
during extension could pull the knees into valgus.  Gastrocnemius tightness might contribute 
to knee valgus during a squat.  There appears to be three distinct populations when 
considering this knee valgus squatting position.  1. Normal individuals who do not have 
valgus.  2. Ankle dysfunction individuals who’s valgus position corrects with a heel block.  
3.  Hip dysfunction individuals who’s valgus position does not correct with a heel block.  
Keywords: Knee valgus, double leg squat, hip adductor activity, gastrocnemius flexibility 
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 CHAPTER 1 – INTRODUCTION 
 
 
Introduction 
 
Baseline screenings are commonly utilized in sports medicine as a method to assess 
injury status and establish return to play criteria should injury occur.  More recently baseline 
screenings are used to develop corrective exercise programs to prevent injury from occurring.  
Typically baseline screenings have utilized isolated measures of flexibility, muscle strength, 
and functional performance; as well as identifying faulty posture.  Acquiring this information 
serves two purposes.  Initially this information is required to ensure that the athletes are not 
injured coming into the season.  However, most often this information is important in the 
ongoing attempt to prevent those injuries from occurring.  It is inevitable that certain injuries 
are going to occur during a season; however, if certain risk factors can be identified and 
corrected in the preseason, some of these injuries can be prevented. 
 Posture is a very important and often neglected part of overall health.  Ideal posture 
maintains that structural integrity and optimum alignment of each component of the kinetic 
chain (Clark, 2001).  The kinetic chain consists of the myofascial system, articular system, 
and the neural system (Clark, 2001).  When one component of this system is out of 
alignment, then the entire system is placed at a disadvantage.  Postural malalignment is 
thought to create predictable patterns of tissue overload and dysfunction, initiating the
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cumulative injury cycle (Clark, 2001).  This cumulative injury cycle begins with tissue 
trauma, inflammation, leading to muscle spasm, adhesions, altered neuromuscular control, 
and muscle imbalance.  This cycle is thought to cause decreased athletic performance and 
eventual injury (Clark, 2001). 
Functional movement analyses are becoming increasingly popular as a tool during 
dynamic postural assessment.  Double leg and single leg squatting tasks are common during 
functional movement analyses.  These methods can be easily implemented and are time 
efficient, thus are attractive measures for the clinician.  During functional movement analyses 
the clinician observes for dysfunctional movement patterns that are believed to represent 
muscle imbalances caused by lack of flexibility, muscle weakness, and/or muscle activation.  
For example, individuals who demonstrate excessive knee valgus during a double leg squat 
are hypothesized to display a tight adductor muscle complex and weak gluteus medius and 
maximus muscles, as well as a lack of neuromuscular control in the aforementioned muscles. 
(Clark 2001)  However, research has not been performed to validate the idea of functional 
movement analyses as a method to identify muscle imbalances. 
 Lack of muscle flexibility is one of the most common thought of risk factors for 
muscular injury. (van Mechelen, Hlobil et al. 1992; Garrett 1996; Gleim and McHugh 1997)  
It is theorized that if a muscle is unable to lengthen to a point that is considered normal ROM 
when stressed during activity, then it has a greater potential to fail.  One study has shown that 
decreased flexibility in certain muscle groups can be considered an important factor in the 
development of injuries in soccer players. (Witvrouw, Danneels et al. 2003).  In contrast, 
another study has shown that there was no significant difference in preseason adductor 
flexibility in professional ice hockey players who sustained adductor muscles injuries and 
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those who did not. (Tyler, Nicholas et al. 2001)  The literature is inconclusive as to whether 
or not flexibility of a muscle is directly related to injury, but most evidence seems to suggest 
that it is a contributing factor to most muscular injuries.  (Worrell 1994; Gleim and McHugh 
1997; Thacker, Gilchrist et al. 2004) 
 Muscular weakness is another potential risk factor to muscular injury.  Some studies 
have examined individual muscle strength and how it relates to injury of that specific muscle. 
(Worrell 1994)  Although, few studies have analyzed whether or not weakness in one muscle 
has any relationship to injury in another area along the kinetic chain.  Muscular weakness 
may develop secondary to changes in its antagonistic muscle.  If a muscle is tight or 
overactive, then its antagonistic muscle may become weak or inhibited.  This concept, called 
reciprocal inhibition, is considered to be another risk factor that contributes to athletic 
injury.(Clark M 2001)  If a muscle is weak or inhibited, then it cannot fully function to 
mobilize or stabilize the structure for which is it intended.  Muscle weakness can cause 
certain movement dysfunctions that can put certain muscles or joints in positions considered 
to be of high risk for injury.(Clark M 2001)  This concept has yet to be fully investigated in 
the literature. 
 It is logical to assume that athletes, notably lower extremity athletes, may not have 
lower extremity muscular tightness or weakness.  However, the idea of reciprocal inhibition 
brings to light another aspect of injury risk, which is muscle activation.  If athletes do not 
posses the neuromuscular control to avoid these dysfunctional movements, then strength or 
flexibility would not matter.  Extensive research currently explains the muscle activation 
patterns of the gluteus medius muscle during functional tasks.  (Soderberg and Dostal 1978; 
Schmitz, Riemann et al. 2002; Earl 2005; Garrison, Hart et al. 2005)  Also, research has 
4 
looked at the gluteus maximus activation in various functional tasks, although it is less 
understood. (Zeller, McCrory et al. 2003)  However, research has yet to fully investigate hip 
musculature muscle activation, flexibility, and strength measurements during functional tasks 
and its relation to knee valgus. 
As mentioned before, certain movement dysfunctions have been identified that are 
believed to be caused by the above mentioned risk factors.(Clark 2001)  Knee valgus 
alignment during dynamic tasks (e.g. squatting) is a common postural dysfunction seen in the 
lower extremity.  Knee valgus alignment during squatting is defined as the mid-patella 
moving medially and crossing over the ipsilateral great toe as the knee flexes while squatting 
downward.  Knee valgus alignment has been described as a potentially dangerous movement 
pattern (Ireland 1999).  Knee valgus alignment is accompanied by movement of the hip into 
adduction and internal rotation, which are commonly described mechanisms for anterior 
cruciate ligament (ACL) injury (Ireland 1999).  It has also been shown that patello-femoral 
compressive forces increase with knee valgus alignment (Escamilla 2001)  Thus, knee valgus 
alignment is also believed to be a contributing factor to patello-femoral pain syndrome.  
Furthermore, the medial collateral ligament (MCL) is stressed when the knee is exposed to a 
valgus moment.  The MCL can become injured when that valgus stress becomes too great.  
Individuals who undergo excessive knee valgus motion during functional tasks may place 
greater stress on the MCL and be at greater risk for injury.  These injuries can be detrimental 
to an individual’s physical well-being.  Therefore, it is important to understand the factors 
that influence knee valgus alignment as this may improve our understanding of lower 
extremity injury risk factor, which may lead to the development of exercise programs to 
correct knee valgus alignment and reduce injury risk.  Currently, knee valgus alignment is 
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thought to occur due to weakness or inhibition in the hip abdcutor muscles (e.g. gluteus 
medius, gluteus maximus) and hip external rotator muscles.  Meanwhile, the hip adductor 
and internal rotator muscles are believed to be tight or overactive (Clark 2001).  However, 
research has not investigated if these hypothesized muscle imbalances actually exist in 
individuals demonstrating knee valgus alignment during a functional squatting task. 
Squat tests, both single and double legged, have been used in the past as functional 
tests because they put the knee through common motions found in athletics.(Beutler, L.W. et 
al. 2002; Loudon, Wiesner et al. 2002; Zeller, McCrory et al. 2003)  Moreover, studies have 
been done that examine knee valgus during squat tasks. (Zeller, McCrory et al. 2003)  
However, currently research has yet to focus on how the abovementioned risk factors 
associated with injury differ between subjects who experience a position of great knee valgus 
versus those who do not when performing a squat.] 
 
Statement of Purpose 
Closed-chain knee flexion is a very common athletic position.  When this position is 
accompanied by knee valgus stress the risk for a knee injury is increased.(Ireland 1999)  A 
double-legged squatting task (DLST) is a functional test that can be used clinically to mimic 
this closed-chain knee flexion.  When someone’s knee adducts during this squatting task, it is 
logical to assume it would do the same during an athletic activity.  As of yet no concrete 
evidence exists to suggest what exactly causes this knee adduction during a DLST. 
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Research Questions 
1. Do subjects who demonstrate bilateral knee adduction in a DLST have less hip 
abduction ROM compared to those who do not demonstrate bilateral knee 
adduction? 
2. Do subjects who demonstrate bilateral knee adduction in a DLST have less hip 
external rotation compared to those who do not demonstrate bilateral knee 
adduction? 
3. Do subjects who demonstrate bilateral knee adduction in a DLST have less 
straight knee ankle dorsiflexion compared to those who do not demonstrate 
bilateral knee adduction? 
4. Do subjects who demonstrate bilateral knee adduction in a DLST have less bent 
knee ankle dorsiflexion compared to those who do not demonstrate bilateral knee 
adduction? 
5. Do subjects who demonstrate bilateral knee adduction in a DLST have less 
gluteus medius muscle strength compared to those who do not demonstrate 
bilateral knee adduction? 
6. Do subjects who demonstrate bilateral knee adduction in a DLST have less 
gluteus maximus muscle strength compared to those who do not demonstrate 
bilateral knee adduction? 
7. Do subjects who demonstrate bilateral knee adduction in a DLST have less hip 
external rotator muscle strength compared to those who do not demonstrate 
bilateral knee adduction? 
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8. Do subjects who demonstrate bilateral knee adduction in a DLST have more hip 
internal rotator muscle strength compared to those who do not demonstrate 
bilateral knee adduction? 
9. Do subjects who demonstrate bilateral knee adduction in a DLST have less mean 
gluteus medius EMG activity compared to those who do not demonstrate bilateral 
knee adduction? 
10. Do subjects who demonstrate bilateral knee adduction in a DLST have less mean 
gluteus maximus EMG activity compared to those who do not demonstrate 
bilateral knee adduction? 
11. Do subjects who demonstrate bilateral knee adduction in a DLST have more mean 
adductor complex EMG activity compared to those who do not demonstrate 
bilateral knee adduction? 
 
Research Hypotheses 
1. Subjects who demonstrate bilateral knee adduction in a DLST will have less hip 
abduction ROM compared to those who do not demonstrate bilateral knee 
adduction. 
2. Subjects who demonstrate bilateral knee adduction in a DLST will have less hip 
external rotation ROM compared to those who do not demonstrate bilateral knee 
adduction. 
3. Subjects who demonstrate bilateral knee adduction in a DLST will have less 
straight knee ankle dorsiflexion ROM compared to those who do not demonstrate 
bilateral knee adduction. 
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4. Subjects who demonstrate bilateral knee adduction in a DLST will have less bent 
knee ankle dorsiflexion ROM compared to those who do not demonstrate bilateral 
knee adduction. 
5. Subjects who demonstrate bilateral knee adduction in a DLST will have less 
gluteus medius muscle strength compared to those who do not demonstrate 
bilateral knee adduction. 
6. Subjects who demonstrate bilateral knee adduction in a DLST will have less 
gluteus maximus muscle strength compared to those who do not demonstrate 
bilateral knee adduction. 
7. Subjects who demonstrate bilateral knee adduction in a DLST will have less hip 
external rotator muscle strength compared to those who do not demonstrate 
bilateral knee adduction. 
8. Subjects who demonstrate bilateral knee adduction in a DLST will have more hip 
internal rotator muscle strength compared to those who do not demonstrate 
bilateral knee adduction. 
9. Subjects who demonstrate bilateral knee adduction in a DLST will have less mean 
gluteus medius EMG activity compared to those who do not demonstrate bilateral 
knee adduction. 
10. Subjects who demonstrate bilateral knee adduction in a DLST will have less mean 
gluteus maximus EMG activity compared to those who do not demonstrate 
bilateral knee adduction. 
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11. Subjects who demonstrate bilateral knee adduction in a DLST will have more 
mean adductor complex EMG activity compared to those who do not demonstrate 
bilateral knee adduction. 
 
Null Hypotheses 
1. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in hip abduction ROM compared to those who do not demonstrate 
bilateral knee adduction. 
2. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in hip external rotation ROM compared to those who do not 
demonstrate bilateral knee adduction. 
3. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in straight knee ankle dorsiflexion ROM compared to those who do not 
demonstrate bilateral knee adduction. 
4. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in bent knee ankle dorsiflexion ROM compared to those who do not 
demonstrate bilateral knee adduction. 
5. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in gluteus medius muscle strength compared to those who do not 
demonstrate bilateral knee adduction. 
6. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in gluteus maximus muscle strength compared to those who do not 
demonstrate bilateral knee adduction. 
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7. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in hip external rotator muscle strength compared to those who do not 
demonstrate bilateral knee adduction. 
8. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in hip internal rotator muscle strength compared to those who do not 
demonstrate bilateral knee adduction. 
9. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in mean gluteus medius EMG activity compared to those who do not 
demonstrate bilateral knee adduction. 
10. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in mean gluteus maximus EMG activity compared to those who do not 
demonstrate bilateral knee adduction. 
11. Subjects who demonstrate bilateral knee adduction in a DLST will have no 
difference in mean adductor complex EMG activity compared to those who do not 
demonstrate bilateral knee adduction. 
Variables 
Independent Variable:  
1.  Group:  Subjects will be placed into one of two groups based on their knee motion 
in an OHST   
a). Ankle Dysfunction Group: Demonstrates bilateral knee adduction 
in DLST that is corrected by placing a two-inch heel block under the 
calcaneous. 
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b). Control Group: Does not demonstrate bilateral knee adduction in 
DLST with or without 2-inch heel block. 
Dependent Variables:  
2. Flexibility as measured in degrees by a manual goniometer will be measured for 
the following muscles and ROMs: 
a. Adductor Complex 
b. Hip IR 
c. Gastrocnemius 
d. Soleus 
3. Concentric and eccentric strength as measured in Newton-meters (N*m) by an 
isokinetic dynamometer for the following movements: 
a.  Hip Abduction 
b. Hip Extension 
c. Hip External Rotation 
d. Hip Internal Rotation 
4. Mean amplitude EMG activity during a DLST for the following muscles: 
a. Gluteus Medius 
b. Gluteus Maximus 
c. Adductor Complex 
 
Definition of Terms 
1.   Reciprocal Inhibition – The process whereby a tight or overactive agonist inhibits 
its functional antagonist. 
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2.   Flexibility – As measured by a goniometer in degrees. 
3. Strength – As measured by an isokinetic dynamometer in Newton meters (N*m). 
4. Electromyography (EMG) – A measure of the neuromuscular action potential of a 
muscle; typically measured as peak, average onset time, and mean amplitude. 
5. Isokinetic Testing – A measure of muscle contraction in which the length of the 
muscle is changing while the contraction velocity remains constant. 
 
Operational Definitions 
 
1. Double-Legged Squat Test (DLST) – Subject stands with feet shoulder width 
apart, feet facing forward, and hands raised above head. Subject then proceeds to 
squat down as if trying to sit in a chair. 
2. Knee Adduction -  The subject’s knees will be such that the center of their patella 
is medial to the ipsilateral medial maleolus when they are in a squatted position. 
3. Knee Valgus – Adduction and internal rotation of the femur on the tibia. 
4. EMG –  
a. Peak: The highest magnitude of EMG activity during a dynamic 
maneuver. 
b. Mean Amplitude: The average magnitude of EMG activity for a given 
time interval. 
c. Onset Time: Point in time when EMG amplitude reaches a predetermined 
magnitude. 
5. Torque – 
a. Peak: The greatest moment produced at one point in a range of motion. 
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b. Mean: The average moment produced throughout a range of motion. 
6. Adductor Complex – Adductor magnus, adductor longus, and adductor brevis 
 
Assumptions 
1.  Subjects will be truthful in the consent form about previous and current injury 
status. 
 2.  Subjects will provide maximum effort in performing strength assessments. 
 3.  Tester is reliable in obtaining accurate measurements of strength and flexibility. 
 4.  EMG was collected without noise affecting the signal. 
 5.  Tester will provide each subject with exact same instructions prior to testing. 
 
Limitations 
1.  EMG may measure different portions of muscles due to skin movement during the 
DLST. 
2.  Subjects’ previous experience with squatting exercises could affect their form in a 
squatting activity. 
 
Delimitations 
 
1.  Subjects in both groups will be asymptomatic with and without activity and during 
the DLST 
2. Subjects in the hip dysfunction group will demonstrate bilateral knee adduction in 
the DLST with and without a 2-inch heel block. 
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3. Subjects in the control group will not demonstrate bilateral knee adduction in the 
DLST with or without the 2-inch heel block. 
4. Subjects in both groups will have no previous history of surgery in either lower 
extremity. 
5. Subjects in control group will be matched to subjects in hip dysfunction group 
based on height, weight, age, gender, and physical activity level. 
 
Significance of Study 
 
 The significance of this study is to ascertain what factors lead to knee valgus during a 
closed chain flexed knee position.  If these factors can be determined, then an intervention 
protocol can be established to correct them.  This correction could then be studied further to 
examine its impact on decreasing knee injuries thought to be caused by this valgus position
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CHAPTER 2 – REVIEW OF THE LITERATURE 
 
Introduction 
 
 Preseason screenings are used by sports medicine professionals to gain knowledge 
about the health of their athletes.  These baseline tests are used for documentation, 
assessment, and prediction of performance.(Crill, Kolba et al. 2004)  It is believed that 
findings such as muscular imbalances and postural faults, both static and dynamic, can help 
predict not only performance but also risk of injury.  Injury has been thought to be due to two 
different factors, both extrinsic and intrinsic.  Extrinsic factors are those thought to be 
environment related such as weather, playing surfaces, ect., while intrinsic are those that are 
related to the individual person.(Taimela, Kujala et al. 1990; van Mechelen, Hlobil et al. 
1992; Inklaar 1994)  Intrinsic factors can be the neuromuscular control and postural 
imbalances that are sought out during preseason screenings.  It is thought that since these 
factors are related to the athlete, then they can be altered through corrective exercise. 
 Injuries are inherent in sport.  Some injuries, such as contact related traumatic 
injuries, are difficult, sometimes impossible, to prevent.  Other injuries, such as muscular 
strain injuries are considered to be preventable with proper training.  It is these preventable 
injuries that are of utmost importance to study.  If it can be determined why or how muscular 
strain injuries occur then, theoretically, they can be prevented.  The most widely believed 
cause of these injuries is muscular tightness.
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(van Mechelen, Hlobil et al. 1992; Garrett 1996; Gleim and McHugh 1997)  It is also 
believed that muscular tightness can lead to injuries as well, such as sprains and overuse 
injuries.(Worrell 1994; Krivickas 1997)  
Before examining the concept of tightness in a muscle, there are two important terms 
that must first be defined.  These are flexibility and stiffness.  Muscular flexibility has most 
simply been defined as the angle beyond which no further displacement is 
possible.(Riemann, DeMont et al. 2001)  Muscular stiffness represents the amount of 
deformation proportional to the load applied. (Blackburn, Padua et al. 2004)  It is important 
to keep in mind that although these two concepts are related when assessing muscular length, 
they are two different characteristics of muscle. 
Knee valgus occurs when there is a simultaneous internal rotation and adduction of 
the femur on the tibia.  While these are normal biomechanical motions, this valgus position 
has been theorized to be a mechanism of injury for the ACL and MCL when the ROM 
becomes extreme. (Bendjaballah, Shirazi-Adl et al. 1997; Ireland 1999; Boden, Dean et al. 
2000)  The knee joint ligaments are designed to provide support to the joint; however, knee 
joint stability is not solely dependent upon these ligaments.  As soon as the weight-bearing 
knee is flexed surrounding musculature is activated to increase joint stability.(Rosse 1997)  
This surrounding musculature involves muscles that cross the knee joint as well as the hip 
joint.  If these muscles cannot effectively increase the joint stability, then the risk of injury to 
the knee joint increases.  Unfortunately, little research exists to explain the role this 
musculature has in either leading to, or preventing, injury. 
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Muscular Tightness – Anatomy 
Adductor Complex 
 
 When examining the movement of hip adduction, there are five muscles that are 
typically grouped into the hip adductors.  These muscles are the pectineus, adductor longus, 
adductor brevis, adductor magnus, and the gracilis.  However, when referring to the adductor 
complex, the most commonly though of muscles are the adductor longus, brevis, and 
magnus.  Although all of these muscles can contribute to hip flexion and internal rotation, 
together their primary role is hip adduction.  Investigation of these muscles and their role in 
muscular injuries in athletes is limited and inconclusive.  A study done by Witvrouw et al 
showed that there was no significant difference between the adduction flexibility of soccer 
players who sustained adductor muscle strains as compared to non-injured players. 
(Witvrouw, Danneels et al. 2003)  Another study on professional ice hockey players found no 
significant difference in adductor flexibility between players sustaining adductor injuries and 
players who did not. (Tyler, Nicholas et al. 2001)  In contrast, Ekstrand and Gillquist found a 
correlation between tightness of the adductor muscles and the presence of adductor muscle 
strains in their prospective study of male soccer players. (Ekstrand and Gillquist 1983)    It is 
important to note that in the study done by Witvrouw et al, players studied as a whole did not 
suffer many adductor injuries.  Thus, their study did not have very much statistical power in 
regards to adductor muscle involvement in developing muscular injury.  Further attention 
should be devoted towards resolving this conflict, because the current literature has yet to 
sufficiently explain the hip adductors role in muscular injury. 
 The pectineus muscle lies just medial to the iliopsoas and forms the medial part of the 
floor of the femoral triangle.  It originates from the pectin of the pubis and the bone anterior 
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to the pectin, and inserts on the pectineal line, the proximal extension of the linea aspera, of 
the femur (Rosse 1997).  The pectineus receives its vascular supply from the medial femoral 
circumflex artery and obturator artery, and it is innervated by the femoral nerve (Rosse 
1997). 
 The adductor longus is the most anterior member of the adductor group.  It originates 
from the superior pubic ramus and inserts into the medial lip of the linea aspera on the femur 
(Rosse 1997).  The adductor longus receives its vascular supply from the medial femoral 
circumflex and obturator arteries, and it is innervated by the anterior division of the obturator 
nerve (Rosse 1997). 
 The adductor brevis is deep to the pectineus and adductor longus.  It originates from 
the inferior pubic ramus and inserts into the medial lip of the linea aspera, superior to the 
adductor longus, on the femur (Rosse 1997).  The adductor brevis receives its vascular 
supply from the medial femoral circumflex and obturator arteries, and it is innervated by the 
anterior division of the obturator nerve (Rosse 1997). 
 The adductor magnus is a combination of two muscles with different innervations.  
Both parts originate from the inferior pubic ramus, the ischiopubic ramus, and the ischial 
tuberosity.  However, the adductor head inserts into the medial lip of the linea aspera on the 
femur and has horizontal fibers.  The ischiocondylar head inserts on the adductor tubercule of 
the femur (Rosse 1997).  The adductor head is innervated by the posterior division of the 
obturator nerve; while, the ischiocondylar head is innervated by the tibial nerve.  Both 
portions receive their vascular supply from the deep femoral, medial femoral circumflex, and 
obturator arteries (Rosse 1997). 
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 The gracilis is a long slender muscle lying superficially along the medial side of the 
thigh.  It originates from the inferior pubic ramus and the pubic symphysis, and it inserts on 
the anteromedial part of the medial tibial condyle, via the pes anserine insertion (Rosse 
1997).  The gracilis receives its vascular supply from the medial femoral circumflex and 
obturator arteries, and it is innervated by the anterior division of the obturator nerve (Rosse 
1997). 
 
Gastrocnemius/Soleus Complex 
 The gastrocnemius is the superficial muscle of the triceps surae.  It has two heads, 
meadial and lateral, that originate just superior to the medial and lateral femoral condyles 
respectively.  It receives its vascular supply from the posterior tibial and sural arteries and is 
innervated by the tibial nerve (Rosse 1997).  The soleus is the deep muscle of the triceps 
surae.  It originates from the upper part of the fibula and the soleal line on the tibia.  The 
soleus receives its vascular supply from the posterior tibial artery (Rosse 1997).  Both the 
gastrocnemius and soleus insert together into the calcaneus via the Achilles tendon (Rosse 
1997). 
 
Muscular Tightness – Assessment 
 
 Since it is widely thought that muscular tightness is a factor for muscular injury, it 
becomes important to have a way to quantify the flexibility of a muscle.  Manual 
goniometers commonly regarded as the easiest and are the most widely used devices to 
measure range of motion in a joint. (Gajdosik and Bohannon 1987)  However, they have their 
limitations.  They have a single hinge and lack the ability to accurately measure movements 
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made by more than one joint.  Furthermore, if proper anatomical landmarks are not 
established and adhered to for the measurement, then the measurement itself would be 
useless to a clinician.   Despite these limitations though, they seem to be the preferred 
method of ROM testing.  This ROM assessment is used by most studies to make inferences 
about muscle length and tightness.(Tyler, Nicholas et al. 2001; Witvrouw, Danneels et al. 
2003; Decoster, Scanlon et al. 2004) 
 
Hip Abduction 
 
 The proper patient positioning for ROM measurement for hip abduction is supine.  
The fulcrum of the goniometer is placed over the anterior superior iliac spine (ASIS) of the 
extremity being measured.  The stationary arm is placed along an imaginary line from one 
ASIS to the other.  The movement arm is placed along the anterior midline of the femur 
using the midline of the patella for reference.(Norkin 1995) 
 
Hip Internal Rotation 
 
The proper patient positioning for ROM measurement for hip internal rotation is 
seated with knees flexed to 90 degrees over the edge of the surface.  The hip is in neutral 
abduction as well as adduction and is flexed to 90 degrees.  A towel roll may be placed under 
the distal end if necessary to maintain the femur in a horizontal plane.  The fulcrum of the 
goniometer is over the anterior center aspect of the patella.  The stationary arm is positioned 
perpendicular to the floor.  The movement arm is placed along the anterior midline of the 
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tibia pointing towards the anterior midpoint of the ankle between the two melleoli.(Norkin 
1995) 
 
Ankle Dorsiflexion 
The proper patient positioning for ROM measurement of straight knee dorsiflexion 
was supine with the dominant knee in full extenion.  The ankle is in neutral 
inversion/eversion.  The axis of the goniometer is the distal lateral maleolus.  The stationary 
arm is positioned with the lateral midline of the fibula, using the fibular head for reference.  
The movement arm is placed parallel to the lateral aspect of the fifth metatarsal (Norkin 
1995).  
The proper patient positioning for ROM measurement of bent knee dorsiflexion is the 
same as straight knee; however, a bolster is placed under the subject’s dominant knee so that 
it is flexed to at least 30 degrees (Norkin 1995). 
 
Muscular Strength – Anatomy 
 
 Muscular strength is another intrinsic factor believed to be associated with muscular 
injury. (Knapik, Bauman et al. 1991; Tyler, Nicholas et al. 2001)  If a muscle has inadequate 
strength then it may break down due to the physical demands placed upon it during 
functional activities.  Unfortunately, the literature fails to fully outline how muscular strength 
pertains to injury. 
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Gluteus Medius 
 
 The gluteus medius muscle originates on the lateral aspect of the ilium between the 
anterior and posterior gluteal lines, and it inserts on the greater trochanter of the femur.  It 
receives its vascular supply from the superior gluteal artery and is innervated by the superior 
gluteal nerve (Rosse 1997).  The main action of this muscle is hip abduction and internal 
rotation of the hip, although it functions effectively as a pelvic stabilizer during standing and 
as a pelvic rotator during gait. (Gottschalk, Kourosh et al. 1989; Earl 2005)  The fibers of the 
gluteus medius muscle are arranged in such a fashion as to suggest it is capable of 
performing many functions in many different positions of hip flexion and extension.  The 
muscle itself has been looked at in the past as having three separate sections divided into 
anterior, middle, and posterior portions.(Gottschalk, Kourosh et al. 1989; Schmitz, Riemann 
et al. 2002)  The anterior and middle portions have been shown to be most active during hip 
abduction and internal rotation, while the posterior portion is most active in pulling the 
femoral head into the acetabulum and stabilizing the hip joint.(Earl 2005)  Soderberg and 
Dostal examined the gluteus medius muscle’s EMG activity during a variety of function 
tasks.  They found that the three portions each had the highest amount of activity in 
movements that required maximum control of the femur.(Soderberg and Dostal 1978)  This 
would suggest that the gluteus medius muscle plays an important role in controlling the 
femur in multiple planes during functional activities. 
The common injury of concern when talking about gluteus medius weakness and poor 
control at the hip is the anterior cruciate ligament (ACL). (Zeller, McCrory et al. 2003)  It has 
been reported that this lack of proper hip control leads to increased hip adduction when the 
hip is loaded.  This increase in adduction causes the femur to internally rotate and provide a 
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valgus stress to the knee. (Zeller, McCrory et al. 2003)  This is considered a deleterious 
position for the knee to be in and may predispose the ACL to injury.(Beutler, L.W. et al. 
2002; Mattacola, Perrin et al. 2002; Zeller, McCrory et al. 2003)  While the function of this 
muscle has been studied quite thoroughly during many functional tasks, such as single leg 
stance, closed-chain hip rotation, and single leg squat, the step has not yet been taken to fully 
understand what effects it has on injury. (Schmitz, Riemann et al. 2002; Zeller, McCrory et 
al. 2003; Earl 2005)  
 
Gluteus Maximus 
The gluteus maximus muscle originates from the posterior gluteal line of the ilium, 
the lateral sacrum and coccyx, and the sacrotuberous ligatment, and it inserts into the 
iliotibial tract and the gluteal tuberosity of the femur.  It receives its vascular supply from the 
inferior gluteal artery and is innervated by the inferior gluteal nerve (Rosse 1997).  This 
muscle is the prime hip extensor and is also involved in hip external rotation. 
The external rotation moment arm of the gluteus maximus has been shown to 
decrease as the hip moves into flexion.  Although the external rotation moment arm of the 
posterior fibers has been shown to remain even with a flexed hip.(Delp, Hess et al. 1999)  
This suggests that the gluteus maximus can be used to help control femoral internal rotation 
even when the hip if flexed.  Moreover, it has been speculated that increasing strength and 
neuromuscular control of the gluteus maximus can help correct excessive femoral internal 
rotation in individuals that are believed to be at a higher risk of knee injury due to increased 
knee valgus in a position of hip and knee flexion.(Delp, Hess et al. 1999) 
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As stated before, this muscle is also believed to work in conjunction with the 
latissimus dorsi to aid in stabilization of the sacroiliac joint. (Clark 2001)  Recently though, it 
has been theorized that its function as an external rotator plays a significant role in 
controlling functional movements.  It is thought that it plays an important role in 
eccentrically controlling excess femoral internal rotation and avoiding the dangerous knee 
position previously outlined. (Clark 2001)  However, its function in this capacity has 
currently not been researched enough to fully understand. 
 
Muscular Strength – Assessment 
Much like muscular length testing, a clinician must be able to assess and quantify 
muscular strength.  Dynamometers make it possible to evaluate maximal muscular 
performance clinically.  The many measurement methods that can be utilized include static, 
isokinetic, and, more recently, isotonic, isoinertial, and isoaccelerative. (Nadeau, Gravel et al. 
1996)  Each method controls one mechanical variable (angle, velocity, load inertia, or 
acceleration) and measures changes in some of the remaining variables.  Static testing is 
generally considered the easiest way to test muscular strengths at certain positions in the 
joint’s range of motion.  While isokinetic testing is commonly considered the more popular 
method of quantifying dynamic muscular strength. (Osternig 1986; Cabri 1991) 
 
Gluteus Medius 
The proper positioning for the gluteus medius to be strength tested is to have the 
patient side-lying with the test leg being the uppermost.  The patient starts with the test limb 
slightly extended beyond the midline and the pelvis rotated slightly forwards.  The lowermost 
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knee is flexed for stability.  The tester stands behind the patient.  One hand is used to palpate 
the gluteus medius just proximal to the greater trochanter of the femur.  The hand providing 
resistance is placed on the lateral surface of the knee joint.  Resistance is given in a straight 
downward direction.  The patient abducts the hip through the full range of motion without 
flexing the hip or rotating it in either direction. (Kendall 1993; Hislop 2002) 
 
Gluteus Maximus 
The proper positioning for the gluteus maximus to be strength tested is to have the 
patient supine with knee flexed to ninety degrees.  The tester stands at the side to be tested at 
the level of the pelvis.  One hand is place over the sacrum to stabilize the alignment of the 
pelvis.  The hand providing resistance is placed over the posterior thigh just above the knee.  
Resistance is provided in a straight downward manner.  The patient extends the hip through 
the full available range of motion while maintaining knee flexion. (Kendall 1993; Hislop 
2002) 
 
Proper Double-Legged Squat Technique 
The National Strength and Conditioning Association (NSCA) has outlined the proper 
body mechanics for a squat.  The subject is to hold the chest up and out while pulling the 
scapulae towards each other.  The head is tilted slightly upward.  The feet are positioned 
should-width apart, even with each other, with the toes pointed straight ahead or just slightly 
outward (externally rotated).  The subject allows the hips and knees to slowly flex while 
keeping the torso-to-floor angle relatively constant during the downward movement phase.  
The heels of the feet are to remain on the floor and the knees stay aligned over the feet.  The 
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torso is not to be flexed forward or the low back rounded.  The subjects continues the 
simultaneous hip and knee flexion until the thighs are parallel to the floor.(Baechle 2000) 
 
Isokinetic Testing 
Isokinetic testing is a form of strength testing that offers an objective measure of 
muscular strength.  Isokinetic machines allow the subject to offer a maximal contraction 
force throughout a range of motion at a predetermined angular velocity.  The objective 
measures that can be obtained from an isokinetic machine are muscular strength 
isometrically, concentrically, and eccentrically.(Arnheim 2000) 
 Strength measurement on isokinetic devices are measured in torque or moment.  
Torque is measured in foot-pounds or Newton-meters.  Peak torque is the maximum moment 
recorded in the range of motion.  Average torque is the mean torque produced by the muscle 
throughout the entire range of motion.  Subjects who differ in body size make it difficult to 
compare isokinetic data in Newton-meters.  This difficulty is avoided by dividing the torque 
measurements by the subject’s body weight. 
 Different hip motion isokinetic testing positions currently exist.  Some studies have 
suggested that hip abductor/adductor strength testing should be done in the side-lying 
position with the hip extended, and hip external rotation should be tested with the subject 
supine.(Burnett, Betts et al. 1990)  Kincom (Chattanooga Group Inc.) recommends in their 
clinical desk reference that hip flexion/extension be tested in a standing position, hip 
abduction/adduction be tested in a supine position, and hip external/internal rotation be tested 
in a seated position. 
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Electromyography (EMG) 
 In their resting state, all body cells exhibit a resting membrane potential.  This 
potential typically ranges from –20 to –200 millivolts (mV).(Marieb 1999)  This potential 
can be characterized as the relative charge between the inside and outside of the cell and is 
negative because the inside of the cell is negative as compared to the outside.(Marieb 1999) 
 When a muscle fiber is activated by a motor neuron, and electrical impulse is 
conducted along the length of the its axon.  This response is call and action potential.  This 
potential is always the same, regardless of the source or type of stimulus.(Marieb 1999)  
Muscles respond to these action potential by forming stable bonds between contractile 
myofibrils and creating force.(Marieb 1999) 
 Surface EMG uses electrodes placed on the skin to detect these action potentials.  
Typically, two electrodes are place in a parallel over the muscle 2-4 cm apart.  The 
extracellular charge is positive before muscular contraction.  As the muscle fibers depolarize 
under the first electrode, the action potential under that electrode becomes negative with 
respect to the second electrode.  The EMG system can measure this difference between the 
electrodes. 
 One problem with EMG measurements is that they can vary greatly between subjects.  
This makes it difficult to compare the raw date between different subjects.  A reference 
standard must first be defined before data can be interpreted across different subjects.  This 
process is known as normalization.  A common way to normalize EMG data across different 
subjects is through a measurement of maximal voluntary isometric contraction (MVIC).  The 
EMG data is expressed as a percentage of the MVIC.  
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CHAPTER 3 - METHODS 
 
Subjects 
Approximately 70 subjects were screened by the principal investigator by watching 
them perform a double leg squat.  Those subjects that were observed to exhibit a valgus 
motion during the squat were then observed with a two-inch heel block underneath their 
calcaneus.  These subjects were recruited through volunteers from emails, fliers, and personal 
recruiting in classes.  Subjects were divided into two groups based upon their results on the 
double leg squat task (DLST).  The valgus group consisted of subjects who demonstrated 
bilateral knee adduction during the DLST that was corrected by placing a two-inch heel 
block under their calcaneus.  The control group consisted of subjects who did not 
demonstrate knee adduction on either leg during the DLST.  Subjects in the control group 
were matched to subjects in the hip dysfunction group by age, height, and weight.  The 
control group consisted of 17 subjects while the valgus group consisted of 14 subjects whose 
ages ranged from 18-26 years.  Subject demographics are located in Table 1.  Subjects were 
otherwise healthy individuals that had no current musculoskeletal injuries or had not 
sustained an injury to either lower extremity in the past six months.  Subjects were also 
excluded if they had surgery to either lower extremity in the past year.  Furthermore, subjects 
in both groups were asymptomatic with and without activity, and subjects were 
asymptomatic during the DLST.  Prior to all testing all subjects read and signed an informed 
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consent form approved by a University of North Carolina at Chapel Hill Biomedical 
Institutional Review Board (IRB). 
 
Measurement and Instrumentation 
A manual goniometer was used to measure joint angles in degrees for ROM 
assessment of the muscles of interest.  Flexibility measurements were taken for the hip 
adductors (ICC(2,1) .89 SEM = 1.743), the hip internal rotators (ICC(2,1) .97 SEM  2.625), 
gastrocnemius, and soleus.  ICCs were not calculated for these final two range of motion 
measures. 
Concentric and eccentric muscle strength was evaluated using a Biodex System 3 Pro 
isokinetic dynamometer (Biodex Medical Systems, Shirley, NY), measured in Foot-pounds 
(Ft*lbs) of torque.  The data were then analyzed with a customized Matlab 7.0 program (The 
Mathworks, Inc., Natick, MA) to determine the average peak torque, as well as time to peak 
torque, for the hip external rotators, internal rotators, hip abductors, and hip extensors.  Each 
average was measured over the middle three of five total trials.   
The mean amplitude electromyographic (EMG) activity of the gluteus medius, gluteus 
maximus, and adductor group was measured using an eight channel DelSys Bagnoli EMG 
System (Boston, MA).  DE-2.1 single differential surface electrodes (DelSys Boston, MA) 
with a contact dimension of 1.0cm x 0.1cm and a contact spacing of 1.0cm over the muscle 
bellies and parallel to the fibers of the gluteus medius, gluteus maximus, and adductor 
muscles.  Electrodes were plugged into a belt mounted I/O unit that plugged into the DelSys 
Bagnoli EMG system.  This system amplified (x10,000 Hz) the EMG signal as it passed into 
the computer and was stored for analysis.  The EMG data were processed with passive 
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demeaning (0.0 ms begin/ 10.0 ms end), a Butterworth notch filter at 60.0 Hz, a band pass 
Butterworth filter from 10.0 Hz – 350 Hz, and finally RMS smoothing was used at a time 
constant of 25 msec.  All EMG data were normalized to the percentage of maximum 
voluntary isometric contraction to allow for comparison between subjects.  All EMG data 
collection and processing was done using Datapac2K2 (Run Technologies, Mission Viejo, 
CA). 
An electro-goniometer was placed over the knee joint so that knee joint ankle could be 
recorded and related to EMG activity during the DLST.  Electro-goniometer data were 
filtered with a low pass Butterworth at 15.0 Hz. 
A tripod was used to standardize squat depth; as well as a metronome to standardize 
squat speed at 66 beats per minute.  Subjects used two beats to descend, two beats to ascend 
and one beat to rest between squats. 
 
Procedures 
 Students and faculty of the University of North Carolina at Chapel Hill were asked 
through email and fliers to volunteer for screening for this study.  Screening consisted of a 
questionnaire pertaining to previous history of injury or surgery to the lower extremity.  Each 
subject completed their individual testing in one session.  Prior to testing, subjects had the 
testing procedures explained to them and were asked to read and sign an informed consent 
form.  Each testing session began with the recording of the subject’s gender, age (years), 
height (cm), and weight (kg).  Subjects were then video taped performing the DLST both 
with and without a two-inch heel block to ensure that they met the inclusion criteria for their 
assigned group.  The tester then assessed the subject’s dominant leg, defined as the leg they 
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would use to kick a soccer ball for maximum distance, for the following variables: the 
subject’s passive hip abduction ROM; passive external rotation ROM; passive straight knee 
ankle dorsiflexion ROM; passive bent knee dorsiflexion ROM; Concentric/eccentric 
isokinetic strength for hip external and internal rotation, hip abduction, and hip extension; 
and EMG activity during a DLST in the gluteus medius, gluteus maximus, and adductor 
complex.  The valgus group also had EMG recorded for a DLST while standing on a two-
inch heel block.  Prior to testing subjects were allowed to warm up for five minutes on a 
stationary bike at a self-determined pace.   
 
ROM measurements 
Subject positioning for ROM measurement of hip abduction was supine.  The axis of 
the goniometer was placed over the ASIS of the extremity being measured.  The stationary 
arm was placed along an imaginary line from one ASIS to the other.  The movement arm was 
placed along the anterior midline of the femur using the midline of the patella for reference.  
The subject was then passively abducted until the tester felt the contralateral ASIS begin to 
move (Norkin 1995)  Three separate measurements were taken and the mean was recorded. 
Subject positioning for ROM measurement for hip internal rotation was supine with 
the dominant hip and knee flexed to 90 degrees.  The hip was in neutral abduction/adduction.  
The axis of the goniometer was the anterior center aspect of the patella.  The stationary arm 
was positioned parallel to the table.  The movement arm was placed along the anterior 
midline of the tibia pointing towards the anterior midpoint of the ankle between the two 
melleoli.(Norkin 1995)  The subject’s hip was passively externally rotated until the tester felt 
the end range. Three separate measurements were taken and the mean was recorded.  
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Subject positioning for ROM measurement of straight knee dorsiflexion was supine 
with the dominant knee in full extenion.  The ankle was in neutral inversion/eversion.  The 
axis of the goniometer was distal lateral maleolus.  The stationary arm was positioned with 
the lateral midline of the fibula, using the fibular head for reference.  The movement arm was 
placed parallel to the lateral aspect of the fifth metatarsal (Norkin 1995).  The subject’s ankle 
was then passively dorsiflexed until the tester felt the end range.  Three separate 
measurements were taken and the mean was recorded. 
Subject positioning for ROM measurement of bent knee dorsiflexion was the same as 
straight knee; however, a bolster was placed under the subject’s dominant knee so that it was 
flexed to at least 30 degrees(Norkin 1995).  The subject’s ankle was then passively 
dorsiflexed until the tester felt the end range.  Three separate measurements were taken and 
the mean was recorded. 
 
Electromyography 
 
The sites for electrode placement were shaven and cleansed with alcohol to improve 
signal transmission from the muscles.  Electrodes were placed over the muscle bellies of the 
gluteus medius, gluteus maximus, and adductor complex.  A reference electrode was placed 
on the tibial tuberosity.  Electrodes were placed in a parallel to muscle fibers. 
The electrodes for the gluteus medius were placed halfway between the iliac crest and 
the greater trochanter of the femur (Kleissen 1990).  The electrodes for the gluteus maximus 
were placed 20% of the distance between the spinous process of S2 and a point 10 cm distal 
to the greater trochanter.  The electrodes for the adductor complex were placed on the muscle 
belly at the mid point of the femur (Leveau 1992).  All electrode placements were confirmed 
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with an isometric manual muscle test and checked for cross talk.  Maximal voluntary 
isometric contraction (MVIC) was used to normalize muscle activity between subjects (% 
MVIC). 
 
Strength Measurements 
 Reliability for all strength tests was demonstrated by Halverson and Hawkey, abstract 
published in Journal of Athletic Training supplement 2004. 
The hip external rotators were tested in a seated position.  The subject’s hip and knee 
was flexed to 90 degrees.  The dynamometer was aligned with the long axis of the femur.  
Pressure was applied to the medial aspect of the distal tibia.  The thigh was stabilized to the 
chair using straps.  A towel was also placed between the subjects’ knees to act as a fulcrum 
for external rotation and prevent adduction.  The external rotators were tested through twenty 
degrees of motion that began at five degrees of external rotation and ended at fifteen degrees 
of internal rotation. 
The hip internal rotators were tested in a seated position.  The subject’s hip and knee 
were flexed to 90 degrees.  The dynamometer was aligned with the long axis of the femur.  
Pressure was applied to the lateral aspect of the distal tibia.  The thigh was stabilized to the 
chair using straps.  The internal rotators were tested through twenty degrees of motion that 
began at five degrees of internal rotation and ended at fifteen degrees of external rotation. 
The hip abductors were tested with the subject in a side-lying position to isolate the 
gluteus medius.  The joint axis was located at 0.5 inches medial to the ASIS at the level of 
the greater trochanter (Lyons, Perry et al. 1983).  The hip was abducted and externally 
rotated, making sure not to let the trunk and pelvis rotate backward.  Pressure was applied 
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against the thigh in the direction of adduction.  Pressure was not applied against the external 
rotation component of the start position (Kendall 1993).  The trunk was stabilized by 
strapping the subject to the chair.  The muscle was tested from 0-20 degrees of hip abduction. 
The hip extensors were tested in a supported, standing position in an attempt to 
isolate the gluteus maximus and maximize stabilization.  The dynamometer axis of rotation 
was aligned with the anterior superior tip of the greater trochanter (Lyons, Perry et al. 1983).  
The subjects stood in front of the Biodex chair, and the seat was raised to the level of the 
subjects’ ASIS.  If the chair was unable to reach the subjects’ ASIS, the subjects were then 
asked to flex the contralateral knee until the chair was even with the level of the ASIS.  The 
subjects flexed their trunk to ninety degrees and laid their chest on the chair.  The trunk was 
stabilized to the Biodex chair prior to testing using straps.  This stabilization was aimed at 
preventing accessory trunk motions that might influence strength testing.  The knee of the 
test leg was flexed to ninety degrees.  The stance leg (non-test leg) was flexed at the knee 
such that the subjects’ chest was comfortably resting on the chair.  The subjects were then 
asked to actively extend the hip through a range of motion that began at ninety degrees of hip 
flexion (femur perpendicular to the groud) and ended at fifty degrees of hip flexion.  Pressure 
was applied against the distal portion of the posterior thigh in the direction of hip flexion 
(Kendall 1993). 
All muscles were tested concentrically and eccentrically at 60 deg * sec-1.  The testing 
procedure accounted for gravity corrections during hip abduction and hip extension testing 
since the test limb was sufficiently close to the horizontal plane.  The test limb did not come 
close enough to the horizontal plane to warrant a gravity correction during the testing of the 
hip external or internal rotators. 
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Following the isokinetic testing of each muscle group, the subject’s strength was 
tested isometrically.  The positioning and alignment of the subjects was exactly the same for 
the isometric testing as it was used during the isokinetic testing.  The test limb was 
positioned in the middle of the isokinetic ROM or neutral position for isometric testing.  The 
test limb was placed at seventy degrees of hip flexion while testing the hip extensors.  The 
test limb was placed at ten degrees of hip abduction while testing the hip abductors.  The test 
limb was placed in a neutral position (zero degrees of abduction/adduction) while testing the 
hip adductors.  Each subject performed three maximal isometric contractions.  The 
contractions were held for five seconds each, and there was 10-12 seconds rest between each 
repetition.  The mean amplitude of the three trials during the middle three seconds of each 
trial was recorded. 
The EMG data for the MVIC of the gluteus maximus was recorded while testing hip 
extension.  The EMG data for the MVIC of the gluteus medius was recorded while testing 
hip abduction.  The EMG data for the MVIC of the adductor complex was recorded while 
still in the testing position for hip abduction.  The subjects were asked to maximally adduct 
the hip against the Biodex dynamometer for five seconds.  EMG from these MVIC’s was 
recorded so that the EMG data recorded during the DLST could be normalized and used to 
compare between subjects. 
 
Double-Legged Squat Task 
Subjects were asked to stand with hips, feet, and knees facing forward and arms fully 
extended overhead parallel to their ears.  The subjects then were instructed to go down into a 
squat position as if they were trying to sit in a chair.  Squat depth was standardized to 70 
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degrees of knee flexion to ensure that each subject went through at least 60 degrees of 
motion.  Subjects were instructed to squat while their knee joint angle was measured with a 
manual goniometer.  When the desired amount of 70 degrees of knee flexion was achieved a 
tripod was set up to assist the subject in knowing the proper squat depth.  An 
electrogoniometer was then placed on the subject’s knee so that EMG data could be 
examined in relation to knee position.  The subjects then performed the squat task five times.  
EMG activity was recorded for the gluteus medius, gluteus maximus, and the adductor 
complex from 0-60 degrees of knee flexion during each of the squat tasks.  Subjects in the 
control group only performed the DLST without the heel block.  Subjects in the valgus group 
performed the DLSQ with and without the heel block while EMG data were recorded. 
 
Data Analysis 
 One way analysis of variance tests were used to analyze differences between groups 
in the ROM measurements.  A 2 x 2 analysis of variance was used to analyze the straight and 
bent knee ankle dorsiflexion ROMs.  2 x 2 mixed model analysis of variance tests were used 
to analyze differences between groups in concentric and eccentric peak torque as well as time 
to peak torque.  EMG data differences were analyzed both between groups and between 
phases within groups with separate 2 x 2 mixed model analyses of variances.  Tukey Post 
Hoc testing was used to identify where significance was found for the ankle dorsiflexion and 
EMG data.  All data were analyzed using SPSS 13.0 (Chicago, IL).  All null hypotheses were 
tested for significance at p < .05. 
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CHAPTER 4 – RESULTS 
 
ROM Measurements 
Means, standard deviations, and effect size for hip abduction ROM are presented in 
Table 2.  There was no significant difference [F(1,29) = 0.01, p = .920] for hip abduction range 
of motion between the control and the valgus groups.  Means, standard deviations, and effect 
size are presented in Table 2. There was no significant difference [F(1,29) = 0.859, p = .362] 
for hip external rotation ROM between the control and the valgus groups.  There was a 
significant group by knee position interaction effect for ankle dorsiflexion [F(1,26) = 17.4 p < 
.001].  Tukey Post Hoc tests revealed that the difference between groups with straight knee 
dorsiflexion was significant.  This difference is illustrated in Figure 1. 
 
Hip External Rotation Concentric/Eccentric Peak Torque 
Means, standard deviations, and effect sizes are presented in Table 3.  There was no 
significant difference for hip external rotation concentric [F(1,29) = 1.309, p = .262] or 
eccentric [F(1,29) = .514, p = .479] peak torque between the control and valgus groups. 
 
Hip Internal Rotation Concentric/Eccentric Peak Torque 
No significant differences were observed for hip internal rotation concentric [F(1,29) = 
0.00, p = .985] or eccentric [F(1,29) = 0.06, p = .808] peak torque between the control and 
valgus groups.  
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Hip Extension Concentric/Eccentric Peak Torque 
There was no significant difference [F(1,29) = 0.046, p = .833] for hip extension 
concentric peak torque between the control and valgus groups.  There was no significant 
difference [F(1,29) = 0.305, p = .585] for hip extension eccentric peak torque between the 
control and valgus groups. 
 
Hip Abduction Concentric/Eccentric Peak Torque 
There was no significant difference [F(1,29) = 3.682, p = .065] for hip abduction 
concentric peak torque between the control and valgus groups.  However, the p value 
suggests a trend and the finding might reach significance if the statistical power was greater.  
This trend is illustrated in Figure 2.  There was no significant difference [F(1,29) = 0.006, p = 
.939] for hip abduction eccentric peak torque between the normal and valgus groups.   
 
Hip External Rotation Concentric/Eccentric Time to Peak Torque 
Means, standard deviations, and effect size are presented in Table 4.  There was no 
significant difference [F(1,29) = 0.376, p = .544] for hip external rotation concentric time to 
peak torque between the control and valgus groups.  There was no significant difference 
[F(1,29) = 0.038, p = .847] for hip external rotation eccentric time to peak torque between the 
control and valgus groups. 
 
Hip Internal Rotation Concentric/Eccentric Time to Peak Torque 
There was a significant difference [F(1,29) = 4.976, p = .034] for hip internal rotation 
concentric time to peak torque between the control and valgus groups.  The normal group 
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achieved peak torque almost a full second faster (2 sec vs. 3 sec) than the valgus group (fig 
3).  There was no significant difference [F(1,29) = 0.023, p = .880] for hip internal rotation 
eccentric time to peak torque between the normal and valgus groups. 
 
Hip Extension Concentric/Eccentric Time to Peak Torque 
There was no significant difference [F(1,29) = 0.456, p = .501] for hip extension 
concentric time to peak torque between the control and valgus groups.  There was no 
significant difference [F(1,29) = 1.235, p = .276] for hip extension eccentric time to peak 
torque between the control and valgus groups. 
 
Hip Abduction Concentric/Eccentric Time to Peak Torque 
There was no significant difference [F(1,29) = 3.218, p = .083] for abduction concentric 
time to peak torque between the control and valgus groups.  However, the p value suggests a 
trend that the valgus group required a half second longer (1.1 sec vs. 1.6 sec) to reach peak 
torque.  This trend is illustrated in Figure 4.  There was no significant difference [F(1,29) = 
1.725, p = .199] for hip abduction rotation eccentric time to peak torque between the normal 
and valgus groups. 
 
Gluteus Maximus EMG Mean Amplitude During a Squatting Task 
Means, standard deviations, and effect size are presented in Table 5.  There was no 
main effect for group [F(1,27) = 0.002, p = .962] for gluteus maximus activity during the 
ascending and descending phases of the squat.  No main effect for phase [F(1,27) = 0.024, p = 
.877] was observed for gluteus maximus activity between the ascending and descending 
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phases of the squat for the control or valgus groups.  There was no group by phase interaction 
effect [F(1,27) = 0.020, p = .888] for gluteus maximus activity during the squat task. 
 
Gluteus Medius EMG Mean Amplitude During a Squatting Task 
There was no main effect for group [F(1,27) = 1.037, p = .318] during the ascending or 
descending phases of the squat between the control or valgus groups.  There was no main 
effect for phase [F(1,27) = 0.101, p = .753] of gluteus medius activity between ascending and 
descending phases of the squat for either group.  No group by phase interaction effect [F(1,27) 
= 0.098, p = .757] was observed for gluteus medius activity during the squat task. 
 
Adductor Mean EMG Amplitude During Squatting 
There was a group by phase interaction [F(1,27) = 6.095, p = .020] for adductor activity 
during the squat task.  The control group had higher mean amplitude during the descending 
portion of the squat and decreased during the ascending phase.  In contrast, the valgus group 
had higher adductor activity during ascending than decending.  Tukey post hoc testing 
revealed that the difference between adductor activity of the control group and the valgus 
group during the ascent phase was significant.  This significance is illustrated in Figure 5.  
No main effect for group [F(1,27) = 0.163, p = .690] was observed for adductor activity during 
the ascending or descending phases of the squat.  There was no main effect for phase [F(1,27) = 
0.196, p = .661] for adductor activity between the ascending and descending phases of the 
squat for either the normal or the valgus group.   
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Gluteus Maximus EMG Mean Amplitude During Squatting with Heel Block 
Means, standard deviations, and effect size for mean gluteus maximus amplitude 
during the squatting task on the heel block are presented in Table 6.  There was no main 
effect for the heel block [F(1,11) = 0.134, p = .721] for gluteus maximus activity during the 
ascending and descending phases of the squat between the valgus group with and without the 
heel block.  There was no main effect for phase [F(1,11) = 1.525, p = .241] for gluteus 
maximus activity between the ascending and descending phases of the squat for the valgus 
group either with or without the heel block.  There was no heel block x phase interaction 
effect [F(1,27) = 1.430, p = .255] for gluteus maximus activity during the squat task. 
 
Gluteus Medius Mean EMG Amplitude During Squatting with a Heel Block 
Means, standard deviations, and effect size for gluteus medius EMG mean amplitude 
during the squatting task on the heel block are presented in Table 6.  No main effect was 
observed for gluteus medius activity [F(1,11) = 0.022, p = .885] during ascending and 
descending phases of a squat between the valgus group with and without the heel block.  
There was no main effect for phase [F(1,11) = 2.034, p = .179] of gluteus medius activity 
between the ascending and descending phases of the squat for the valgus group either with or 
without the heel block.  There was no heel block by phase interaction effect [F(1,11) = 1.955, p 
= .187] for gluteus medius activity during the squat task. 
 
Adductor EMG Mean Amplitude During Squatting with and without a Heel Block 
Means, standard deviations, and effect size for mean adductor amplitude during the 
squatting task on the heel block are presented in Table 6.  There was no main effect for heel 
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block [F(1,11) = 2039, p = .148] for adductor activity during the ascending and descending 
phases of the squat between the valgus group with and without the heel block.  There was a 
main effect for phase [F(1,11) = 10.951, p = .006] of adductor activity between the ascending 
and descending phases of the squat for the valgus group while on the heel block.  Adductor 
activity during the descending phase of the squat was less than the ascending phase.  This 
significance is illustrated in Figure 6.  There was no heel block by phase interaction effect 
[F(1,11) = 1.7, p = .217] for adductor activity during the squat task.  
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CHAPTER 5 – DISCUSSION 
 
The most important findings from this study are that individuals who demonstrated 
knee valgus during a squat and have the valgus position corrected with a two-inch heel block 
have different adductor muscle activity during a squat.  Our results also show these valgus 
individuals have less passive ankle dorsiflexion ROM (with a straight knee) when compared 
to a control group.  Moreover, the passive bent knee ankle dorsiflexion ROM of the valgus 
group was significantly increased over their straight knee ankle dorsiflexion.  The control 
group reached concentric peak torque of the internal rotators quicker than the valgus group.  
Trends in the data suggest that the control group has larger concentric peak torque in the 
abductors and achieve peak torque during concentric abduction faster when compared to the 
valgus group.  
 
Muscle Activity During Squatting 
An analysis of the control group shows that muscle activity during different phases of 
a squat (descending and ascending) is not different.  This means the control group uses hip 
musculature equally.  This is not the case for those who display a valgus motion during a 
squat and the difference seems to be in the adductor complex.  The other two muscles 
examined (gluteus maximus and gluteus medius) showed similar activity patterns when 
compared to the control group.
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A group by phase interaction was demonstrated by the adductor muscle complex 
during the squat task.  When comparing maximal muscle activity, the control group’s 
adductor muscle had the greatest activity during the decent phase while the valgus group was 
most active during the ascent phase (Figure 5).  Thus, subjects performing proper squat 
posture utilized all three muscles simultaneously to eccentrically lower themselves, while the 
valgus group adductor complex was not as active in the eccentric lowering during the descent 
phase.  However, during the ascent phase the control group’s adductors were not as active 
and relied on the gluteus maximus to assist with hip extension.  It is important to note that 
neither the decrease in the adductor activity nor the increase in the gluteus maximus activity 
from the descent phase to the ascent phase in the normal group were deemed significant.  The 
opposite situation was found to exist with the adductor complex of the valgus group.  
Adductor activity during the decent phase was significantly less than adductor activity during 
the ascent phase.  Furthermore, their adductor activity during the ascent phase was 
significantly greater than that of the normal group during the same phase.   
Subjects in the valgus group in this study had their valgus corrected when squatting 
on a two-inch heel block.  Current theory (Clark 2001) suggests valgus may result from tight 
musculature of the ankle rather than weak hip musculature.  The heel block allows for 
increased length of the gastrocnemius and soleus complex, allowing normal motion and 
correcting valgus.  Further research needs to identify individuals that present with valgus that 
is not corrected by a heel block and validate that hip musculature is the issue and what role it 
may play in knee valgus. 
 Increased adductor activity in the valgus group during the ascent phase of a squat 
could be explained an improved length-tension relationship of the muscle group due to 
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increased hip flexion.  One study examined moment arms of hip extensor muscles (gluteus 
maximus and adductor magnus) and found that the gluteus maximus moment arm decreased 
while the adductor magnus moment arm increased while the hip was flexed.  The adductor 
magnus extension moment arm was shown to continue to increase until 75 degrees of hip 
flexion (Nemeth and Ohlsen 1985).  Furthermore, it has been shown that women demonstrate 
significantly more hip flexion and adduction during single-legged squats (Zeller, McCrory et 
al. 2003).  While our study examines double-legged squats, this is still relevant because 
valgus was part of our inclusion criteria and a majority of our valgus subjects were women.  
Females are being put into a position of hip flexion and adduction that may increase their 
adductor muscle activity during the ascent phase.   While in the control group the gluteus 
maximus increases during the ascent phase, it actually slightly decreases in the ascent phase 
for the valgus group.  This may be explained by the increase in hip adduction decreasing the 
gluteus maximus’ ability to function as an extensor.  This position of knee adduction is 
associated with femoral internal rotation (Ireland 1999).  During the ascent phase the gluteus 
maximus may be functioning more in its role as a hip external rotator to compensate for 
femoral internal rotation.  If this is the case, then it makes sense that the adductor activity 
increases as they function more in extension.  However, the changes in gluteus maximus 
muscle activity in our study were not found to be significant.  Moreover, we did not measure 
hip flexion angles in our subjects.  Therefore this theory needs to be explained further 
through future research. 
 A final possible explanation of the difference seen between our groups in adductor 
muscle activity arises from stance width.  Research suggests stance width has a significant 
effect on adductor longus muscle activity during a squat task (McCaw and Melrose 1999).  
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Stance width was not measured in this study but we used a self-selected stance width set at 
shoulder width apart and researcher verified.  We think this minimizes any effect stance 
width may have on our data. 
 There were no significant differences found in any of the muscles tested in the valgus 
group between the regular squat and the squat on the heel block, except for the significant 
difference in adductor activity between phases that had already been discussed in comparison 
to the control group.  This is the first study to examine how hip muscle activity changes when 
individuals with knee valgus squat on a two-inch heel block.  More research needs to be done 
to fully understand how plantar flexing the ankle by placing and individual on a two-inch 
heel block affects squatting 
 The lack of significance in the muscle activity between the valgus group with and 
without the heel block begins to outline three populations.  These populations are a normal or 
control group, an ankle dysfunction group and a hip dysfunction group.  The control group 
demonstrates a proper squat technique and keeps their knees centered over their toes (Clark 
2001).  The ankle dysfunction group is the group examined in our study and demonstrates 
knee valgus during a squat that is corrected by placing a two inch block under their heel.  The 
hip dysfunction group consists of individuals who demonstrate knee valgus during a squat 
that is not corrected by the heel block.  Currently no study has focused on the hip dysfunction 
group to verify current theory as to what is causing their knee valgus.   
 
Straight and Bent Knee Ankle Dorsiflexion ROM 
Another significant finding of this study was the difference of the straight knee ankle 
dorsiflexion ROM between the valgus group and control group and the difference of the 
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valgus group between straight knee and bent knee.  The valgus group had significantly less 
straight knee dorsiflexion.  The gastrocnemius is a bi-articulate muscle crossing the ankle and 
knee.  When the knee is straight, ROM of the ankle decreases because the gastrocnemius 
reaches end range, limiting motion.  Tightness in the gastrocnemius muscle may have played 
a role in valgus during the DLST.  This point is illustrated further when the knee was bent.  
The valgus group’s dorsiflexion range of motion was significantly increased and 
approximately equal to the control group.  This idea is the foundation of current theory!  
When the valgus group squatted with the heel block, the gastrocnemius shorts and the 
resulting tension is removed from the squat, correcting knee valgus.  This suggests that the 
tightness in the gastrocnemius muscle played a role in the knee valgus.  It is important to note 
that when the valgus group was on the heel block, there were no significant changes in hip 
musculature activity. 
 Ankle dorsiflexion has been shown to be around 10 degrees during the stance phase 
of gait (Murray 1967).  During more function tasks, such as sit-to-stand, stair climbing, and 
sport specific activities, the requirement for ankle dorsiflexion ROM can increase to about 25 
degrees (Andriacchi, Andersson et al. 1980; Lindsjo, Danckwardt-Lilliestrom et al. 1985; 
Livingston, Stevenson et al. 1991).  The double-legged squat used in our study can be related 
to the function activities that can require the greater dorsiflexion.  Thus, the lack of motion 
seen in the valgus group can explain their inability to perform the task properly.  However, it 
becomes hard to explain why gastrocnemius tightness in and of itself would contribute to 
knee valgus.  It may be a unilateral issue.  If the lateral gastroc is tight or short, it may be 
responsible for pulling the knee into a valgus position.  Currently it is believed that during a 
squat decreased ankle dorsiflexion would lead to the heels of the individual rising up off of 
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the floor (Clark 2001).  This idea makes more sense when examining the gastrocnemius 
muscle by itself; however, when considering the entire kinetic chain there appears to be more 
to the picture.  It makes more sense to think that this tightness in the gastrocnemius would 
pull, from its insertion, the calcaneus into eversion, thus causing the foot to pronate.  Our 
study did not examine foot and ankle pronation but if this is the case, then our results seem to 
suggest that when the arch flattens and pronation ceases the gastrocnemius begins to 
influence an increase in knee valgus.  Therefore it seems that more research needs to be done 
to determine whether or not the gastrocnemius muscle itself can cause knee valgus or it if 
only contributes to increased valgus when it is already present. 
 
Internal Rotation Time to Peak Torque 
Our study found that the control group reached their internal rotation concentric peak 
torque approximately a full second (2 sec vs. 3 sec) before the valgus group.  This difference 
was deemed statistically significant and further strengthens the idea that there is a difference 
in adductor activity between groups.  The current literature suggests that the gluteus maximus 
and gluteus medius are important hip stabilizers (Gottschalk, Kourosh et al. 1989; Clark 
2001; Schmitz, Riemann et al. 2002)  Our study showed that the gluteus maximus and 
gluteus medius activity between the control and the valgus groups were similar even though 
the valgus group demonstrated poor proximal hip control.  This suggests that it may not be 
the gluteal muscles that are responsible for stabilization but rather other hip internal and 
external rotators.  This can be further explained by the differences discussed above about the 
adductor activity between the two groups, as the adductors also function as hip internal 
rotators. 
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Abduction Concentric Peak Torque and Time to Peak Torque 
There was a trend discovered in our study that suggests the control group produced 
greater concentric peak torque in the abductors than the valgus group and the control group 
achieved peak torque a half second faster (1.1 sec vs. 1.6 sec).  The lack of significance of 
this may be due to lack of statistical power; an increase in power may draw out the 
significance of this finding.  Regardless, this finding is clinically significant as it suggests 
that one potential cause of the knee valgus position is that the valgus group lacks abduction 
strength as well as the ability to achieve maximum strength in time to prevent hip adduction.  
This could be related to the previous stated findings of ankle dorsiflexion range of motion.  It 
may be that the adduction begins due to a lack of abduction stabilization strength and is 
increased by the lack of gastrocnemius flexibility and decreased ankle dorsiflexion 
Ireland has described a “position of no return” as when an athlete has poor hip control 
and the hip moves into adduction, leading to femoral internal rotation and a position of knee 
valgus (Ireland 1999).  These trends discovered in our study seem to support this and further 
explain it by demonstrated ankle dorsiflexion ROM’s role in this knee adduction.  However, 
further research is required to further explore these trends and determine if they are 
significant. 
 
 
Hip Abduction and Internal Rotation ROM 
No difference was observed in hip abduction or internal rotation ROM between the 
control and valgus groups.  Initially, we hypothesized that tight adductors or tight internal 
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rotators may pull individuals into knee valgus.  However, our study failed to identify this as a 
contributing factor.  In fact the means of each ROM between groups was almost identical.  
 
Hip Extension and External Rotation Concentric and Eccentric Peak Torque 
No statistical difference was observed between group concentric or eccentric peak 
torques.  This finding is clinically significant because it suggests that the gluteus maximus 
muscle does not play a significant role in preventing knee valgus during a squat.  It is 
currently thought that individuals who demonstrate knee valgus have weak gluteus maximus 
control during squatting (Clark 2001).  Again it becomes important to note that it appears that 
the subjects tested had ankle dysfunction and not necessarily hip dysfunction, and that 
individuals not corrected by the heel block may have differences in gluteus maximus 
strength. 
 
Limitations 
The greatest limitation of this study was the lack of statistical power for some of the 
analyses.  Ideally, each group would have around 20 subjects to have enough power to draw 
out significant differences that may exist.  This was unable to be achieved in this study due to 
the difficulty in identifying subjects who met the valgus group criteria.  However, most of the 
analyses that lacked power also had small effect sizes.  Therefore, if power was increased 
such that significance was found, it still may not be clinically significant. 
 Another limitation for this study is that the order of testing was not randomized.  
Every subject followed the same protocol in the same order.  However, since the subjects 
were observed to exhibit the bilateral knee valgus both before and after ROM and strength 
51 
testing it is not believed that either altered the way in which the subjects performed the squat 
task. 
 The inability to identify many males who fit the inclusion criteria for the valgus group 
limits the generalizability this study.  The control group is more evenly divided between 
males and females; however, the valgus group consists of primarily females.  Although, the 
demographics between each group suggest that subjects were closely matched by age, height, 
and weight. 
 The lack of lower leg EMG activity is also a limitation of this study.   While the 
ROM of ankle dorsiflexion was measured, no information about the muscle activity around 
the ankle of the ankle dysfunction group was available to help further understand what may 
be contributing to their valgus knee position. 
 
Future Research 
Current theory places subjects into categories if they are identified has having knee 
valgus (Clark 2001).  There is a control population that demonstrates correct squat technique.  
There is a hip dysfunction population that demonstrates bilateral knee valgus both with and 
without a two-inch heel block.  Finally, there is an ankle dysfunction population that 
demonstrates bilateral knee valgus during a squat that is corrected by a two-inch heel block.  
This study contrasted the control population against the ankle population and how hip 
musculature and ankle ROM contributes to knee valgus.  Future research needs to verify that 
this classification system is correct and document differences between groups.  Areas of 
focus should be the hip musculature (gluteus maximus, gluteus medius and adductor 
complex), ankle musculature (medial and lateral gastrocnemius, tibialis anterior, and soleus), 
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and these variables relation to this position of knee valgus during a squat task.  Future 
research should also focus on the kinematics of the squat to verify that valgus is corrected or 
not with the heel block.  Finally, once the theory has been estabilished, research should 
attempt to implement training programs to correct valgus. 
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APPENDIX A: TABLES 
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Table 1: Subject Demographics; Mean and Standard Deviation     
Group   Gender   Age(yr)   Height(cm)   Weight(kg) 
    Male   Female   Mean   SD   Mean   SD   Mean   SD 
Normal   7   10   23.82  5.76   166.12   31.13   69.59   15.37 
                 
Valgus   2   12   22.36   3.08   167.21   9.3   65.93   9.9 
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Table 2: Ranges of Motion; Means and Standard Deviations 
ROM   Normal   Valgus   Effect Size 
    Mean   SD   Mean   SD     
Hip Abd   36.88 ± 5.34   35.29 ± 3.97   0.35 
           
Hip ER  73.92 ± 17.51  74.23 ± 7.02  0.04 
           
AnkleSKD  17.88 ± 7.93  13.43 ± 7.85*  0.59 
           
AnkleBKD   19.86 ± 8.37   19.88 ± 8.37**   0.003 
p < .001 for group by ROM interaction     
           
* Denotes Significant Difference from Normal Group AnkleSKD 
** Denotes Significant Difference from Valgus Group AnkleSKD 
           
Abd - Abduction         
ER - External Rotation        
SKD - Straight Knee Dorsiflexion      
BKD - Bent Knee Dorsiflexion       
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Table 3: Isokinetic Peak Torque Normalized to Body Weight (ft * lbs/kg); Means and 
Standard Deviations 
ROM Contraction   Normal   Valgus   Effect Size 
      Mean   SD   Mean   SD     
Hip ER Concentric   0.315 ± 0.075   0.273 ± 0.134   0.43 
            
 Eccentric  0.605 ± 0.143  0.557 ± 0.229  0.27 
            
Hip IR Concentric  0.806 ± 0.293  0.804 ± 0.201  <.000 
            
 Eccentric  0.444 ± 0.18  0.428 ± 0.188  0.09 
            
Hip Ext Concentric  1.281 ± 0.521  1.244 ± 0.424  0.08 
            
 Eccentric  0.806 ± 0.415  0.73 ± 0.335  0.21 
            
Hip Abd Concentric  0.438 ± 0.175  0.327 ± 0.142*  0.76 
            
  Eccentric   0.508 ± 0.277   0.501 ± 0.217   0.03 
            
* Denotes trend that Valgus group shows less concentric hip abduction peak torque (p = .065) 
            
ER - External Rotation          
IR - Internal Rotation           
Ext - Extension           
Abd - Abduction           
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Table 4: Isokinetic Time to Peak Torque (seconds); Means and Standard Deviations 
ROM Contraction   Normal   Valgus   Effect Size  
      Mean   SD   Mean   SD      
Hip ER Concentric   3.35 ± 1.63   2.98 ± 1.75   0.23  
             
 Eccentric  3.23 ± 1.24  3.12 ± 1.83  0.07  
             
Hip IR Concentric  2.29 ± 1.11  3.21 ± 1.18*  0.83  
             
 Eccentric  2.76 ± 1.35  2.86 ± 2.16  0.06  
             
Hip Ext Concentric  4.49 ± 1.76  4.9 ± 1.58  0.25  
             
 Eccentric  2.51 ± 1.98  3.31 ± 1.92  0.41  
             
Hip Abd Concentric  1.18 ± 0.58  1.62 ± 0.79**  0.7  
             
  Eccentric   2.73 ± 1.42   3.36 ± 1.22   0.49  
             
* Denotes that Valgus group took significantly longer to reach IR concentric peak torque (p = .034) 
** Denotes trend that Valgus group shows longer time to concentric peak torque (p = .083) 
             
ER - External Rotation           
IR - Internal Rotation            
Ext - Extension            
Abd - Abduction            
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Table 5: Mean EMG Amplitude (Normalized to MVIC) During a Squat Task;   
Means and Standard Deviations          
      Normal   Valgus   
Effect 
Size 
      Mean   SD   Mean   SD     
Gluteus Maximus Descending   10.98 ± 12.53   11.37 ± 5.65   0.02 
            
 Ascending  11.52 ± 8.03  11.4 ± 5.72  0.02 
            
Gluteus Medius Descending  14.99 ± 10.04  19.02 ± 9.72  0.39 
            
 Ascending  15.5 ± 11.02  19.03 ± 9.75  0.39 
            
Adductors Descending  29.68 ± 39.02  18.85 ± 14.26  0.16 
            
  Ascending   18.02 ± 7.62   35.6 ± 33.78*†   0.16 
p = .020 for group x phase interaction         
            
* Denotes significant difference from valgus group descending activity     
† Denotes significant difference from normal group ascending activity     
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Table 6: Mean EMG Amplitude (Normalized to MVIC) During a Squat Task with Heel Block; 
Means and Standard Deviations          
      Valgus   Valgus   Effect Size 
    (no heel block)  (heel block)   
      Mean   SD   Mean   SD     
Gluteus Maximus Descending   11.37 ± 5.65   10.58 ± 5.06   0.5 
            
 Ascending  11.4 ± 5.72  13.07 ± 8.6  0.5 
            
Gluteus Medius Descending  19.02 ± 9.72  18.14 ± 9.43  0.58 
            
 Ascending  19.03 ± 9.75  20.26 ± 11.86  0.58 
            
Adductors Descending  18.85 ± 14.26  18.09 ± 14.08  0.73 
            
  Ascending   35.6 ± 33.78   28.49 ± 20.95   0.73 
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Figure 2: Hip Abduction Isokinetic Strength (Normalized to Body Weight)
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Figure 3: Internal Rotation Time to Peak Torque
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Figure 4: Abduction Concentric Time to Peak Torque
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Figure 5: Adductor Mean EMG Amplitudes
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Figure 6: Hip Abduction ROM Measurement Positioning 
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Figure 7: Hip External Rotation Measurement Positioning 
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Figure 8: Straight Knee Ankle Dorsiflexion ROM Measurement Positioning 
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Figure 9: Bent Knee Ankle Dorsiflexion ROM Measurement Positioning 
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Figure 10: Gluteus Medius Electrode Placement 
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Figure 11: Gluteus Maximus Electrode Placement 
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Figure 12: Adductor Electrode Placement 
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Figure 13: Hip External Rotation Strength Measurement Positioning 
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Figure 14: Hip Internal Rotation Strength Measurement Positioning 
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Figure 15: Hip Extension Strength Measurement Positioning 
 
 
 
 
 
76 
Figure 16: Hip Abduction Strength Measurement Positioning 
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Figure 17: Squat Task Positioning 
 
 
 
 
 
 
 
 
 
78 
Figure 18: Squat Task Positioning – Heel Block 
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APPENDIX C: MANUSCRIPT 
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The Effects of Hip Musculature on Knee Valgus During a Squat Task; and How Muscle 
Activity Changes When Standing on a Two-Inch Heel Block 
 
Objective: To compare hip ROM, strength, muscle activity, and ankle dorsiflexion ROM 
between groups that demonstrate knee valgus during a squat task and those that do not (control).  
Also, determine if muscle activity changes after knee valgus is corrected by a two-inch heel 
block. 
Design: A single-session experimental research design was used to compare the control group 
and the valgus group 
Participants: Seventeen (10 Females, 7 Males) control subjects (age[yr] = 23.82 ± 5.76, 
height[cm] = 166.12 ± 31.13, weight[kg] = 69.59 ± 15.37) and fourteen (12 Female, 2 Male) 
valgus subjects (age[yr] = 22.36 ± 3.08, height[cm] = 167.21 ± 9.3, weight[kg] = 65.93 ± 9.9) 
without lower extremity injury. 
Dependent Variables: Supine hip abduction and external rotation ROM.  Ankle dorsiflexion 
ROM (straight and bent knee).  Hip internal rotation, external rotation, extension, and abduction 
eccentric and concentric peak torque and time to peak torque.  EMG mean amplitude of the 
gluteus maximus, gluteus medius and adductor complex during a squat with and without a two 
inch heel block. 
Data Analysis: Mixed model analysis of variance tested for difference both between and within 
groups. 
Results: A significant group by phase interaction effect (p = 0.02) existed for mean adductor 
amplitude between the valgus and the control group.  A significant difference (p < .001) in 
straight knee ankle dorsiflexion ROM existed between the control and the valgus group.  A 
81 
significant difference (p = 0.034) existed between the internal rotation concentric time to peak 
torque between the two groups. 
Conclusion:  The adductor complex plays a significant role in hip extension.  Increased activity 
of the adductor during extension could pull the knees into valgus.  Gastrocnemius tightness 
might contribute to knee valgus during a squat.  There appears to be three distinct populations 
when considering this knee valgus squatting position.  1. Normal individuals who do not have 
valgus.  2. Ankle dysfunction individuals who’s valgus position corrects with a heel block.  3.  
Hip dysfunction individuals who’s valgus position does not correct with a heel block. 
Keywords: Knee valgus, double leg squat, hip adductor activity, gastrocnemius flexibility 
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INTRODUCTION 
Baseline screenings are commonly utilized in sports medicine as a method to assess 
injury status and establish return to play criteria should injury occur (McKeag 1985; Adirim and 
Cheng 2003).  More recently baseline screenings have been used to develop corrective exercise 
programs to prevent injury from occurring (Nicholas and Tyler 2002).  Typically baseline 
screenings have utilized isolated measures of flexibility, muscle strength, and functional 
performance; as well as identifying faulty posture (Wang, Chen et al. 2006).  Acquiring this 
information serves two purposes.  Initially this information is required to ensure that the athletes 
are not injured at the beginning of a competitive season.  However, most often this information is 
used to identify possible problematic alignments and movements that might predispose an athlete 
to injury and address the problem before injury occurs. If risk factors can be identified and 
corrected in the preseason, some of these injuries may be prevented. 
 Posture is a very important and often neglected part of overall health.  Ideal posture 
maintains that structural integrity and optimum alignment of each component of the kinetic chain 
(Clark, 2001).  The kinetic chain consists of the myofascial system, articular system, and the 
neural system (Clark, 2001).  When one component of this system is out of alignment, then the 
entire system is placed at a disadvantage.  Postural malalignment is thought to create predictable 
patterns of tissue overload and dysfunction, initiating the cumulative injury cycle (Clark, 2001).  
This cumulative injury cycle begins with tissue trauma, inflammation, leading to muscle spasm, 
adhesions, altered neuromuscular control, and muscle imbalance.  This cycle is thought to cause 
decreased athletic performance and eventual injury (Clark, 2001). 
Functional movement analyses are becoming increasingly popular as a tool during 
dynamic postural assessment.  Double leg and single leg squatting tasks are common during 
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functional movement analyses.  These methods can be easily implemented and are time efficient, 
thus are attractive measures for the clinician.  During functional movement analyses, the 
clinician observes for dysfunctional movement patterns that are believed to represent muscle 
imbalances caused by lack of flexibility, muscle weakness, and/or muscle activation.  For 
example, individuals who demonstrate excessive knee valgus during a double leg squat are 
hypothesized to display a tight adductor muscle complex, tight gastrocnemius/soleus complex, 
and weak gluteus medius and maximus muscles, as well as a lack of neuromuscular control in 
the aforementioned muscles. (Clark 2001)  However, research has not been performed to validate 
the idea of functional movement analyses as a method to identify muscle imbalances. 
 The adductor muscle complex functions both as a hip adductor and internal rotator. 
(Rosse 1997)  Tightness in this complex would not allow full motion and cause the femur to pull 
into adduction and internal rotation.  During a squat task, this may result in a valgus motion at 
the knee.  The gluteus medius muscle has various functions.  The anterior fibers function to 
internally rotate the hip. (Earl 2005)  However, the most common thought of function of the 
gluteus medius is its role in hip abduction and stabilizing the hip and limiting adduction. 
(Schmitz, Riemann et al. 2002; Earl 2005)  A weaknesss in this muscle that affected motion 
would allow the hip to excessively adduct that may cause the knee to exhibit a valgus motion.  
The gastrocnemius muscle is the prime mover in ankle plantar flexion. (Rosse 1997)  A tightness 
in this muscle could affect both the ankle or the knee joint because it is bi-articular.  During 
functional movements, it may cause either the heel to rise or the knee to flex excessively.  Also 
due to its insertion into the calcaneus it may have an impact on the foot flattening.  These muscle 
imbalances can lead to movement dysfunctions that cause an increase in stress to certain 
structures and contribute to the cumulative injury cycle. 
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Knee valgus alignment during dynamic tasks (e.g. squatting) is a common postural 
dysfunction seen in the lower extremity.  Knee valgus alignment during squatting is defined as 
the mid-patella moving medially and crossing over the ipsilateral great toe as the knee flexes 
while squatting downward.  Knee valgus alignment has been described as a potentially 
dangerous movement pattern (Ireland 1999).  Knee valgus alignment is accompanied by 
movement of the hip into adduction and internal rotation, which are commonly described 
mechanisms for anterior cruciate ligament (ACL) injury (Ireland 1999).  It has also been shown 
that patello-femoral compressive forces increase with knee valgus alignment (Escamilla 2001)  
Thus, knee valgus alignment is also believed to be a contributing factor to patello-femoral pain 
syndrome.  Furthermore, the medial collateral ligament (MCL) is stressed when the knee is 
exposed to a valgus moment.  The MCL can become injured when that valgus stress becomes too 
great.  Individuals who undergo excessive knee valgus motion during functional tasks may place 
greater stress on the MCL and be at greater risk for injury.  These injuries can be detrimental to 
an individual’s physical well-being.  Therefore, it is important to understand the factors that 
influence knee valgus alignment as this may improve our understanding of lower extremity 
injury risk factor, which may lead to the development of exercise programs to correct knee 
valgus alignment and reduce injury risk.  Currently, knee valgus alignment is thought to occur 
due to weakness or inhibition in the hip abdcutor muscles (e.g. gluteus medius, gluteus maximus) 
and hip external rotator muscles.  Meanwhile, the hip adductor and internal rotator muscles are 
believed to be tight or overactive (Clark 2001).  However, research has not investigated if these 
hypothesized muscle imbalances actually exist in individuals demonstrating knee valgus 
alignment during a functional squatting task. 
Squat tests, both single and double legged, have been used in the past as functional tests 
because they put the knee through common motions found in athletics.(Beutler, L.W. et al. 2002; 
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Loudon, Wiesner et al. 2002; Zeller, McCrory et al. 2003)  Moreover, studies have been done 
that examine knee valgus during squat tasks. (Zeller, McCrory et al. 2003)  However, currently 
research has yet to focus on how the abovementioned risk factors associated with injury differ 
between subjects who experience a position of knee valgus versus those who do not when 
performing a squat. 
METHODS 
Subjects 
Approximately 70 subjects were screened by the principal investigator by watching them 
perform a double leg squat.  Those subjects that were observed to exhibit a valgus motion during 
the squat were then observed with a two-inch heel block underneath their calcaneus.  These 
subjects were recruited through volunteers from emails, fliers, and personal recruiting in classes.  
Subjects were divided into two groups based upon their results on the double leg squat task 
(DLST).  The valgus group consisted of subjects who demonstrated bilateral knee adduction 
during the DLST that was corrected by placing a two-inch heel block under their calcaneus.  The 
control group consisted of subjects who did not demonstrate knee adduction on either leg during 
the DLST.  Subjects in the control group were matched to subjects in the hip dysfunction group 
by age, height, and weight.  The control group consisted of 17 subjects while the valgus group 
consisted of 14 subjects whose ages ranged from 18-26 years.  Subject demographics are located 
in Table 1.  Subjects were otherwise healthy individuals that had no current musculoskeletal 
injuries or had not sustained an injury to either lower extremity in the past six months.  Subjects 
were also excluded if they had surgery to either lower extremity in the past year.  Furthermore, 
subjects in both groups were asymptomatic with and without activity, and subjects were 
asymptomatic during the DLST.  Prior to all testing all subjects read and signed an informed 
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consent form approved by a University of North Carolina at Chapel Hill Biomedical Institutional 
Review Board (IRB). 
Measurement and Instrumentation 
A manual goniometer was used to measure joint angles in degrees for ROM assessment 
of the muscles of interest.  Flexibility measurements were taken for the hip adductors (ICC(2,1) 
.89 SEM = 1.743), the hip internal rotators (ICC(2,1) .97 SEM  2.625), gastrocnemius, and soleus.  
ICCs were not calculated for these final two range of motion measures. 
Concentric and eccentric muscle strength was evaluated using a Biodex System 3 Pro 
isokinetic dynamometer (Biodex Medical Systems, Shirley, NY), measured in Foot-pounds 
(Ft*lbs) of torque.  The data were then analyzed with a customized Matlab 7.0 program (The 
Mathworks, Inc., Natick, MA) to determine the average peak torque, as well as time to peak 
torque, for the hip external rotators, internal rotators, hip abductors, and hip extensors.  Each 
average was measured over the middle three of five total trials.   
The mean amplitude electromyographic (EMG) activity of the gluteus medius, gluteus 
maximus, and adductor group was measured using an eight channel DelSys Bagnoli EMG 
System (Boston, MA).  DE-2.1 single differential surface electrodes (DelSys Boston, MA) with a 
contact dimension of 1.0cm x 0.1cm and a contact spacing of 1.0cm over the muscle bellies and 
parallel to the fibers of the gluteus medius, gluteus maximus, and adductor muscles.  Electrodes 
were plugged into a belt mounted I/O unit that plugged into the DelSys Bagnoli EMG system.  
This system amplified (x10,000 Hz) the EMG signal as it passed into the computer and was 
stored for analysis.  The EMG data were processed with passive demeaning (0.0 ms begin/ 10.0 
ms end), a Butterworth notch filter at 60.0 Hz, a band pass Butterworth filter from 10.0 Hz – 350 
Hz, and finally RMS smoothing was used at a time constant of 25 msec.  All EMG data were 
normalized to the percentage of maximum voluntary isometric contraction to allow for 
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comparison between subjects.  All EMG data collection and processing was done using 
Datapac2K2 (Run Technologies, Mission Viejo, CA). 
An electro-goniometer was placed over the knee joint so that knee joint ankle could be 
recorded and related to EMG activity during the DLST.  Electro-goniometer data were filtered 
with a low pass Butterworth at 15.0 Hz. 
A tripod was used to standardize squat depth; as well as a metronome to standardize squat 
speed at 66 beats per minute.  Subjects used two beats to descend, two beats to ascend and one 
beat to rest between squats. 
Procedures 
 Students and faculty of the University of North Carolina at Chapel Hill were asked 
through email and fliers to volunteer for screening for this study.  Screening consisted of a 
questionnaire pertaining to previous history of injury or surgery to the lower extremity.  Each 
subject completed their individual testing in one session.  Prior to testing, subjects had the testing 
procedures explained to them and were asked to read and sign an informed consent form.  Each 
testing session began with the recording of the subject’s gender, age (years), height (cm), and 
weight (kg).  Subjects were then video taped performing the DLST both with and without a two-
inch heel block to ensure that they met the inclusion criteria for their assigned group.  The tester 
then assessed the subject’s dominant leg, defined as the leg they would use to kick a soccer ball 
for maximum distance, for the following variables: the subject’s passive hip abduction ROM; 
passive external rotation ROM; passive straight knee ankle dorsiflexion ROM; passive bent knee 
dorsiflexion ROM; Concentric/eccentric isokinetic strength for hip external and internal rotation, 
hip abduction, and hip extension; and EMG activity during a DLST in the gluteus medius, 
gluteus maximus, and adductor complex.  The valgus group also had EMG recorded for a DLST 
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while standing on a two-inch heel block.  Prior to testing subjects were allowed to warm up for 
five minutes on a stationary bike at a self-determined pace.   
ROM Measurements 
Subject positioning for ROM measurement of hip abduction was supine.  The axis of the 
goniometer was placed over the ASIS of the extremity being measured.  The stationary arm was 
placed along an imaginary line from one ASIS to the other.  The movement arm was placed 
along the anterior midline of the femur using the midline of the patella for reference.  The subject 
was then passively abducted until the tester felt the contralateral ASIS begin to move (Norkin 
1995)  Three separate measurements were taken and the mean was recorded. 
Subject positioning for ROM measurement for hip internal rotation was supine with the 
dominant hip and knee flexed to 90 degrees.  The hip was in neutral abduction/adduction.  The 
axis of the goniometer was the anterior center aspect of the patella.  The stationary arm was 
positioned parallel to the table.  The movement arm was placed along the anterior midline of the 
tibia pointing towards the anterior midpoint of the ankle between the two melleoli.(Norkin 1995)  
The subject’s hip was passively externally rotated until the tester felt the end range. Three 
separate measurements were taken and the mean was recorded.  
Subject positioning for ROM measurement of straight knee dorsiflexion was supine with 
the dominant knee in full extenion.  The ankle was in neutral inversion/eversion.  The axis of the 
goniometer was distal lateral maleolus.  The stationary arm was positioned with the lateral 
midline of the fibula, using the fibular head for reference.  The movement arm was placed 
parallel to the lateral aspect of the fifth metatarsal (Norkin 1995).  The subject’s ankle was then 
passively dorsiflexed until the tester felt the end range.  Three separate measurements were taken 
and the mean was recorded. 
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Subject positioning for ROM measurement of bent knee dorsiflexion was the same as 
straight knee; however, a bolster was placed under the subject’s dominant knee so that it was 
flexed to at least 30 degrees(Norkin 1995).  The subject’s ankle was then passively dorsiflexed 
until the tester felt the end range.  Three separate measurements were taken and the mean was 
recorded. 
Electromyography 
 
The sites for electrode placement were shaven and cleansed with alcohol to improve 
signal transmission from the muscles.  Electrodes were placed over the muscle bellies of the 
gluteus medius, gluteus maximus, and adductor complex.  A reference electrode was placed on 
the tibial tuberosity.  Electrodes were placed in a parallel to muscle fibers. 
The electrodes for the gluteus medius were placed halfway between the iliac crest and the 
greater trochanter of the femur (Kleissen 1990).  The electrodes for the gluteus maximus were 
placed 20% of the distance between the spinous process of S2 and a point 10 cm distal to the 
greater trochanter.  The electrodes for the adductor complex were placed on the muscle belly at 
the mid point of the femur (Leveau 1992).  All electrode placements were confirmed with an 
isometric manual muscle test and checked for cross talk.  Maximal voluntary isometric 
contraction (MVIC) was used to normalize muscle activity between subjects (% MVIC). 
Strength Measurements 
 Reliability for all strength tests was demonstrated by Halverson and Hawkey, abstract 
published in Journal of Athletic Training supplement 2004. 
The hip external rotators were tested in a seated position.  The subject’s hip and knee was 
flexed to 90 degrees.  The dynamometer was aligned with the long axis of the femur.  Pressure 
was applied to the medial aspect of the distal tibia.  The thigh was stabilized to the chair using 
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straps.  A towel was also placed between the subjects’ knees to act as a fulcrum for external 
rotation and prevent adduction.  The external rotators were tested through twenty degrees of 
motion that began at five degrees of external rotation and ended at fifteen degrees of internal 
rotation. 
The hip internal rotators were tested in a seated position.  The subject’s hip and knee 
were flexed to 90 degrees.  The dynamometer was aligned with the long axis of the femur.  
Pressure was applied to the lateral aspect of the distal tibia.  The thigh was stabilized to the chair 
using straps.  The internal rotators were tested through twenty degrees of motion that began at 
five degrees of internal rotation and ended at fifteen degrees of external rotation. 
The hip abductors were tested with the subject in a side-lying position to isolate the 
gluteus medius.  The joint axis was located at 0.5 inches medial to the ASIS at the level of the 
greater trochanter (Lyons, Perry et al. 1983).  The hip was abducted and externally rotated, 
making sure not to let the trunk and pelvis rotate backward.  Pressure was applied against the 
thigh in the direction of adduction.  Pressure was not applied against the external rotation 
component of the start position (Kendall 1993).  The trunk was stabilized by strapping the 
subject to the chair.  The muscle was tested from 0-20 degrees of hip abduction. 
The hip extensors were tested in a supported, standing position in an attempt to isolate the 
gluteus maximus and maximize stabilization.  The dynamometer axis of rotation was aligned 
with the anterior superior tip of the greater trochanter (Lyons, Perry et al. 1983).  The subjects 
stood in front of the Biodex chair, and the seat was raised to the level of the subjects’ ASIS.  If 
the chair was unable to reach the subjects’ ASIS, the subjects were then asked to flex the 
contralateral knee until the chair was even with the level of the ASIS.  The subjects flexed their 
trunk to ninety degrees and laid their chest on the chair.  The trunk was stabilized to the Biodex 
chair prior to testing using straps.  This stabilization was aimed at preventing accessory trunk 
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motions that might influence strength testing.  The knee of the test leg was flexed to ninety 
degrees.  The stance leg (non-test leg) was flexed at the knee such that the subjects’ chest was 
comfortably resting on the chair.  The subjects were then asked to actively extend the hip 
through a range of motion that began at ninety degrees of hip flexion (femur perpendicular to the 
groud) and ended at fifty degrees of hip flexion.  Pressure was applied against the distal portion 
of the posterior thigh in the direction of hip flexion (Kendall 1993). 
All muscles were tested concentrically and eccentrically at 60 deg * sec-1.  The testing 
procedure accounted for gravity corrections during hip abduction and hip extension testing since 
the test limb was sufficiently close to the horizontal plane.  The test limb did not come close 
enough to the horizontal plane to warrant a gravity correction during the testing of the hip 
external or internal rotators. 
Following the isokinetic testing of each muscle group, the subject’s strength was tested 
isometrically.  The positioning and alignment of the subjects was exactly the same for the 
isometric testing as it was used during the isokinetic testing.  The test limb was positioned in the 
middle of the isokinetic ROM or neutral position for isometric testing.  The test limb was placed 
at seventy degrees of hip flexion while testing the hip extensors.  The test limb was placed at ten 
degrees of hip abduction while testing the hip abductors.  The test limb was placed in a neutral 
position (zero degrees of abduction/adduction) while testing the hip adductors.  Each subject 
performed three maximal isometric contractions.  The contractions were held for five seconds 
each, and there was 10-12 seconds rest between each repetition.  The mean amplitude of the 
three trials during the middle three seconds of each trial was recorded. 
The EMG data for the MVIC of the gluteus maximus was recorded while testing hip 
extension.  The EMG data for the MVIC of the gluteus medius was recorded while testing hip 
abduction.  The EMG data for the MVIC of the adductor complex was recorded while still in the 
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testing position for hip abduction.  The subjects were asked to maximally adduct the hip against 
the Biodex dynamometer for five seconds.  EMG from these MVIC’s was recorded so that the 
EMG data recorded during the DLST could be normalized and used to compare between 
subjects. 
Double-Legged Squat Task 
Subjects were asked to stand with hips, feet, and knees facing forward and arms fully 
extended overhead parallel to their ears.  The subjects then were instructed to go down into a 
squat position as if they were trying to sit in a chair.  Squat depth was standardized to 70 degrees 
of knee flexion to ensure that each subject went through at least 60 degrees of motion.  Subjects 
were instructed to squat while their knee joint angle was measured with a manual goniometer.  
When the desired amount of 70 degrees of knee flexion was achieved a tripod was set up to assist 
the subject in knowing the proper squat depth.  An electrogoniometer was then placed on the 
subject’s knee so that EMG data could be examined in relation to knee position.  The subjects 
then performed the squat task five times.  EMG activity was recorded for the gluteus medius, 
gluteus maximus, and the adductor complex from 0-60 degrees of knee flexion during each of 
the squat tasks.  Subjects in the control group only performed the DLST without the heel block.  
Subjects in the valgus group performed the DLSQ with and without the heel block while EMG 
data were recorded. 
Data Analysis 
 One way analysis of variance tests were used to analyze differences between groups in 
the ROM measurements.  A 2 x 2 analysis of variance was used to analyze the straight and bent 
knee ankle dorsiflexion ROMs.  2 x 2 mixed model analysis of variance tests were used to 
analyze differences between groups in concentric and eccentric peak torque as well as time to 
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peak torque.  EMG data differences were analyzed both between groups and between phases 
within groups with separate 2 x 2 mixed model analyses of variances.  Tukey Post Hoc testing 
was used to identify where significance was found for the ankle dorsiflexion and EMG data.  All 
data were analyzed using SPSS 13.0 (Chicago, IL).  All null hypotheses were tested for 
significance at p < .05. 
RESULTS 
ROM Measurements 
Means, standard deviations, and effect size for hip abduction ROM are presented in Table 
2.  There was no significant difference [F(1,29) = 0.01, p = .920] for hip abduction range of 
motion between the control and the valgus groups.  Means, standard deviations, and effect size 
are presented in Table 2. There was no significant difference [F(1,29) = 0.859, p = .362] for hip 
external rotation ROM between the control and the valgus groups.  There was a significant group 
by knee position interaction effect for ankle dorsiflexion [F(1,26) = 17.4 p < .001].  Tukey Post 
Hoc tests revealed that the difference between groups with straight knee dorsiflexion was 
significant.  This difference is illustrated in Figure 1. 
Hip External Rotation Concentric/Eccentric Peak Torque 
Means, standard deviations, and effect sizes are presented in Table 3.  There was no 
significant difference for hip external rotation concentric [F(1,29) = 1.309, p = .262] or eccentric 
[F(1,29) = .514, p = .479] peak torque between the control and valgus groups. 
Hip Internal Rotation Concentric/Eccentric Peak Torque 
No significant differences were observed for hip internal rotation concentric [F(1,29) = 
0.00, p = .985] or eccentric [F(1,29) = 0.06, p = .808] peak torque between the control and valgus 
groups.   
Hip Extension Concentric/Eccentric Peak Torque 
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There was no significant difference [F(1,29) = 0.046, p = .833] for hip extension concentric 
peak torque between the control and valgus groups.  There was no significant difference [F(1,29) = 
0.305, p = .585] for hip extension eccentric peak torque between the control and valgus groups. 
Hip Abduction Concentric/Eccentric Peak Torque 
There was no significant difference [F(1,29) = 3.682, p = .065] for hip abduction concentric 
peak torque between the control and valgus groups.  However, the p value suggests a trend and 
the finding might reach significance if the statistical power was greater.  This trend is illustrated 
in Figure 2.  There was no significant difference [F(1,29) = 0.006, p = .939] for hip abduction 
eccentric peak torque between the normal and valgus groups.   
Hip External Rotation Concentric/Eccentric Time to Peak Torque 
Means, standard deviations, and effect size are presented in Table 4.  There was no 
significant difference [F(1,29) = 0.376, p = .544] for hip external rotation concentric time to peak 
torque between the control and valgus groups.  There was no significant difference [F(1,29) = 
0.038, p = .847] for hip external rotation eccentric time to peak torque between the control and 
valgus groups. 
Hip Internal Rotation Concentric/Eccentric Time to Peak Torque 
There was a significant difference [F(1,29) = 4.976, p = .034] for hip internal rotation 
concentric time to peak torque between the control and valgus groups.  The normal group 
achieved peak torque almost a full second faster (2 sec vs. 3 sec) than the valgus group (fig 3).  
There was no significant difference [F(1,29) = 0.023, p = .880] for hip internal rotation eccentric 
time to peak torque between the normal and valgus groups. 
Hip Extension Concentric/Eccentric Time to Peak Torque 
There was no significant difference [F(1,29) = 0.456, p = .501] for hip extension concentric 
time to peak torque between the control and valgus groups.  There was no significant difference 
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[F(1,29) = 1.235, p = .276] for hip extension eccentric time to peak torque between the control and 
valgus groups. 
Hip Abduction Concentric/Eccentric Time to Peak Torque 
There was no significant difference [F(1,29) = 3.218, p = .083] for abduction concentric 
time to peak torque between the control and valgus groups.  However, the p value suggests a 
trend that the valgus group required a half second longer (1.1 sec vs. 1.6 sec) to reach peak 
torque.  This trend is illustrated in Figure 4.  There was no significant difference [F(1,29) = 1.725, 
p = .199] for hip abduction rotation eccentric time to peak torque between the normal and valgus 
groups. 
Gluteus Maximus EMG Mean Amplitude During a Squatting Task 
Means, standard deviations, and effect size are presented in Table 5.  There was no main 
effect for group [F(1,27) = 0.002, p = .962] for gluteus maximus activity during the ascending and 
descending phases of the squat.  No main effect for phase [F(1,27) = 0.024, p = .877] was observed 
for gluteus maximus activity between the ascending and descending phases of the squat for the 
control or valgus groups.  There was no group by phase interaction effect [F(1,27) = 0.020, p = 
.888] for gluteus maximus activity during the squat task. 
Gluteus Medius EMG Mean Amplitude During a Squatting Task 
There was no main effect for group [F(1,27) = 1.037, p = .318] during the ascending or 
descending phases of the squat between the control or valgus groups.  There was no main effect 
for phase [F(1,27) = 0.101, p = .753] of gluteus medius activity between ascending and descending 
phases of the squat for either group.  No group by phase interaction effect [F(1,27) = 0.098, p = 
.757] was observed for gluteus medius activity during the squat task. 
Adductor Mean EMG Amplitude During Squatting 
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There was a group by phase interaction [F(1,27) = 6.095, p = .020] for adductor activity 
during the squat task.  The control group had higher mean amplitude during the descending 
portion of the squat and decreased during the ascending phase.  In contrast, the valgus group had 
higher adductor activity during ascending than decending.  Tukey post hoc testing revealed that 
the difference between adductor activity of the control group and the valgus group during the 
ascent phase was significant.  This significance is illustrated in Figure 5.  No main effect for 
group [F(1,27) = 0.163, p = .690] was observed for adductor activity during the ascending or 
descending phases of the squat.  There was no main effect for phase [F(1,27) = 0.196, p = .661] for 
adductor activity between the ascending and descending phases of the squat for either the normal 
or the valgus group.   
Gluteus Maximus EMG Mean Amplitude During Squatting with Heel Block 
Means, standard deviations, and effect size for mean gluteus maximus amplitude during 
the squatting task on the heel block are presented in Table 6.  There was no main effect for the 
heel block [F(1,11) = 0.134, p = .721] for gluteus maximus activity during the ascending and 
descending phases of the squat between the valgus group with and without the heel block.  There 
was no main effect for phase [F(1,11) = 1.525, p = .241] for gluteus maximus activity between the 
ascending and descending phases of the squat for the valgus group either with or without the heel 
block.  There was no heel block x phase interaction effect [F(1,27) = 1.430, p = .255] for gluteus 
maximus activity during the squat task. 
Gluteus Medius Mean EMG Amplitude During Squatting with a Heel Block 
Means, standard deviations, and effect size for gluteus medius EMG mean amplitude 
during the squatting task on the heel block are presented in Table 6.  No main effect was 
observed for gluteus medius activity [F(1,11) = 0.022, p = .885] during ascending and descending 
phases of a squat between the valgus group with and without the heel block.  There was no main 
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effect for phase [F(1,11) = 2.034, p = .179] of gluteus medius activity between the ascending and 
descending phases of the squat for the valgus group either with or without the heel block.  There 
was no heel block by phase interaction effect [F(1,11) = 1.955, p = .187] for gluteus medius 
activity during the squat task. 
Adductor EMG Mean Amplitude During Squatting with and without a Heel Block 
Means, standard deviations, and effect size for mean adductor amplitude during the 
squatting task on the heel block are presented in Table 6.  There was no main effect for heel 
block [F(1,11) = 2039, p = .148] for adductor activity during the ascending and descending phases 
of the squat between the valgus group with and without the heel block.  There was a main effect 
for phase [F(1,11) = 10.951, p = .006] of adductor activity between the ascending and descending 
phases of the squat for the valgus group while on the heel block.  Adductor activity during the 
descending phase of the squat was less than the ascending phase.  This significance is illustrated 
in Figure 6.  There was no heel block by phase interaction effect [F(1,11) = 1.7, p = .217] for 
adductor activity during the squat task.   
DISCUSSION 
 The most important findings from this study are that individuals who demonstrated knee 
valgus during a squat and have the valgus position corrected with a two-inch heel block have 
different adductor muscle activity during a squat.  Our results also show these valgus individuals 
have less passive ankle dorsiflexion ROM (with a straight knee) when compared to a control 
group.  Moreover, the passive bent knee ankle dorsiflexion ROM of the valgus group was 
significantly increased over their straight knee ankle dorsiflexion.  The control group reached 
concentric peak torque of the internal rotators quicker than the valgus group.  Trends in the data 
suggest that the control group has larger concentric peak torque in the abductors and achieve 
peak torque during concentric abduction faster when compared to the valgus group.  
98 
Muscle Activity During Squatting 
An analysis of the control group shows that muscle activity during different phases of a 
squat (descending and ascending) is not different.  This means the control group uses hip 
musculature equally.  This is not the case for those who display a valgus motion during a squat 
and the difference seems to be in the adductor complex.  The other two muscles examined 
(gluteus maximus and gluteus medius) showed similar activity patterns when compared to the 
control group. 
A group by phase interaction was demonstrated by the adductor muscle complex during 
the squat task.  When comparing maximal muscle activity, the control group’s adductor muscle 
had the greatest activity during the decent phase while the valgus group was most active during 
the ascent phase (Figure 5).  Thus, subjects performing proper squat posture utilized all three 
muscles simultaneously to eccentrically lower themselves, while the valgus group adductor 
complex was not as active in the eccentric lowering during the descent phase.  However, during 
the ascent phase the control group’s adductors were not as active and relied on the gluteus 
maximus to assist with hip extension.  It is important to note that neither the decrease in the 
adductor activity nor the increase in the gluteus maximus activity from the descent phase to the 
ascent phase in the normal group were deemed significant.  The opposite situation was found to 
exist with the adductor complex of the valgus group.  Adductor activity during the decent phase 
was significantly less than adductor activity during the ascent phase.  Furthermore, their adductor 
activity during the ascent phase was significantly greater than that of the normal group during the 
same phase.   
Subjects in the valgus group in this study had their valgus corrected when squatting on a 
two-inch heel block.  Current theory (Clark 2001) suggests valgus may result from tight 
musculature of the ankle rather than weak hip musculature.  The heel block allows for increased 
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length of the gastrocnemius and soleus complex, allowing normal motion and correcting valgus.  
Further research needs to identify individuals that present with valgus that is not corrected by a 
heel block and validate that hip musculature is the issue and what role it may play in knee 
valgus. 
 Increased adductor activity in the valgus group during the ascent phase of a squat could 
be explained an improved length-tension relationship of the muscle group due to increased hip 
flexion.  One study examined moment arms of hip extensor muscles (gluteus maximus and 
adductor magnus) and found that the gluteus maximus moment arm decreased while the adductor 
magnus moment arm increased while the hip was flexed.  The adductor magnus extension 
moment arm was shown to continue to increase until 75 degrees of hip flexion (Nemeth and 
Ohlsen 1985).  Furthermore, it has been shown that women demonstrate significantly more hip 
flexion and adduction during single-legged squats (Zeller, McCrory et al. 2003).  While our 
study examines double-legged squats, this is still relevant because valgus was part of our 
inclusion criteria and a majority of our valgus subjects were women.  Females are being put into 
a position of hip flexion and adduction that may increase their adductor muscle activity during 
the ascent phase.   While in the control group the gluteus maximus increases during the ascent 
phase, it actually slightly decreases in the ascent phase for the valgus group.  This may be 
explained by the increase in hip adduction decreasing the gluteus maximus’ ability to function as 
an extensor.  This position of knee adduction is associated with femoral internal rotation (Ireland 
1999).  During the ascent phase the gluteus maximus may be functioning more in its role as a hip 
external rotator to compensate for femoral internal rotation.  If this is the case, then it makes 
sense that the adductor activity increases as they function more in extension.  However, the 
changes in gluteus maximus muscle activity in our study were not found to be significant.  
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Moreover, we did not measure hip flexion angles in our subjects.  Therefore this theory needs to 
be explained further through future research. 
 A final possible explanation of the difference seen between our groups in adductor 
muscle activity arises from stance width.  Research suggests stance width has a significant effect 
on adductor longus muscle activity during a squat task (McCaw and Melrose 1999).  Stance 
width was not measured in this study but we used a self-selected stance width set at shoulder 
width apart and researcher verified.  We think this minimizes any effect stance width may have 
on our data. 
 There were no significant differences found in any of the muscles tested in the valgus 
group between the regular squat and the squat on the heel block, except for the significant 
difference in adductor activity between phases that had already been discussed in comparison to 
the control group.  This is the first study to examine how hip muscle activity changes when 
individuals with knee valgus squat on a two-inch heel block.  More research needs to be done to 
fully understand how plantar flexing the ankle by placing and individual on a two-inch heel 
block affects squatting 
 The lack of significance in the muscle activity between the valgus group with and without 
the heel block begins to outline three populations.  These populations are a normal or control 
group, an ankle dysfunction group and a hip dysfunction group.  The control group demonstrates 
a proper squat technique and keeps their knees centered over their toes (Clark 2001).  The ankle 
dysfunction group is the group examined in our study and demonstrates knee valgus during a 
squat that is corrected by placing a two inch block under their heel.  The hip dysfunction group 
consists of individuals who demonstrate knee valgus during a squat that is not corrected by the 
heel block.  Currently no study has focused on the hip dysfunction group to verify current theory 
as to what is causing their knee valgus.   
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Straight and Bent Knee Ankle Dorsiflexion ROM 
Another significant finding of this study was the difference of the straight knee ankle 
dorsiflexion ROM between the valgus group and control group and the difference of the valgus 
group between straight knee and bent knee.  The valgus group had significantly less straight knee 
dorsiflexion.  The gastrocnemius is a bi-articulate muscle crossing the ankle and knee.  When the 
knee is straight, ROM of the ankle decreases because the gastrocnemius reaches end range, 
limiting motion.  Tightness in the gastrocnemius muscle may have played a role in valgus during 
the DLST.  This point is illustrated further when the knee was bent.  The valgus group’s 
dorsiflexion range of motion was significantly increased and approximately equal to the control 
group.  This idea is the foundation of current theory!  When the valgus group squatted with the 
heel block, the gastrocnemius shorts and the resulting tension is removed from the squat, 
correcting knee valgus.  This suggests that the tightness in the gastrocnemius muscle played a 
role in the knee valgus.  It is important to note that when the valgus group was on the heel block, 
there were no significant changes in hip musculature activity. 
 Ankle dorsiflexion has been shown to be around 10 degrees during the stance phase of 
gait (Murray 1967).  During more function tasks, such as sit-to-stand, stair climbing, and sport 
specific activities, the requirement for ankle dorsiflexion ROM can increase to about 25 degrees 
(Andriacchi, Andersson et al. 1980; Lindsjo, Danckwardt-Lilliestrom et al. 1985; Livingston, 
Stevenson et al. 1991).  The double-legged squat used in our study can be related to the function 
activities that can require the greater dorsiflexion.  Thus, the lack of motion seen in the valgus 
group can explain their inability to perform the task properly.  However, it becomes hard to 
explain why gastrocnemius tightness in and of itself would contribute to knee valgus.  It may be 
a unilateral issue.  If the lateral gastroc is tight or short, it may be responsible for pulling the knee 
into a valgus position.  Currently it is believed that during a squat decreased ankle dorsiflexion 
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would lead to the heels of the individual rising up off of the floor (Clark 2001).  This idea makes 
more sense when examining the gastrocnemius muscle by itself; however, when considering the 
entire kinetic chain there appears to be more to the picture.  It makes more sense to think that this 
tightness in the gastrocnemius would pull, from its insertion, the calcaneus into eversion, thus 
causing the foot to pronate.  Our study did not examine foot and ankle pronation but if this is the 
case, then our results seem to suggest that when the arch flattens and pronation ceases the 
gastrocnemius begins to influence an increase in knee valgus.  Therefore it seems that more 
research needs to be done to determine whether or not the gastrocnemius muscle itself can cause 
knee valgus or it if only contributes to increased valgus when it is already present. 
Internal Rotation Time to Peak Torque 
Our study found that the control group reached their internal rotation concentric peak 
torque approximately a full second (2 sec vs. 3 sec) before the valgus group.  This difference was 
deemed statistically significant and further strengthens the idea that there is a difference in 
adductor activity between groups.  The current literature suggests that the gluteus maximus and 
gluteus medius are important hip stabilizers (Gottschalk, Kourosh et al. 1989; Clark 2001; 
Schmitz, Riemann et al. 2002)  Our study showed that the gluteus maximus and gluteus medius 
activity between the control and the valgus groups were similar even though the valgus group 
demonstrated poor proximal hip control.  This suggests that it may not be the gluteal muscles 
that are responsible for stabilization but rather other hip internal and external rotators.  This can 
be further explained by the differences discussed above about the adductor activity between the 
two groups, as the adductors also function as hip internal rotators. 
Abduction Concentric Peak Torque and Time to Peak Torque 
There was a trend discovered in our study that suggests the control group produced 
greater concentric peak torque in the abductors than the valgus group and the control group 
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achieved peak torque a half second faster (1.1 sec vs. 1.6 sec).  The lack of significance of this 
may be due to lack of statistical power; an increase in power may draw out the significance of 
this finding.  Regardless, this finding is clinically significant as it suggests that one potential 
cause of the knee valgus position is that the valgus group lacks abduction strength as well as the 
ability to achieve maximum strength in time to prevent hip adduction.  This could be related to 
the previous stated findings of ankle dorsiflexion range of motion.  It may be that the adduction 
begins due to a lack of abduction stabilization strength and is increased by the lack of 
gastrocnemius flexibility and decreased ankle dorsiflexion 
Ireland has described a “position of no return” as when an athlete has poor hip control 
and the hip moves into adduction, leading to femoral internal rotation and a position of knee 
valgus (Ireland 1999).  These trends discovered in our study seem to support this and further 
explain it by demonstrated ankle dorsiflexion ROM’s role in this knee adduction.  However, 
further research is required to further explore these trends and determine if they are significant. 
Hip Abduction and Internal Rotation ROM 
No difference was observed in hip abduction or internal rotation ROM between the 
control and valgus groups.  Initially, we hypothesized that tight adductors or tight internal 
rotators may pull individuals into knee valgus.  However, our study failed to identify this as a 
contributing factor.  In fact the means of each ROM between groups was almost identical.  
Hip Extension and External Rotation Concentric and Eccentric Peak Torque 
No statistical difference was observed between group concentric or eccentric peak 
torques.  This finding is clinically significant because it suggests that the gluteus maximus 
muscle does not play a significant role in preventing knee valgus during a squat.  It is currently 
thought that individuals who demonstrate knee valgus have weak gluteus maximus control 
during squatting (Clark 2001).  Again it becomes important to note that it appears that the 
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subjects tested had ankle dysfunction and not necessarily hip dysfunction, and that individuals 
not corrected by the heel block may have differences in gluteus maximus strength. 
Limitations 
The greatest limitation of this study was the lack of statistical power for some of the 
analyses.  Ideally, each group would have around 20 subjects to have enough power to draw out 
significant differences that may exist.  This was unable to be achieved in this study due to the 
difficulty in identifying subjects who met the valgus group criteria.  However, most of the 
analyses that lacked power also had small effect sizes.  Therefore, if power was increased such 
that significance was found, it still may not be clinically significant. 
 Another limitation for this study is that the order of testing was not randomized.  Every 
subject followed the same protocol in the same order.  However, since the subjects were 
observed to exhibit the bilateral knee valgus both before and after ROM and strength testing it is 
not believed that either altered the way in which the subjects performed the squat task. 
 The inability to identify many males who fit the inclusion criteria for the valgus group 
limits the generalizability this study.  The control group is more evenly divided between males 
and females; however, the valgus group consists of primarily females.  Although, the 
demographics between each group suggest that subjects were closely matched by age, height, 
and weight. 
 The lack of lower leg EMG activity is also a limitation of this study.   While the ROM of 
ankle dorsiflexion was measured, no information about the muscle activity around the ankle of 
the ankle dysfunction group was available to help further understand what may be contributing to 
their valgus knee position. 
Future Research 
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Current theory places subjects into categories if they are identified has having knee 
valgus (Clark 2001).  There is a control population that demonstrates correct squat technique.  
There is a hip dysfunction population that demonstrates bilateral knee valgus both with and 
without a two-inch heel block.  Finally, there is an ankle dysfunction population that 
demonstrates bilateral knee valgus during a squat that is corrected by a two-inch heel block.  
This study contrasted the control population against the ankle population and how hip 
musculature and ankle ROM contributes to knee valgus.  Future research needs to verify that this 
classification system is correct and document differences between groups.  Areas of focus should 
be the hip musculature (gluteus maximus, gluteus medius and adductor complex), ankle 
musculature (medial and lateral gastrocnemius, tibialis anterior, and soleus), and these variables 
relation to this position of knee valgus during a squat task.  Future research should also focus on 
the kinematics of the squat to verify that valgus is corrected or not with the heel block.  Finally, 
once the theory has been estabilished, research should attempt to implement training programs to 
correct valgus. 
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OFFICE OF HUMAN RESEARCH ETHICS -- Institutional Review Board 
INSTRUCTIONS FOR APPLICATION FOR IRB APPROVAL 
OF HUMAN SUBJECTS RESEARCH 
Version 28-Sep-2005 
  
 
 
What is the purpose of this form? 
 
This application is to seek initial IRB approval for a research study. 
 
What parts of this application should you submit? 
 
  For all studies, submit Part A, which consists of these sections: 
Part A.1.  Contact Information, Agreements, and Signatures 
Part A.2.  Summary Checklist 
Part A.3.  Conflict of Interest Questions and Certification 
Part A.4.  Questions Common to All Studies 
Part A.5.  The Consent Process and Consent Documentation (including Waivers) 
 
  For studies that involve direct interaction with human subjects (any contact with subjects 
including questionnaires, interviews, focus groups, observation, treatment interventions, etc), 
submit: 
Part B.  Questions for Studies that Involve Direct Interaction with Human Subjects 
 
  For studies that use data, records or human biological specimens without direct subject 
contact, submit: 
Part C.  Questions for Studies using Data, Records or Human Biological Specimens 
without Direct Contact with Subjects 
 
Note:  You should submit Parts B or C only as applicable.  If the study involves both direct 
interaction and data collection without contact, use both Parts B and C in addition to Part A. 
 
Who can serve as principal investigator (PI)? 
 
The PI is the person who will personally conduct or supervise this research study.  Under 
most circumstances, this will be a faculty member.  For IRB communication purposes, a 
trainee/student may be listed as PI.  However, a faculty advisor must be identified, who holds 
ultimate responsibility for ensuring that this project complies with all University, regulatory, 
and fiscal requirements. 
 
 
→ See next page for additional instructions 
 
---- Instructions – Do not submit this page with your application ---- 
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Unless otherwise instructed, submit to the IRB that typically serves the home department of the principal 
investigator (PI).  How many copies to submit depends on the IRB and type of review required for a given 
study (table).  Complete submission instructions can be found at 
http://ohre.unc.edu/submission_instructions.php.  All application and consent materials should be copied 
or printed on one side only.  
 
Special submission instructions apply for studies that require additional review.  Examples include the 
General Clinical Research Center (GCRC; http://gcrc.med.unc.edu/investigators/admin/gcrcapp.htm) or 
the Oncology Protocol Review Committee (PRC; http://cancer.med.unc.edu/research/prc/default.asp).  
See their web sites for details. 
 
Number of Copies to be Submitted by Type of Review and IRB 
(number below must include one original) 
IRB 
Exempt 
or 
Expedited 
Full Board Address for mailing complete application 
Behavioral 1 16 
CB# 3378, Bank of America Center 
Chapel Hill, NC  27599-3378 
Biomedical 
(includes 
Dental) 
3 3 
CB# 7097, Medical Building 52 
Chapel Hill, NC  27599-7097 
Nursing 1 14 
CB# 7460, Carrington Hall 
Chapel Hill, NC  27599-7460 
Public Health 2 14 
CB# 7400, Rosenau Hall 
Chapel Hill, NC  27599-7400 
 
Types of Review 
 
There are three levels of IRB Review (full board, expedited, and exempt), determined by the nature of the 
project, level of potential risk to human subjects, and the subject population.  The final determination of 
type of review applicable to a particular study is made by the IRB.  Regardless of the kind of review, all 
applications use the same submission form. 
 
Exempt and expedited review can be given to studies that constitute no more than minimal risk to the 
human subjects, i.e., the risk one experiences in daily living.  These reviews are done in the IRB office on 
a continual basis.  
 
Full board review is required for studies that involve greater than minimal risk or vulnerable populations 
that require special protection by the IRB.  These require review by the convened IRB at the next 
scheduled meeting.  See http://ohre.unc.edu/guide_to_irb.php for additional guidance. 
 
 
---- Instructions – Do not submit this page with your application ---- 
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OFFICE OF HUMAN RESEARCH ETHICS 
Institutional Review Board 
 
APPLICATION FOR IRB APPROVAL OF 
HUMAN SUBJECTS RESEARCH 
Version 28-Sep-2005 
  
 
Part A.1.  Contact Information, Agreements, and Signatures 
 
Title of Study:  The Effects of Hip Strength, Range of Motion, and Muscle Activity on a Knee Valgus 
Posistion During Functional Movement Tasks Date:  2-1-05 
 
Name and degrees of Principal Investigator:  Brian Vesci BS, LAT, ATC, PES 
Department:  Exercise and Sports Science Mailing address/CB #:  Sports Medicine Research 
Lab 
   Fetzer Gymnasium CB 8700 
   UNC-CH 
   Chapel Hill NC, 27514 
UNC-CH PID:  711073070 Pager:  N/A 
Phone #:  412-855-3080 Fax #:  919-962-0489 Email Address:  vesci@email.unc.edu 
 
For trainee-led projects: __ undergraduate  _X_ graduate  __ postdoc  __ resident  __ other 
Name of faculty advisor:  Dr. Darin Padua 
Department:  Exercise and Sports Science Mailing address/CB #:  Sports Medicine Research 
Lab 
   Fetzer Gymnasium CB 8700 
   UNC-CH 
   Chapel Hill NC, 27514 
 
Phone #:  919-843-5117 Fax #:  919-962-0489 Email Address:  dpadua@email.unc.edu 
 
Name, phone number, email address of project manager or coordinator, if any:   
 
List all other project personnel including co-investigators, and anyone else who has contact with 
subjects or identifiable data from subjects:  Lindsay Strickland, David Bell 
 
Name of funding source or sponsor:   
_X  not funded   __  Federal   __  State   __  industry   __  foundation   __  UNC-CH 
_    other (specify):      Sponsor or award number:   
 
Include following items with your submission, where applicable.  Check the items below and include in 
order listed. 
x This application.  One copy must have original PI signatures. 
x Consent and assent forms, fact or information sheets; include phone and verbal consent scripts 
□ HIPAA authorization addendum to consent form 
x All recruitment materials including scripts, flyers and advertising, letters, emails 
□ Questionnaires, scripts used to guide phone or in-person interviews, etc. 
□ Focus group guides 
□ Data use agreements (may be required for use of existing data from third parties) 
□ Addendum for Multi-Site Studies where UNC-CH is the Lead Coordinating Center 
For IRB Use 
Behav    Bio    Dent    Nurs    PH 
IRB Study #  
Rec’d  
 Full Expedited Exempt 
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□ Documentation of reviews from any other committees (e.g., GCRC, Oncology) 
□ Documentation of training in human research ethics for all study personnel 
□ Investigator Brochure if a drug study 
□ Protocol, grant application or proposal supporting this submission; (e.g., extramural grant 
application to NIH or foundation, industry protocol, student proposal) 
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Principal Investigator:  I will personally conduct or supervise this research study.  I will ensure 
that this study is performed in compliance with all applicable laws, regulations and University 
policies regarding human subjects research.  I will obtain IRB approval before making any 
changes or additions to the project.  I will notify the IRB of any other changes in the information 
provided in this application.  I will provide progress reports to the IRB at least annually, or as 
requested.  I will report promptly to the IRB all unanticipated problems or serious adverse events 
involving risk to human subjects.  I will follow the IRB approved consent process for all 
subjects.  I will ensure that all collaborators, students and employees assisting in this research 
study are informed about these obligations.  All information given in this form is accurate and 
complete.  
 
     
Signature of Principal Investigator Date 
 
Faculty Advisor if PI is a Student or Trainee Investigator:  I accept ultimate responsibility for 
ensuring that this study complies with all the obligations listed above for the PI. 
 
     
Signature of Faculty Advisor Date 
 
 
Department or Division Chair, Center Director (or counterpart) of PI:  (or Vice-Chair or 
Chair’s designee if Chair is investigator or otherwise unable to review):  I certify that this 
research is appropriate for this Principal Investigator, that the investigators are qualified to 
conduct the research, and that there are adequate resources (including financial, support and 
facilities) available.  I support this application, and hereby submit it for further review. 
 
    
Signature of Department Chair or designee Date 
 
    
Print Name of Department Chair or designee Department 
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Part A.2.  Summary Checklist 
 Are the following involved?  Yes No 
A.2.1.  Existing data, research records, patient records, and/or human biological specimens?   __   _X 
A.2.2.  Surveys, questionnaires, interviews, or focus groups with subjects?   _X_   __ 
A.2.3.  Videotaping, audiotaping, filming of subjects?   _X_   __ 
A.2.4.  Do you plan to enroll subjects from these vulnerable or select populations: 
a.  UNC-CH students or UNC-CH staff?  ........................................................................  
b.  Non-English-speaking?  ..............................................................................................  
c.  Decisionally impaired?  ...............................................................................................  
d.  Patients?  ......................................................................................................................  
e.  Prisoners, parolees and other convicted offenders?  ....................................................  
f.  Pregnant women?  ........................................................................................................  
g.  Minors (less than 18 years)?  If yes, give age range:      to     years  ...........................  
 
  _X_ 
  __ 
  __ 
  __ 
  __ 
  __ 
  __ 
 
  __ 
  _X_ 
  _X_ 
  _X_ 
  _X_ 
  _X_ 
  _X_ 
A.2.5.  a.  Is this a multi-site study (i.e., involves organization(s) outside UNC-CH)? 
b.  Will any of these sites be outside the United States? 
If yes, provide contact information for the foreign IRB. 
c.  Is UNC-CH the sponsor or lead coordinating center? 
If yes, include the Addendum for Multi-site Studies where UNC-CH is the Lead 
Coordinating Center. 
  __ 
  __ 
 
  __ 
 
  _X_ 
  _X_ 
 
  _X_ 
 
A.2.6.  Will there be a data and safety monitoring committee (DSMB or DSMC)?   __   _X_ 
A.2.7.  a.  Are you collecting sensitive information such as sexual behavior, HIV status, 
recreational drug use, illegal behaviors, child/physical abuse, immigration status, etc? 
b.  Do you plan to obtain a federal Certificate of Confidentiality for this study? 
 
 
  __ 
  __ 
 
 
  _X_ 
  _X_ 
A.2.8.  a.  Investigational drugs?  (provide IND #   )  
b.  Approved drugs for “non-FDA-approved” conditions? 
All studies testing substances in humans must provide a letter of acknowledgement from 
the UNC Health Care Investigational Drug Service (IDS). 
  __ 
  __ 
  _X_ 
  _X_ 
A.2.9.  Placebo(s)?   __   _X_ 
A.2.10.  Investigational devices, instruments, machines, software?  (provide IDE #  )   __   _X_ 
A.2.11.  Fetal tissue?   __  _X_ 
A.2.12.  Genetic studies on subjects’ specimens?   __   _X_ 
A.2.13.  Storage of subjects’ specimens for future research? 
 If yes, see instructions within the form Consent for Stored Samples.  
  __   _X_ 
A.2.14.  Diagnostic or therapeutic ionizing radiation, or radioactive isotopes, which subjects 
would not receive otherwise? 
 If yes, approval by the UNC-CH Radiation Safety Committee is required. 
  __ 
   
  _X_ 
   
A.2.15.  Recombinant DNA or gene transfer to human subjects? 
 If yes, approval by the UNC-CH Institutional Biosafety Committee is required. 
  __   _X_ 
A.2.16.  Does this study involve UNC-CH cancer patients? 
 If yes, submit this application directly to the Oncology Protocol Review Committee. 
  __   _X_ 
A.2.17.  Will subjects be studied in the General Clinical Research Center (GCRC)? 
 If yes, obtain the GCRC Addendum from the GCRC and submit complete application 
(IRB application and Addendum) to the GCRC. 
  __  _X_ 
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Part A.3.  Conflict of Interest Questions and Certification 
 
The following questions apply to all investigators and study staff engaged in the design, conduct, or 
reporting results of this project and/or their immediate family members.  For these purposes, "family" 
includes the individual’s spouse and dependent children.  “Spouse” includes a person with whom one 
lives together in the same residence and with whom one shares responsibility for each other’s welfare and 
shares financial obligations. 
 
A.3.1.  Currently or during the term of this research study, does any member of the 
research team or his/her family member have or expect to have: 
(a) A personal financial interest in or personal financial relationship (including 
gifts of cash or in-kind) with the sponsor of this study? 
(b) A personal financial interest in or personal financial relationship (including 
gifts of cash or in-kind) with an entity that owns or has the right to commercialize 
a product, process or technology studied in this project? 
(c) A board membership of any kind or an executive position (paid or unpaid) 
with the sponsor of this study or with an entity that owns or has the right to 
commercialize a product, process or technology studied in this project? 
 
 
 
__  yes 
 
 
__  yes 
 
 
__  yes 
 
 
 
_X  no 
 
 
_X  no 
 
 
_X  no 
A.3.2.  Has the University or has a University-related foundation received a cash or 
in-kind gift from the Sponsor of this study for the use or benefit of any member of the 
research team? 
 
 
__  yes 
 
 
_X  no 
A.3.3.  Has the University or has a University-related foundation received a cash or 
in-kind gift for the use or benefit of any member of the research team from an entity 
that owns or has the right to commercialize a product, process or technology studied 
in this project? 
 
 
 
__  yes 
 
 
 
_X  no 
 
If the answer to ANY of the questions above is yes, the affected research team member(s) must 
complete and submit to the Office of the University Counsel the form accessible at http://coi.unc.edu.  
List name(s) of all research team members for whom any answer to the questions above is yes:  
 
  
 
Certification by Principal Investigator:  By submitting this IRB application, I (the PI) 
certify that the information provided above is true and accurate regarding my own 
circumstances, that I have inquired of every UNC-Chapel Hill employee or trainee who will 
be engaged in the design, conduct or reporting of results of this project as to the questions 
set out above, and that I have instructed any such person who has answered “yes” to any of 
these questions to complete and submit for approval a Conflict of Interest Evaluation 
Form.  I understand that as Principal Investigator I am obligated to ensure that any 
potential conflicts of interest that exist in relation to my study are reported as required by 
University policy. 
 
    
Signature of Principal Investigator Date 
 
Faculty Advisor if PI is a Student or Trainee Investigator:  I accept ultimate responsibility 
for ensuring that the PI complies with the University’s conflict of interest policies and 
procedures.
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Signature of Faculty Advisor Date 
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Part A.4.  Questions Common to All Studies 
 
 
For all questions, if the study involves only secondary data analysis, focus on your proposed design, 
methods and procedures, and not those of the original study that produced the data you plan to use. 
 
A.4.1.  Brief Summary.  Provide a brief non-technical description of the study, which will be used for 
internal and external communications regarding this research.  Include purpose, methods, and 
participants.  Typical summaries are 50-100 words. 
 
  Lower extremity postural alignment, such as knee valgus (e.g. knock knees), is commonly 
described as a potential risk factor for various lower extremity injuries (e.g. anterior cruciate ligament 
sprain, patello-femoral pain).  Thus, an understanding of factors that influence knee valgus is believed 
to be an important aspect of understanding potential causes of lower extremity injuries.  Muscle 
strength, activation, and flexibility are all believed to be contributing factors to knee valgus 
alignment.  However, research has not investigated the influence of muscle strength, activation, and 
flexibility on knee valgus alignment.  Therefore, the purpose of this study is to determine if there are 
significant differences in hip muscle strength, activation, and flexibility in individuals with knee 
valgus alignment compared to those with normal knee alignment.  A secondary purpose of this study 
is to investigate the effects of a 6-week exercise program on knee valgus alignment, muscle strength, 
muscle activation, and flexibility.  Sixty participants will be recruited from the general population at 
the University of North Carolina at Chapel Hill as part of this study. 
 
A.4.2.  Purpose and Rationale.  Provide a summary of the background information, state the research 
question(s), and tell why the study is needed.  If a complete rationale and literature review are in an 
accompanying grant application or other type of proposal, only provide a brief summary here.  If there is 
no proposal, provide a more extensive rationale and literature review. 
 
  Posture is a very important and often neglected part of overall health.  Ideal posture maintains 
that structural integrity and optimum alignment of each component of the kinetic chain (Clark, 2001).  
The kinetic chain consists of the myofascial system, articular system, and the neural system (Clark, 
2001).  When one component of this system is out of alignment, then the entire system is placed at a 
disadvantage.  Postural malalignment is thought to create predictable patterns of tissue overload and 
dysfunction, initiating the cumulative injury cycle (Clark, 2001).  This cumulative injury cycle begins 
with tissue trauma, inflammation, leading to muscle spasm, adhesions, altered neuromuscular control, 
and muscle imbalance.  This cycle is thought to cause decreased athletic performance and eventual 
injury (Clark, 2001). 
 
  Knee valgus alignment during dynamic tasks (e.g. squatting) is a common postural dysfunction 
seen in the lower extremity.  Knee valgus alignment during squatting is defined as the mid-patella 
moving medially and crossing over the ipsilateral great toe as the knee flexes while squatting 
downward.  Knee valgus alignment has been described as a potentially dangerous movement pattern 
(Ireland, 1999).  Knee valgus alignment is accompanied by movement of the hip into adduction and 
internal rotation, which are commonly described mechanisms for anterior cruciate ligament (ACL) 
injury (Ireland, 1999).  It has also been shown that patello-femoral compressive forces increase with 
knee valgus alignment (Escamilla, 2001).  Thus, knee valgus alignment is also believed to be a 
contributing factor to patello-femoral pain syndrome.  Furthermore, the medial collateral ligament 
(MCL) is stressed when the knee is exposed to a valgus moment.  The MCL can become injured 
when that valgus stress becomes too great.  Individuals who undergo excessive knee valgus motion 
during functional tasks may place greater stress on the MCL and be at greater risk for injury.  These 
injuries can be detrimental to an individual’s physical well-being.  Therefore, it is important to 
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understand the factors that influence knee valgus alignment as this may improve our understanding of 
lower extremity injury risk factor, which may lead to the development of exercise programs to correct 
knee valgus alignment and reduce injury risk.  Currently, knee valgus alignment is thought to occur 
due to weakness or inhibition in the hip abdcutor muscles (e.g. gluteus medius, gluteus maximus) and 
hip external rotator muscles.  Meanwhile, the hip adductor and internal rotator muscles are believed to 
be tight or overactive (Clark, 2001).  However, research has not investigated if these hypothesized 
muscle imbalances actually exist in individuals demonstrating knee valgus alignment during a 
functional squatting task. 
 
  The purpose of this study is to ascertain what factors lead to knee valgus during squatting tasks.  
Once these factors are determined, a one-time intervention protocol will be administered to test 
whether or not these factors can be altered with an immediate intervention.  This intervention will 
focus on lengthening tight hip musculature, strengthening weakened hip musculature, and performing 
functional lower extremity exercises intending to improve muscular activation.  Furthermore, a six-
week long intervention protocol will also be implemented to study how these factors can be changed 
over time. 
 
  
  Specific Aim 1:  To compare hip muscle strength, hip muscle flexibility, and hip 
muscle activation between individuals with knee valgus alignment and those without 
knee valgus alignment (normal alignment) 
 
 Specific Aim 2:  To compare knee valgus alignment, hip muscle strength, hip 
muscle flexibility, and hip muscle activation before and after a one-time supervised 
exercise program. 
 
  Specific Aim 3:  To compare knee valgus alignment, hip muscle strength, hip 
muscle flexibility, and hip muscle activation before and after a six-week long exercise 
program. 
 
  
A.4.3.  Full description of the study design, methods and procedures.  Describe the research study.  
Discuss the study design; study procedures; sequential description of what subjects will be asked to do; 
assignment of subjects to various arms of the study if applicable; doses; frequency and route of 
administration of medication and other medical treatment if applicable; how data are to be collected 
(questionnaire, interview, focus group or specific procedure such as physical examination, venipuncture, 
etc.).  Include information on who will collect data, who will conduct procedures or measurements.  
Indicate the number and duration of contacts with each subject; outcome measurements; and follow-up 
procedures.  If the study involves medical treatment, distinguish standard care procedures from those that 
are research.  If the study is a clinical trial involving patients as subjects and use of placebo control is 
involved, provide justification for the use of placebo controls.   
 
  This study’s design incorporates a single testing session for the normal knee alignment (NKA) 
control group and a repeated measures design for the dysfunction groups, the knee valgus intervention 
and knee valgus control (KVI and KVC). Volunteers from the university community will attend a 
general screening session in the Sports Medicine Research Laboratory. During this screening session, 
volunteers will be asked to perform a double-leg squat test and assessed by the researchers for the 
knee valgus alignment in real time. Forty volunteers who demonstrate a noticeable knee valgus 
position, as defined by demonstrating medial mid-patella movement crossing over the ipsilateral great 
toe bilaterally, during the final descent phase of the squat, with and without a 2-inch heel block under 
their heel, will be asked to volunteer for the study. From this group of subjects, twenty subjects will 
be randomly assigned to one of the dysfunction groups, either the knee valgus intervention (KVI) 
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group or knee valgus control (KVC) group.  Twenty volunteers who do not demonstrate the knee 
valgus position will also be asked to volunteer for the study and be placed in the NKA control group.  
  
  Following the general screening session, all subjects will report to the Sports Medicine Research 
Laboratory for a single testing session. Upon arrival, all subjects will complete an informed consent 
form approved by the Institutional Review Board at the University of North Carolina at Chapel Hill 
along with a general health and activity level questionnaire. All subjects will be dressed in a t-shirt, 
athletic shorts and shoes.  Subjects will be video taped performing the double leg squat task used in 
the initial screening.  Subjects will then perform a five-minute warm-up on a stationary bicycle at a 
pace deemed comfortable to them. All testing will be performed on the subject’s dominant leg, which 
will be defined as the leg used to kick a ball for maximal distance. 
 
Range of Motion Assessment 
  After the warm-up, range of motion of the hip internal rotators and adductor complex will be 
recorded using a manual goniometer. For both range of motion measurements, the subjects will be in 
a supine position.  In order to measure the hip internal rotator’s range of motion, the subject’s leg will 
be placed into ninety degrees of hip flexion and knee flexion. The axis of the goniometer will be 
placed over the inferior pole of the patella while the stationary arm will be aligned with the subject’s 
trunk and the movement arm will be placed along the anterior midline of the tibia.  The tester will 
passively move the hip into external rotation until resistance is felt by the tester. At this position, the 
hip internal rotators’ range of motion will be recorded from the goniometer.  In order to measure the 
hip adductor complex’s range of motion, the leg will be in full knee extension and zero degrees of hip 
flexion/extension with the toe perpendicular to the floor. The axis of the goniometer will be placed 
over the dominant leg’s ASIS with the stationary arm aligned with the opposite ASIS while the 
movement arm is placed along the anterior midline of the femur using the anterior midline of the 
patella for reference. The tester will passively abduct the leg until resistance is felt by the tester. At 
this position, hip adductor range of motion will be recorded from the goniometer. 
 
Muscle Activation Assessment 
  Following muscle range of motion measurements, surface electromyography (EMG) will be used 
to measure the electrical activity of several hip muscles.  Two surface electrodes will be placed over 
the muscle bellies of the gluteus maximus, gluteus medius, and the adductor complex.  A single 
reference electrode will be placed over the tibial tuberosity to serve as an electrical ground reference.  
To reduce impedance to the EMG signal and allow for proper electrode fixation, electrode sites will 
be prepared by shaving any hair from the immediate vicinity of the muscle belly, lightly abrading the 
skin with an abrasive pad, and cleansing the skin with isopropyl alcohol.  To prevent movement of the 
electrodes and subsequent alteration of the EMG signal, electrodes will be secured to the leg using 
prewrap and athletic tape.  Manual muscle test will be performed to serve as a normalization of 
muscle activation.  Three five-second maximal voluntary contraction trials will be performed during 
manual muscle testing on the isokinetic dynamometer.  Signals from the electrodes will be passed to a 
battery operated FM transmitter worn by the subject, thus allowing for uninhibited movement. A 
receiver and analog-to-digital converted will convert the analog signal into digital data whereby it 
may be further analyzed by a computer utilizing custom software.  These procedures for 
electromyography are similar to a study conducted by Michael DiStefano (IRB # 03-EXSS-648). 
 
  EMG data will be collected while subjects perform the identical squat task as was performed 
during the initial screening procedures.  Following the double leg squat, instructions will then be 
given to each subject regarding the two jump landings and the researcher will demonstrate the 
maneuvers.  Before any trials are recorded, each participant will have three to five trials to practice 
the jump landings.  The practice trials will conclude when the subjects can demonstrate consistent 
movements with the jump landing.  During the first jump landing, subjects will be required to jump 
forward off of a 30-centimeter box onto a force plate located on the ground.  The distance between 
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the front of the box and the center of the force plate will be standardized for each subject, half their 
body height.  Subjects will be instructed to land with their dominant foot in the center of the force 
plate and then jump as high as they can.  This jump landing maneuver has been previously described 
in a study conducted by Lindsay Strickland (IRB # 04-EXSS-450).  The second jump landing task is a 
transverse jump, instead of a forward jump involving similar procedures as the first jump landing task 
described.  Instead of jumping forward onto the force plate, subjects will rotate ninety degrees in the 
air before landing.  After landing, the subjects will then jump again in the air as high as they can as in 
the first jump described.  The ninety-degree turn will occur in the air during the first part of the jump 
landing.  A total of 5 trials will be performed with a 30 second rest period in between each trial.  
Trials will be repeated if there is a problem with the recording, if the subject does not land properly 
on the force plate, or if the subject does not perform the jump landing correctly.  During all jump 
landing trials, EMG and force plate data will be recorded.  
 
Strength Assessment 
  Strength measurements for the hip internal rotators, external rotators, abductors, and extensors 
will be recorded by an isokinetic dynamometer at 60 degrees per second (Strength testing 
procedures are adopted from previous study IRB# 03-EXSS-538). For each strength test, 
subjects will perform one trial with five repetitions.  
 
  For hip internal rotation and external rotation strength, subjects will be seated with the hip and 
knee flexed to ninety degrees and the thigh stabilized with the chair straps. For hip internal rotation 
strength, the dynamometer will be aligned along the long axis of the femur, pressure will be applied 
to the distal lateral fibula, and will be tested through twenty degrees of motion beginning at five 
degrees of internal rotation through fifteen degrees of external rotation. The hip external rotation 
strength will be tested in the same position however the pressure will be applied to the distal medial 
tibia.  Motion will start at five degrees of external rotation and end at fifteen degrees of internal 
rotation.  Also a towel will be placed between the subjects knees to reduce the risk of hip adduction.   
 
  Hip extension strength will be tested in a supported standing position with the chair at the 
subject’s ASIS level.  The subject’s trunk will be stabilized to the chair by straps, and the 
dynamometer axis of rotation will be aligned with the anterior superior tip of the greater trochanter.  
Pressure will be applied to the distal posterior thigh and motion will start at ninety degrees of hip 
flexion and end at fifty degrees of hip flexion.   
 
  Hip abduction strength will be tested in a side lying position with the subject strapped in for 
stability.  The dynamometer axis of rotation will be aligned .5 inches medial to the ASIS at the level 
of the greater trochanter.  Pressure will be applied at the distal femur in the direction of adduction.  
Motion will be tested from zero to twenty degrees of hip abduction.  MVIC’s for the muscles having 
EMG activity recorded will be taken while the subject is in position after each individual isokinetic 
test.  MVIC data will be collected for three seconds. 
 
Intervention 
  The KVI group will perform 2 interventions.  The first intervention will occur during the first 
testing session (acute intervention) and the second intervention will take place over a six-week period 
(long term intervention) both consisting of the same exercises.  The intervention consists of and 
subjects will be asked to perform a series of two myofascial techniques and three static stretching 
exercises, which will take approximately 10 minutes to complete.  Following completion of the 
myofascial release and stretching exercises the subjects will perform two strengthening exercises and 
two integration exercises, which will take approximately 10 minutes to complete We will ask the 
participants to perform all exercises four times a week over the six-week long term intervention 
period.  These specific exercises include: 1) myofascial technique to inhibit the hip adductors 
(1minute), 2) myofascial technique to inhibit the tensor fascia latae (1minute), 3) stretching exercise 
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for the hip adductors (2 repetitions for 30 seconds), 4) stretching exercise for the tensor fascia latae (2 
repetitions for 30 seconds), 5) stretching exercise for the biceps femoris (2 repetitions for 30 seconds) 
6) strengthening exercise for the gluteus medius (3 sets of 10 repetitions) 7) strengthening exercise for 
the gluteus maximus (3 sets of 10 repetitions) 8) lateral tube walking (3 sets of 10 repetitions) and 9) 
single leg reach for balance (3 sets of 3 repetitions).  (Please see the included sheet entitled “Exercise 
Program Quick Reference Guide” for pictures of these exercises).  The KVC group will be asked to 
sit and relax for 20 minutes before repeating the testing again (double leg squat, jump landing, 
transverse jump landing.  Each dysfunction group, (KVI, KVC), will be asked to return 6 weeks after 
the initial testing session in order to be video taped during a squat task, -re-assess measures of 
strength, flexibility, and muscle activation during the three tasks.  The NKA group will be finished 
after their initial testing session. 
 
   
A.4.4.  Benefits to subjects and/or society.  Describe any potential for direct benefit to individual 
subjects, as well as the benefit to society based on scientific knowledge to be gained; these should be 
clearly distinguished.  Consider the nature, magnitude, and likelihood of any direct benefit to subjects.  If 
there is no direct benefit to the individual subject, say so here and in the consent form (if there is a 
consent form).  Do not list monetary payment or other compensation as a benefit. 
 
  All participants will receive an intervention protocol aimed at correcting the movement 
dysfunction through lengthening, strengthening, and improving muscle activity in the hip 
musculature; however, this protocol is one of the aspects of the study being researched, therefore the 
potential exists that it will not benefit the subject whatsoever. In addition, all participants will also 
receive rehabilitation equipment necessary for the intervention program. The subjects in the KVI and 
the KNA group will receive these materials at the time of their first testing session.  The KVC will 
receive the package when they have completed all of their testing. The sports medicine community 
will gain insight into what role flexibility, strength, and muscle activity play in contributing to knee 
valgus during a closed-chain knee flexion position.  Also, if these causative factors can be corrected 
in a one-time intervention or through a six week intervention protocol, then correction of these factors 
could potentially lead to a reduction in knee injuries from athletics.   
 
A.4.5.  Full description of risks and measures to minimize risks.  Include risk of psychosocial harm 
(e.g., emotional distress, embarrassment, breach of confidentiality), economic harm (e.g., loss of 
employment or insurability, loss of professional standing or reputation, loss of standing within the 
community) and legal jeopardy (e.g., disclosure of illegal activity or negligence), as well as known side 
effects of study medication, if applicable, and risk of pain and physical injury.  Describe what will be 
done to minimize these risks.  Describe procedures for follow-up, when necessary, such as when subjects 
are found to be in need of medical or psychological referral.  If there is no direct interaction with subjects, 
and risk is limited to breach of confidentiality (e.g., for existing data), state this. 
 
As with any physical activity, participation in this study carries a risk of bodily injury. The 
motions that subjects will be asked to perform are ones that repeatedly occur during physical activity. 
Therefore, subjects will be familiar and able to perform the tasks with minimal injury risk. To further 
minimize injury risk, participants will be allowed a warm up on a stationary bike to prepare 
themselves for testing. In case of injury, medical personnel (certified athletic trainers) will be located 
in the same building as testing, and ice will be available if needed. The subjects will be free to cease 
participation at any time. 
There exists a risk of embarrassment or discomfort to the subject due to the location of the EMG 
electrode placement.  This will be minimized by the fact that at no time will any subject be asked to 
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remove any article of clothing.  All electrode placements can be easily reached without removing 
clothing and with exposing only a small amount of skin.  To further minimize this risk, a researcher 
of the same sex as the subject will do the electrode placement.  Also, a towel will be used to drape 
and further minimize the amount skin that is exposed. 
There exists a small risk of muscle imbalances developing in subjects who are in the intervention 
group.  Through stretching and strengthening certain muscle groups and not others there always exists 
a small chance of injury due to these imbalances.  However, the exercises that will be given to 
subjects are aimed at correcting imbalances that may already exist, which should minimize any risk of 
injury associated with the intervention.  Also, the potential for muscle strain injuries exist when 
stretching or strengthening, or bruising can occur from myofascial techniques.  To minimize these 
risks, all subjects will receive the same instruction from certified athletic trainers who are trained in 
how to properly execute these exercises so that there is little risk for injury.  Subjects will be given a 
handout describing how to properly perform exercises and at any time have the right to contact the 
researchers to answer any questions they may have about how to properly perform the exercises. 
There exists a risk of minor pain being experienced by the subject from the shaving and abrading 
of the areas prior to electrode placement.  Subjects will be informed of this risk in the consent form 
they read and sign; however, due to the necessity of these steps to ensure a clear EMG signal there are 
no steps to take to avoid this possibility of pain. 
 
 
 
A.4.6.  Data analysis.  Tell how the qualitative and/or quantitative data will be analyzed.  Explain how 
the sample size is sufficient to achieve the study aims.  This might include a formal power calculation or 
explanation of why a small sample is sufficient (e.g., qualitative research, pilot studies). 
 
  The data of each dependent variable will be analyzed using two-way repeated measures analyses 
of variance comparing groups and testing sessions. Prior studies using similar techniques indicate for 
an estimated power of .80, 20 subjects will be needed for each group.  
 
 
 
 
A.4.7.  Will you collect or receive any of the following identifiers as part of the study data?  Does not 
apply to consent forms. 
 
 _    No    _x  Yes    If yes, check all that apply: 
 
 
a. _x Names 
b. _x Telephone numbers   
c. __ Any elements of dates (other than year) 
for dates directly related to an individual, 
including birth date, admission date, 
discharge date, date of death.  For ages 
over 89:  all elements of dates (including 
year) indicative of such age, except that 
such ages and elements may be aggregated 
into a single category of age 90 and older 
d. __ Any geographic subdivisions smaller 
than a State, including street address, city, 
county, precinct, zip code and their 
equivalent geocodes, except for the initial 
three digits of a zip code 
e. __ Fax numbers  
f. _x Electronic mail addresses 
g. __ Social security numbers  
h. __ Medical record numbers 
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i. __ Health plan beneficiary numbers 
j. __ Account numbers  
k. __ Certificate/license numbers  
l. __ Vehicle identifiers and serial numbers 
(VIN), including license plate numbers  
m. __ Device identifiers and serial numbers 
(e.g., implanted medical device) 
n. __ Web universal resource locators (URLs)  
o. __ Internet protocol (IP) address numbers  
p. __ Biometric identifiers, including finger 
and voice prints 
q. _  Full face photographic images and any 
comparable images 
r. __ Any other unique identifying number, 
characteristic or code, other than dummy 
identifiers that are not derived from actual 
identifiers and for which the re-
identification key is maintained by the 
health care provider and not disclosed to the 
researcher 
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A.4.8.  Data sharing.  With whom will identifiable (contains any of the 18 identifiers listed in 
question 7 above) data be shared outside the immediate research team?  For each, explain 
confidentiality measures.  Include data use agreements, if any. 
 
 _x_  No one 
 __  Coordinating Center:   
 __  Statisticians:   
 __  Consultants:   
 __  Other researchers:   
 __  Registries:   
 __  Sponsors:   
 __  External labs for additional testing:   
 __  Journals:   
 __  Publicly available dataset:   
 __  Other:   
 
 
A.4.9.  Confidentiality of the data.  Describe procedures for maintaining confidentiality of the data 
you will collect or will receive.  Describe how you will protect the data from access by those not 
authorized.  How will data be transmitted among research personnel?  Where relevant, discuss the 
potential for deductive disclosure (i.e., directly identifying subjects from a combination of indirect 
IDs).  Describe your plan to destroy identifiers.  When will identifiers be destroyed? 
 
  No subjects will be identified in any report or publication about this study.  All subjects will 
be assigned an identification number (ID) for data collection.  This ID number will be matched to 
the identifiers listed above in an excel document.  This will be the only place in which a subjects 
identifiers and ID number will co-exist.  This document will be stored on a separate cd apart from 
all other data that will be collected.  These identifiers will be collected during the screening 
session for the sole purpose of contacting subjects to schedule subsequent testing sessions.  Once 
a subject has completed all of his/her testing sessions, then their identifiers will be deleted from 
the excel document until all subjects have been tested and the document is destroyed.  All 
information on the data collection form used for testing will be referenced with the subject ID 
number. At no time will the identifiers above be listed on the same document as data collected 
during testing.  All data will be stored on cds which will be kept in the Sports Medicine Research 
Lab.  All videotapes will be stored in a secure area of the Sports Medicine Research Lab. All data 
analysis will be performed on computers in the Sports Medicine Research Lab where a password 
is necessary for access to the computers.  Only members performing research have access to these 
computers, therefore identification of any subjects or data is very unlikely.  If disclosure is ever 
required, UNC-CH will take all steps allowable by law to protect the privacy of personal 
information. 
 
  Personal privacy during testing sessions will be maintained through limiting the people 
within the research lab to current employees of the lab and the testers themselves.  The only door 
to enter the lab is locked with key card access to ensure privacy.  Patients will be properly draped 
with a towel during electrode placement to ensure privacy. 
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A.4.10.  Data security for storage and transmission.  Please check all that apply. 
 
For electronic data: 
 __  Secure network __  Password access __  Encryption  
 __  Other (describe):   
 __  Portable storage (e.g., laptop computer, flash drive) 
 Describe how data will be protected for any portable device:   
 
For hardcopy data (including human biological specimens, CDs, tapes, etc.): 
 __  Data de-identified by research team (stripped of the 18 identifiers listed in question 7 above) 
 _x_  Locked suite or office 
 _x_  Locked cabinet  
 _x_  Data coded by research team with a master list secured and kept separately 
 __  Other (describe):   
 
Part A.5.  The Consent Process and Consent Documentation (including 
Waivers) 
 
The standard consent process is for all subjects to sign a document containing all the elements of 
informed consent, as specified in the federal regulations.  Some or all of the elements of consent, 
including signatures, may be altered or waived under certain circumstances. 
 
• If you will obtain consent in any manner, complete section A.5.1. 
• If you are obtaining consent, but requesting a waiver of the requirement for a signed consent 
document, complete section A.5.2. 
• If you are requesting a waiver of any or all of the elements of consent, complete section A.5.3. 
 
You may need to complete more than one section.  For example, if you are conducting a phone 
survey with verbal consent, complete sections A.5.1, A.5.2, and possibly A.5.3. 
 
 
A.5.1.  Describe the process of obtaining informed consent from subjects.  If children will be 
enrolled as subjects, describe the provisions for obtaining parental permission and assent of the child.  
If decisionally impaired adults are to be enrolled, describe the provision for obtaining surrogate 
consent from a legally authorized representative (LAR).  If non-English speaking people will be 
enrolled, explain how consent in the native language will be obtained.  Address both written 
translation of the consent and the availability of oral interpretation.  After you have completed this 
part A.5.1, if you are not requesting a waiver of any type, you are done with Part A.5.; proceed to 
Part B. 
 
Informed consent will be obtained from all subjects prior to any testing.  Subjects will report 
to the University of North Carolina-Chapel Hill, Sports Medicine Research Lab in Fetzer Gym.  
Before beginning the testing session the subject will be asked to read an informed consent 
agreement outlining the procedures, protocols and potential risks of the study.  This informed 
consent agreement form will be in accordance with the standards set forth by the Medical IRB at 
the University of North Carolina at Chapel Hill.  After the subjects sign the consent form, a copy 
will be given to them, and testing will commence. 
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A.5.2.  Justification for a waiver of written (i.e., signed) consent.  The default is for subjects to sign 
a written document that contains all the elements of informed consent.  Under limited circumstances, 
the requirement for a signed consent form may be waived by the IRB if either of the following is true: 
 
a.  The only record linking the subject and the research would be the consent 
document and the principal risk would be potential harm resulting from a breach 
of confidentiality (e.g., study involves sensitive data that could be damaging if 
disclosed). 
Explain.   
 
b.  The research presents no more than minimal risk of harm to subjects and 
involves no procedures for which written consent is normally required outside of 
the research context (e.g., phone survey). 
Explain.   
 
If you checked “yes” to either, will consent be oral?  Will you give out a fact 
sheet?  Use an online consent form, or include information as part of the survey 
itself, etc?  
__  yes  __  no 
 
 
 
 
 
__  yes  __  no 
 
 
 
A.5.3.  Justification for a full or partial waiver of consent.  The default is for subjects to sign a 
written document that contains all the elements of informed consent.  A waiver might be requested for 
research involving only existing data or human biological specimens (see also Part C).  More rarely, it 
might be requested when the research design requires withholding some study details at the outset 
(e.g., behavioral research involving deception).  In limited circumstances, parental permission may be 
waived.  This section should also be completed for a waiver of HIPAA authorization if research 
involves Protected Health Information (PHI) subject to HIPAA regulation, such as patient records. 
 
 __  Requesting waiver of some elements (specify; see SOP 28 on the IRB web site):   
 __  Requesting waiver of consent entirely 
If you check either of the boxes above, answer items a-f..  To justify a full waiver of the 
requirement for informed consent, you must be able to answer “yes” (or “not applicable” for 
question c) to items a-f.  Insert brief explanations that support your answers. 
 
a.  Will the research involve no greater than minimal risk to subjects or to their 
privacy? 
Explain.   
 
__  yes  __  no 
 
b.  Is it true that the waiver will not adversely affect the rights and welfare of 
subjects?  (Consider the right of privacy and possible risk of breach of 
confidentiality in light of the information you wish to gather.) 
Explain.   
__  yes  __  no 
 
c.  When applicable to your study, do you have plans to provide subjects with 
pertinent information after their participation is over?  (e.g., Will you provide 
__  yes  __  not 
applicable 
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details withheld during consent, or tell subjects if you found information with 
direct clinical relevance?  This may be an uncommon scenario.) 
Explain.   
 
 
d.  Would the research be impracticable without the waiver?  (If you checked 
“yes,” explain how the requirement to obtain consent would make the research 
impracticable, e.g., are most of the subjects lost to follow-up or deceased?).  
Explain.   
__  yes  __  no 
 
e.  Is the risk to privacy reasonable in relation to benefits to be gained or the 
importance of the knowledge to be gained? 
Explain.   
__  yes  __  no 
 
If you are accessing patient records for this research, you must also be able to answer “yes” to 
item f to justify a waiver of HIPAA authorization from the subjects. 
 
f.  Would the research be impracticable if you could not record (or use) Protected 
Health Information (PHI)?  (If you checked “yes,” explain how not recording or 
using PHI would make the research impracticable). 
Explain.   
__  yes  __  no 
 
Part B. Questions for Studies that Involve Direct Interaction with Human 
Subjects 
 →  If this does not apply to your study, do not submit this section. 
 
B.1.  Subjects.  Specify number, gender, ethnicity, race, and age.  Specify whether subjects are 
healthy volunteers or patients.  If patients, specify any relevant disease or condition and indicate how 
potential subjects will be identified. 
 
  Subjects will be divided into two groups based upon their results on the double leg squat task 
(DLST).  The dysfunction group will consist of subjects who demonstrate bilateral knee 
adduction during the DLST both with and without a two-inch heel block place under the 
calcaneus.  The heel block will be used to ensure that tightness in the posterior lower leg is not 
influencing a knee valgus alignment.  The dysfunction group will be further divided, randomly, 
into an intervention group (KVI) and a control group (KVC).  The normal alignment control 
group (NKA) will consist of subjects who do not demonstrate knee adduction on either leg during 
the DLST with and without a two-inch heel block.  Subjects in the control group will be matched 
to subjects in the hip dysfunction groups by age, height, weight, gender and physical activity 
level.  Each group will consist of 20 subjects whose ages range from 18-35 years.  Subjects will 
be otherwise healthy volunteers that have no current musculoskeletal injuries or have not 
sustained an injury to either lower extremity in the past six months.  No potential subject will be 
excluded due to gender, ethnicity, or race. 
 
 
B.2.  Inclusion/exclusion criteria.  List required characteristics of potential subjects, and those that 
preclude enrollment.  Justify exclusion of any group, especially by criteria based on gender, ethnicity, 
race, or age.  If pregnant women are excluded, or if women who become pregnant are withdrawn, 
specific justification must be provided. 
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Inclusion Criteria for Dysfunction Groups:  Aysmptomatic with & without activity and 
during the double leg squat; Demonstrates bilateral knee adduction during double leg squat (no 
heel block); Demonstrates bilateral knee adduction during double leg squat with 2-inch heel block 
placed underneath calcaneus. 
 
Inclusion Criteria for Normal Alignment Group: Aysmptomatic with & without activity and 
during the double leg squat; Does not demonstrate bilateral knee adduction during double leg 
squat with and without a two-inch heel block. 
 
No potential subject will be excluded due to gender, ethnicity, or race.  Pregnant women will 
be excluded and women who become pregnant will be withdrawn due to the complexity and 
activity necessary for the functional tasks. 
 
 
 
B.3.  Methods of recruiting.  Describe how and where subjects will be identified and recruited.  
Indicate who will do the recruiting, and tell how subjects will be contacted.  Describe efforts to ensure 
equal access to participation among women and minorities.  Describe how you will protect the 
privacy of potential subjects during recruitment.  For prospective subjects whose status (e.g., as 
patient or client), condition, or contact information is not publicly available (e.g., from a phone book 
or public web site), the initial contact should be made with legitimate knowledge of the subjects’ 
circumstances.  Ideally, the individual with such knowledge should seek prospective subjects’ 
permission to release names to the PI for recruitment.  Alternatively, the knowledgeable individual 
could provide information about the study, including contact information for the investigator, so that 
interested prospective subjects can contact the investigator.  Provide the IRB with a copy of any 
document or script that will be used to obtain the patients’ permission for release of names or to 
introduce the study.  Check with your IRB for further guidance. 
 
  
 All potential subjects will be recruited through informational emails and flyers written by the 
principal investigator.  The contact number in the email and the flyer will be that of the 
investigator, Brian Vesci.  The potential subjects will have the freedom to either respond or 
ignore the emails; therefore, they will not feel obligated to participate in the study. 
 
 Emails will be sent to the current student and faculty population of the University of North 
Carolina at Chapel Hill via listservs.  Efforts to ensure equal access to participation among 
women and minorities will be limited only by the current population of women and minorities in 
the student body and faculty population. 
 
 
B.4.  Protected Health Information (PHI).  If you need to access Protected Health Information 
(PHI) to identify potential subjects who will then be contacted, you will need a limited waiver of 
HIPAA authorization.  If this applies to your study, please provide the following information. 
 
a. Will the information collected be limited only to that necessary to contact the subjects to ask if 
they are interested in participating in the study?   
 
b. How will confidentiality/privacy be protected prior to ascertaining desire to participate?   
 
c. When and how will you destroy the contact information if an individual declines participation?   
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B.5.  Duration of entire study and duration of an individual subject’s participation, including 
follow-up evaluation if applicable.  Include the number of required contacts and approximate 
duration of each contact. 
 
  All subjects will have an initial contact during the screening process. This will last 
approximately five minutes per subject. 
  
  Subjects in the normal alignment group (NKA) will only require one more contact for the 
testing session. This will last approximately one hour. 
 
  Subjects in the dysfunction groups (KVI, KVC) will require two further contacts beyond the 
initial screening.  Both of these testing sessions will last approximately one and a half hours. The 
first of these testing sessions will occur following the general screening session and the final 
testing session will occur six weeks later.  
 
 
B.6.  Where will the subjects be studied?  Describe locations where subjects will be studied, both 
on and off the UNC-CH campus. 
 
  All subjects will be studied in the Sports Medicine Research Lab in the Fetzer Gymnasium 
building on the campus of the University of North Carolina at Chapel Hill 
 
 
B.7.  Privacy.  Describe procedures that will ensure privacy of the subjects in this study.  Examples 
include the setting for interviews, phone conversations, or physical examinations; communication 
methods or mailed materials (e.g., mailings should not indicate disease status or focus of study on the 
envelope). 
 
  No subjects will be identified in any report or publication about this study.  All subjects will 
be assigned an identification number (ID) for data collection.  All data will be stored on cds 
which will be kept in the Sports Medicine Research Lab.  All videotapes will be stored in a secure 
area of the Sports Medicine Research Lab. All data analysis will be performed on computers in 
the Sports Medicine Research Lab where a password is necessary for access to the computers.  
Only members performing research have access to these computers, therefore identification of 
any subjects or data is very unlikely.  If disclosure is ever required, UNC-CH will take all steps 
allowable by law to protect the privacy of personal information. 
 
  Personal privacy during testing sessions will be maintained through limiting the people 
within the research lab to current employees of the lab and the testers themselves.  The only door 
to enter the lab is locked with key card access to ensure privacy.  Patients will be properly draped 
with a towel during electrode placement to ensure privacy. 
 
 
B.8.  Inducements for participation.  Describe all inducements to participate, monetary or non-
monetary.  If monetary, specify the amount and schedule for payments and how this will be prorated 
if the subject withdraws (or is withdrawn) from the study prior to completing it.  For compensation in 
foreign currency, provide a US$ equivalent.  Provide evidence that the amount is not coercive (e.g., 
describe purchasing power for foreign countries).  Include food or refreshments that may be provided. 
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  All participants in this study will receive an exercise package valued at approximately thirty 
to forty dollars per participant following completion of the study. This package will include 
exercise tubing, foam rollers, and the exercise protocol. 
 
 
B.9.  Costs to be borne by subjects.  Include child care, travel, parking, clinic fees, diagnostic and 
laboratory studies, drugs, devices, all professional fees, etc.  If there are no costs to subjects other 
than their time to participate, indicate this. 
 
 There will be no cost borne by subjects other than their time. 
 
Part C. Questions for Studies using Data, Records or Human Biological 
Specimens without Direct Contact with Subjects 
 →  If this does not apply to your study, do not submit this section. 
 
C.1.  What records, data or human biological specimens will you be using?  (check all that apply): 
 
 __ Data already collected for another research study 
 __ Data already collected for administrative purposes (e.g., Medicare data, hospital discharge 
data) 
 __ Medical records (custodian may also require form, e.g., HD-974 if UNC-Health Care System) 
 __ Electronic information from clinical database (custodian may also require form) 
 __ Patient specimens (tissues, blood, serum, surgical discards, etc.) 
 __ Other (specify):   
 
 
C.2.  For each of the boxes checked in 1, how were the original data, records, or human biological 
specimens collected?  Describe the process of data collection including consent, if applicable. 
 
 
 
 
C.3.  For each of the boxes checked in 1, where do these data, records or human biological specimens 
currently reside? 
 
 
 
 
C.4.  For each of the boxes checked in 1, from whom do you have permission to use the data, records 
or human biological specimens?  Include data use agreements, if required by the custodian of data 
that are not publicly available. 
 
 
 
 
C.5.  If the research involves human biological specimens, has the purpose for which they were 
collected been met before removal of any excess?  For example, has the pathologist in charge or the 
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clinical laboratory director certified that the original clinical purpose has been satisfied?  Explain if 
necessary. 
 
__  yes     __  no      __  not applicable (explain)      
 
 
C.6.  Do all of these data records or specimens exist at the time of this application?  If not, explain 
how prospective data collection will occur. 
 
__  yes      __  no      If no, explain   
 
 
University of North Carolina-Chapel Hill 
Consent to Participate in a Research Study  
Adult Subjects  
Biomedical Form 
 
IRB Study #__05-EXSS-839________  
Consent Form Version Date: _3/2/06_______  
Title of Study: The Effects of Hip Strength, Range of Motion, and Muscle Activity on a 
Knee Valgus Position During Functional Movement Tasks. 
 
Principal Investigator: Brian Vesci, BS, ATC, LAT, PES 
UNC-Chapel Hill Department: Department of Exercise and Sport Science 
UNC-Chapel Hill Phone number: (919) 962-7187 
Email Address: vesci@email.unc.edu 
Co-Investigators: David R. Bell, MEd, ATC, LAT; Lindsay Strickland, MS, ATC, LAT  
Faculty Advisor:  Darin Padua, PhD, ATC, LAT  
Funding Source:  
 
Study Contact telephone number: 919-962-7187 
Study Contact email:vesci@email.unc.edu  
_________________________________________________________________ 
  
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary.  
You may refuse to join, or you may withdraw your consent to be in the study, for any reason. 
 
Research studies are designed to obtain new knowledge that may help other people in the 
future.  You may not receive any direct benefit from being in the research study. There also 
may be risks to being in research studies. 
 
Deciding not to be in the study or leaving the study before it is done will not affect your 
relationship with the researcher, your health care provider, or the University of North 
Carolina-Chapel Hill. 
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Details about this study are discussed below.  It is important that you understand this 
information so that you can make an informed choice about being in this research study.  
You will be given a copy of this consent form.  You should ask the researchers named above, 
or staff members who may assist them, any questions you have about this study at any time. 
                                    
What is the purpose of this study?  
The position of knee valgus (a.k.a. knock knee), which occurs as the knees move inward 
towards the great toe while moving into a squatted position, has been theorized as a position 
that may predispose an individual for various knee and lower extremity injuries. Limited 
research has been performed to investigate potential causes of knee valgus.  Also, there is no 
research investigating exercises to correct knee valgus alignment. Therefore, the primary 
purpose of this study is to investigate the differences in muscle strength, muscle flexibility, 
and muscle activation between subjects with and without knee valgus alignment during 
squatting.  A secondary purpose of this study is to examine the effectiveness of an exercise 
intervention on changing knee valgus alignment, muscle strength, muscle flexibility, and 
muscle activation.  
 
 
Are there any reasons you should not be in this study? 
You should not participate in this study if any of the following apply to you:  
• You are not interested in doing strength or flexibility exercises 
• You have any current symptoms of injury (redness, swelling, pain) 
• You have used an external ankle brace/support on a regular basis within the past three 
months 
• You have had leg surgery in the past year  
• You have had a lower extremity injury in the past three months that required you to 
miss three or more consecutive days of physical activity 
 
How many people will take part in this study? 
If you decide to be in this study, you will be one of approximately 60 participants in this 
research study. 
 
How long will your part in this study last?  
Your participation in this study will depend upon your group assignment. If you are in the 
group identified with normal knee alignment (NKA), you will only take part in one testing 
session that will last approximately one hour.  If you are in the groups identified with a knee 
valgus alignment your involvement will consist of two testing sessions.  The first testing 
session will last approximately one and a half hours.  The second testing session will take 
place six weeks after the first session and will last approximately one and a half hours.   
 
What will happen if you take part in the study? 
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Subjects in the knee valgus intervention group (KVI) and the normal knee alignment group 
(NKA) will receive a foam roller, exercise band, and exercise program aimed at improving 
their knee valgus alignment at the time of their first testing session. The other group, knee 
valgus control (KVC), will receive the same exercise package at the completion of their 
testing. It is important to understand that as a subject you will receive the exercise package 
however you may receive no benefit from the proposed exercises as they are part of what is 
being analyzed in the study and their ability to improve knee valgus alignment has not yet 
been demonstrated. 
 
Subjects will be asked to attend the testing sessions wearing a t-shirt, shorts and athletic 
shoes.  Subjects will be divided into three groups.  One group will consist of those who have 
been identified with normal knee alignment (NKA).  The two additional groups will be 
randomly assigned and are those participants that have been identified as having knee valgus 
during a squat.  One of these groups will be another control group, the knee valgus control 
(KVC), and the other will receive the exercise program, the knee valgus intervention (KVI). 
 
Testing Session 1 (NKA, KVC, KVI): 
The session will begin with you being video taped during a squat task to confirm and 
document whether or not you demonstrate knee valgus.  You will then ride a stationary 
bicycle for five minutes to warm-up.  After you are sufficiently warmed up, we will measure 
the range of motion of your hip.  Adhesive electrodes designed to measure electrical activity 
of your muscles will be placed on the outside and back (high buttocks/low back) of your hip 
as well as approximately half way between your hip and your knee on the inside of your 
thigh.  A small area will be shaven and cleansed with alcohol to ensure that electrodes will be 
secured in place.  An examiner of the same sex as yourself will perform all electrode 
placements.  At no time will you be asked to remove any articles of clothing.  The electrodes 
can be placed properly with minimal skin exposure and a towel will be used for draping in an 
attempt to remove any feelings of discomfort.  Examiners will then measure your hip muscle 
strength on an isokinetic-strength testing machine, meaning that your maximal strength will 
be tested at a predetermined and constant speed.   
 
You will then perform three different activities during which the investigators will measure 
your muscle activity.  They consist of 5 squats, 5 straight ahead jump landings, and 5 jump 
landings in which the subject will rotate 90 degrees in the air, from an approximately 12-inch 
high box to a distance half of your body height away. 
 
At this time the NKA group will be finished with testing and will receive the exercises 
package.  The KVI group will be asked to perform a series of exercises that will take 
approximately 20 minutes to complete.  The exercises include five stretching exercises, two 
strengthening exercises, and two functional exercises.  These specific exercises include: 
  
 1) Foam roller stretch to the inside of the thigh (1 minute) 
 2) Foam roller stretch to the outside of the thigh (1 minute) 
 3) Stretching exercise for the inside of the thigh (2 repetitions for 30 seconds) 
 4) Stretching exercise for the outside of the thigh (2 repetitions for 30 seconds) 
 5) Stretching exercise for the back of the thigh (2 repetitions for 30 seconds) 
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 6) Strengthening exercise for the outside of the thigh (3 sets of 10 repetitions) 
 7) Strengthening exercise for the back of the thigh (3 sets of 10 repetitions) 
 8) Side stepping with resistance band around ankles (3 sets of 10 repetitions) 
 9) Single leg squat reach for balance (3 sets for 3 repetitions) 
 
The KVC group will rest for 20 minutes instead of performing exercises.  After the rest or 
exercise period each subject will perform the squats, jump landing, and transverse jump 
landing for a second time.  Subjects will not have to repeat the strength testing after the rest 
or exercises.  Finally, the exercise group (KVI) will be asked to perform the exercise 
program at home, four times a week over a six-week period.  Each subject in the exercise 
group will be given a handout with pictures depicting each exercise, as well as a daily 
exercise log to chart when and which exercises were performed.   
 
Testing Session 2 (KVC, KVI): 
Both groups identified with a knee valgus alignment will return to the Sports Medicine 
Research Laboratory after 6-weeks.  The second testing session will be very similar to the 
first.  All groups will: 1) warm-up on the stationary bike, 2) have the electrodes placed again, 
and 3) have their strength test again exactly as the first session.  Finally, each group will 
perform 5 squats, 5 jump landings (half the distance of their height), and 5 transverse 
landings (half the distance of their height).  No exercise intervention will take place in the 
second session. At this point after the second testing session the KVC group will be given the 
exercise package and will have the experimental exercise protocol explained to them. 
 
 
What are the possible benefits from being in this study? 
Research is designed to benefit society by gaining new knowledge about knee valgus. The 
benefits to you from being in this study may include a prescriptive exercise program 
designed to attempt to correct hip muscle weakness and tightness that may exist. The 
researcher will discuss your performance on the jumping and squatting maneuvers with you 
if you wish.  This information may help educate you on improving your jumping and 
squatting technique. The results of this study may benefit society by providing data on what 
factors may influence a knee valgus position during functional movements that may 
predispose someone to various knee injuries as well as if any intervention exercise programs 
can be implemented to correct these factors.   
 
What are the possible risks or discomforts involved with being in this study?  
This study involves a jumping and squatting maneuver that may involve the following risks 
and/or discomforts to you:  
• Possibility of a ligament injury to the joints of your lower extremities  
• Possibility of muscle strains/pulls/soreness in your lower extremities  
• Possibility of pain due to shaving and abrading sites of electrode placement  
• Possible embarrassment due to electrode placement 
• There may be uncommon or previously unrecognized risks that might occur  
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While the possibility of the above mentioned risks exist, all appropriate precautions will be 
taken to minimize these risks. 
No penalty will be incurred if you decide to not participate or if you withdraw yourself from 
testing during the study.  Please do not feel pressured to participate, or continue with the 
study if at any point you feel uncomfortable. 
What if we learn about new findings or information during the study?  
You will be given any new information gained during the course of the study that might 
affect your willingness to continue your participation.   
 
How will your privacy be protected?   
No subjects will be identified in any report or publication about this study. All subjects will 
be identified as a number throughout data collection. All data storage and analysis will be on 
computers the sports medicine research lab where a password is necessary for access to the 
computers. Only members performing research have access to the lab and use of its 
computers. Although every effort will be made to keep research records private, there may be 
times when federal or state law requires the disclosure of such records, including personal 
information. This is very unlikely, but if disclosure is ever required, The University of North 
Carolina at Chapel Hill will take all steps allowable by law to protect the privacy of personal 
information.  
 
What will happen if you are injured by this research? 
All research involves a chance that something bad might happen to you.  This may include 
the risk of personal injury. In spite of all safety measures, you might develop a reaction or 
injury from being in this study. If such problems occur, the researchers will help you get 
medical care, but any costs for the medical care will be billed to you and/or your insurance 
company. The University of North Carolina at Chapel Hill has not set aside funds to pay you 
for any such reactions or injuries, or for the related medical care. However, by signing this 
form, you do not give up any of your legal rights. 
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty.  The investigators also have 
the right to stop your participation at any time. This could be because you have had an 
unexpected reaction, or have failed to follow instructions, or because the entire study has 
been stopped. 
 
Will you receive anything for being in this study? 
You will be receiving an exercise package valued at approximately thirty to forty dollars 
consisting of exercise and rehabilitation equipment (foam rollers, exercise tubing), as well as 
the exercise protocol, following completion of the study.  If you are in exercise group (KVI) 
or the normal knee alignment group (NKA) you will receive the exercise equipment and the 
exercise protocol at the time of your first testing session. If you are not in this group, you will 
receive the exercise package, as well as the exercise intervention, when you have completed 
all testing associated with the study. 
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Will it cost you anything to be in this study? 
The only cost to you will be in your time and transportation to the University of North 
Carolina at Chapel Hill Sports Medicine Research Laboratory for your testing session.  
 
What if you are a UNC student? 
You may choose not to be in the study or to stop being in the study before it is over at any 
time.  This will not affect your class standing or grades at UNC-Chapel Hill.  You will not be 
offered or receive any special consideration if you take part in this research. 
 
What if you are a UNC employee? 
Taking part in this research is not a part of your University duties, and refusing will not affect 
your job.  You will not be offered or receive any special job-related consideration if you take 
part in this research.   
 
Who is sponsoring this study? 
The National Academy of Sports Medicine is donating the equipment provided to the 
subjects for this study. However they are not sponsoring the study.  Researchers for this 
study are not receiving any type of compensation for their work. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this 
research. If you have questions, or if a research-related injury occurs, you should contact the 
researchers listed on the first page of this form. 
 
What if you have questions about your rights as a research subject? 
All research on human volunteers is reviewed by a committee that works to protect your 
rights and welfare.  If you have questions or concerns about your rights as a research subject 
you may contact, anonymously if you wish, the Institutional Review Board at 919-966-3113 
or by email to IRB_subjects@unc.edu. 
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
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IRB Study #   05-EXSS-839  
 
Subject’s Agreement:  
 
I have read the information provided above.  I have asked all the questions I have at this time.  
I voluntarily agree to participate in this research study. 
 
_________________________________________   _________________ 
Signature of Research Subject     Date 
 
_________________________________________ 
Printed Name of Research Subject 
 
_________________________________________  _________________ 
Signature of Person Obtaining Consent   Date 
 
_________________________________________ 
Printed Name of Person Obtaining Consent 
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University of North Carolina – Chapel Hill 
Research Study Questionnaire 
Adult Subjects 
             
 
Medical IRB Study # 05-EXSS-839 
 
Title of Study: The Effects of Hip Strength, Range of Motion, and Muscle Activity on a 
Knee Valgus Position During Functional Movement Tasks. 
Principal Investigator: Brian Vesci, BS, ATC, LAT, PES 
UNC-CH Department: EXSS 
Phone Number: 919-962-7187 
 
Co-Investigators: David Bell, Med, ATC, LAT; Lindsay Strickland, MS, ATC, LAT 
 
Sponsor: None 
             
 
1. Are you currently in good general health? 
 
 YES / NO 
 
2. Have you had a lower extremity injury in the past three months that required three 
consecutive days missed from physical activity? 
 
 YES / NO 
 
3. Do you have any current symptoms of injury? 
 
 YES / NO 
 
4. How often do you exercise per week?     Days 
 
5. Approximately how many minutes do you exercise per day?  Minutes 
 
6. What type of exercise activity do you most often participate in (walking, running, 
aerobics, basketball, etc.)? 
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Email to potential subjects 
 
Subject:  
Are you interested in contributing to research aimed at preventing lower extremity knee 
injuries? 
 
Script: 
You may be eligible to participate in a research study investigating lower body posture 
during squatting and jumping.  This study is sponsored by the UNC Department of Exercise 
and Sport Science. 
 
If chosen to participate in this study you will be asked to attend either one (control subjects) 
or two (non-control subjects) testing sessions.  The control subjects session will last 
approximately one hour.  Sessions for the non control subjects will last approximately one 
and a half hours.  During testing sessions you will be video taped while performing a 
squatting task, have strength measurements taken of various hip muscles, EMG muscle 
activity recorded for various hip muscles (including electrode placement on the buttocks and 
halfway down the inside of your thigh), and may asked to participate in an exercise program 
for six weeks at which point you will be tested again.  If you qualify for the control group 
you will not have to participate in any exercise program. 
 
Criteria for inclusion in the control group consists of having no pain while performing a 
squat and having what is judged by the tester as normal knee alignment while squatting.  
Inclusion criteria for the intervention group consists of having no pain while squatting and 
having what the tester judges to be knee valgus (knock knees) alignment while squatting. 
  
Volunteers will be asked to attend a general screening session to determine if they are 
eligible.  To volunteer you must be healthy, free from lower extremity injury, and between 
the ages of 18-35. 
 
If selected to participate as a subject in this study you will receive an exercise package 
including equipment and exercises aimed at improving your lower body posture 
 
All interested individuals should contact the principal investigator, Brian Vesci, at 
vesci@email.unc.edu 
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ARE YOU INTERESTED IN 
CONTRIBUTING TO RESEARCH AIMED 
AT PREVENTING KNEE INJURIES? 
 
 
You may be eligible to participate in a research study investigating lower body 
posture during squatting and jumping.  This study is being conducted by the 
UNC Department of Exercise and Sport Science 
 
If chosen to participate in this study you will be video taped while performing a 
squatting task, have strength measurements taken of various hip muscles, EMG 
muscle activity recorded for various hip muscles (including electrode placement 
on the buttocks and halfway down the inside of your thigh), Control subjects, 
being judged to have normal knee alignment, will have one testing session 
lasting approximately one hour.  Intervention subjects will be asked to 
participate in a six week exercise program and will be tested twice, both 
sessions will last approximately one and a half hours.  
  
Volunteers will be asked to attend a general screening session to determine if 
they are eligible.  To volunteer you must be healthy, free from lower extremity 
injury, have no pain when performing a squat, and between the ages of 18-35. 
 
If selected to participate as a subject in this study you will receive an exercise 
package including equipment and exercises aimed at improving your lower 
body posture 
 
To receive more information, contact: 
 
Brian Vesci LAT, ATC, PES 
vesci@email.unc.edu 
412-855-3080 
 
UNC Sports Medicine Research Lab 
919-962-7187 
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Data Collection Form 
 
Subject ID   
 
Group     Leg        L      R         Sex M    F 
Height  ____ cm  Weight__________kg  Age   
 
Range of Motion 
Passive Hip Abduction 1)  2) 3)  Avg(SPSS)______ 
Passive Hip ER  1) 2) 3)  Avg(SPSS)______ 
 
Electrode Placement 
Iliac crest to greater trochanter    / 2 =    
S2 – 10 cm distal to greater trochanter     x .2 =   
Greater trochanter to lateral epicondyle     / 2 =    
 
Isokinetic Strength (Average Torque) 
 
Hip ER Arm Level     
Hip IR Arm level     
Hip Extension Arm level     
Hip Abduction Arm level    
    
MVIC Testing Order:  Gmax____ Gmed____ Add____ 
 
Activity Testing Order:  DLSQ:____ JL: _____  TJP: _____ 
 
File information:  Sub#: Session:  1 or 2 Pre or Post 
 
 
Please write in all final concatenate files saved for this subject: 
 
1) MVIC File: 
 
2) DLSQ File: 
 
3) Jump Landing File (JL): 
 
4) Transverse Landing File (TJP): 
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Subject Group Height Weight Age Leg Sex HipAB1 HipAB2 HipAB3 HipABAVG 
1 1 175 98 28 2 1 45 37 35 39 
2 1 173 99 25 1 1 40 35 41 38.666667 
3 1 173 66 23 2 1 39 32 36 35.666667 
4 1 193 79 23 1 1 32 34 35 33.666667 
5 1 175 59 24 1 2 45 42 42 43 
6 1 163 54 22 1 2 42 37 38 39 
7 1 168 61 18 2 2 27 24 22 24.333333 
8 1 170 64 18 1 2 38 37 35 36.666667 
9 1 173 54 23 1 2 42 36 41 39.666667 
10 1 170 77 23 2 2 28 32 35 31.666667 
11 1 175 79 24 1 1 34 37 36 35.666667 
12 1 170 64 22 1 2 41 45 38 41.333333 
13 1 48 43 44 1 2 48 43 44 45 
14 1 183 86 25 1 1 36 34 30 33.333333 
15 1 170 59 21 1 2 45 47 43 45 
16 1 170 66 22 1 2 31 33 36 33.333333 
17 1 175 75 20 1 1 32 29 35 32 
18 2 163 61 21 2 2 33 31 32 32 
19 2 168 61 20 1 2 26 40 35 33.666667 
20 2 163 61 20 1 2 34 43 41 39.333333 
21 2 165 54 25 1 2 45 45 44 44.666667 
22 2 165 64 26 1 2 41 39 38 39.333333 
23 2 157 61 22 1 2 35 30 32 32.333333 
24 2 157 61 25 1 2 32 30 34 32 
25 2 183 73 20 1 1 33 34 27 31.333333 
26 2 157 57 21 1 2 35 33 32 33.333333 
27 2 170 84 23 1 2 38 42 40 40 
28 2 163 59 20 1 2 35 36 35 35.333333 
29 2 175 79 20 1 2 37 31 34 34 
30 2 188 84 20 1 1 28 31 40 33 
31 2 167 64 30 1 2 35 29 37 33.666667 
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HipER1 HipER2 HipER3 HipERAVG Gast1 Gast2 Gast3 GastAVG Sol1 Sol2 
40 45 43 42.666667 1 1 3 1.666667 5 6 
64 66 65 65 14 17 16 15.66667 16 12 
76 74 76 75.333333 24 24 23 23.66667 24 23 
49 47 48 48 8 10 11 9.666667 13 14 
105 102 103 103.33333 18 18 22 19.33333 19 26 
83 84 85 84 17 16 15 16 15 16 
62 64 65 63.666667 16 18 16 16.66667 20 22 
72 75 72 73 22 24 26 24 24 25 
105 108 108 107       0     
72 77 73 74 18 17 15 16.66667 21 18 
60 59 58 59       0     
93 93 96 94 18 21 20 19.66667 22 24 
78 83 77 79.333333 23 18 19 20 13 17 
68 71 66 68.333333       0     
86 89 89 88 33 36 35 34.66667 40 42 
68 65 67 66.666667 25 22 24 23.66667 24 24 
64 64 68 65.333333 11 8 8 9 12 11 
78 79 79 78.666667 3 3 4 3.333333 6 8 
63 68 71 67.333333 8 8 9 8.333333 14 16 
78 79 79 78.666667 6 8 7 7 9 12 
63 62 65 63.333333 10 13 13 12 21 20 
68 67 68 67.666667 26 25 24 25 28 27 
78 79 78 78.333333 18 15 17 16.66667 26 27 
86 85 87 86 16 14 17 15.66667 24 27 
65 66 63 64.666667 23 25 25 24.33333 29 35 
68 72 74 71.333333 14 17 13 14.66667 21 23 
75 72 74 73.666667 3 3 3 3 10 12 
65 75 80 73.333333 28 26 30 28 34 29 
84 85 84 84.333333 14 8 12 11.33333 16 15 
78 68 78 74.666667 9 8 11 9.333333 22 20 
76 81 83 80 9 9 10 9.333333 12 13 
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GlutMax1 T1 T2 GlutMax2 T1 T2 GlutMax3 T1 GlutMaxAVG 
0.637 1.99 4.99 0.752 11.41 14.41 0.796 19.91 0.728333333 
0.539 1.99 4.99 0.475 10.99 13.99 0.48 18.5 0.498 
0.93 2.5 5.5 1.498 10 13 1.268 16 1.232 
1.002 3 6 1.272 9.5 12.5 1.459 17.5 1.244333333 
0.198 1.99 4.99 0.188 8.5 11.5 0.237 15 0.207666667 
0.687 1.85 4.85 0.593 10.15 13.15 0.601 17.65 0.627 
1.24 1.75 4.75 0.75 10.25 13.25 0.63 17.75 0.873333333 
0.788 3.93 6.93 0.804 12.25 15.25 0.837 19.75 0.809666667 
0.925 1.99 4.99 0.933 10.5 13.5 1.069 18.99 0.975666667 
0.24 1.99 4.99 0.259 10.3 13.3 0.25 19.8 0.249666667 
0.689 2.79 5.79 0.913 11.3 14.3 1 19.3 0.867333333 
0.546 2.58 5.58 0.719 10.46 13.46 0.652 20.16 0.639 
0.558 2.18 5.18 0.455 10.18 13.18 0.348 18.68 0.453666667 
0.513 3.381 6.381 0.622 13.58 16.58 0.803 21.58 0.646 
1.031 2.38 5.38 0.996 10.38 13.38 0.936 18.88 0.987666667 
0.71 2.58 5.58 0.558 9.88 12.88 0.486 18.38 0.584666667 
0.38 2.18 5.18 0.329 11.18 14.18 0.371 19.18 0.36 
0.591 1.267 4.267 0.517 7.766 10.766 0.488 14.27 0.532 
1.296 1.77 4.77 1.423 8.27 11.27 1.321 15.77 1.346666667 
0.495 1.99 4.99 0.686 9.77 12.77 0.464 16.77 0.548333333 
0.562 1.59 4.59 0.612 9.59 12.59 0.475 17.09 0.549666667 
0.576 1.79 4.79 0.584 8.99 11.99 0.69 16.99 0.616666667 
0.76 1.69 4.69 0.984 9.19 12.19 0.801 16.09 0.848333333 
0.424 7.24 10.24 0.384 16.74 19.74 0.278 26.24 0.362 
1.612 1.99 4.99 1.467 9.5 12.5 1.472 16.99 1.517 
0.31 2.354 5.354 0.22 9.15 12.15 0.22 15.65 0.25 
0.23 1.45 4.45 0.21 9.95 12.95 0.21 16.95 0.216666667 
0.39 1.78 4.78 0.4 8.95 11.95 0.36 16.95 0.383333333 
0.59 1.38 4.38 0.53 9.38 12.38 0.59 16.38 0.57 
0.2 2.89 5.89 0.28 9.28 12.28 0.32 17.78 0.266666667 
0.44 1.89 4.89 0.3 8.89 11.89 0.53 15.89 0.423333333 
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GlutMed1 T1 T2 GlutMed2 T1 T2 GlutMed3 T1 GlutMedAVG 
0.409 26.91 29.91 0.638 34.91 37.91 0.571 42.91 0.539333333 
0.548 25.99 28.99 0.567 36.5 39.5 0.532 44.5 0.549 
0.872 22.5 25.5 0.811 30 33 0.683 36.5 0.788666667 
0.94 23.5 26.5 0.762 31 34 0.602 37.5 0.768 
0.311 20.1 23.1 0.263 28.6 31.6 0.268 34.09 0.280666667 
0.439 26.15 29.15 0.336 35.65 38.65 0.319 44.15 0.364666667 
0.555 25.25 28.25 0.557 34.25 37.25 0.523 41.25 0.545 
0.676 26.25 29.25 0.831 34.75 37.75 0.923 43.25 0.81 
0.341 26.5 29.5 0.317 33.99 36.99 0.38 41.5 0.346 
0.206 26.8 29.8 0.236 39.3 42.3 0.32 48.8 0.254 
0.944 28.79 31.79 1.121 36.73 39.73 0.934 45.09 0.999666667 
0.642 29.16 32.16 0.6 37.16 40.16 0.437 45.36 0.559666667 
0.552 26.18 29.18 0.471 34.18 37.18 0.46 43.18 0.494333333 
0.138 29.48 32.48 0.205 36.88 39.88 0.239 43.18 0.194 
0.494 26.38 29.38 0.51 34.38 37.38 0.501 42.88 0.501666667 
0.737 26.38 29.38 0.684 34.38 37.38 0.671 41.38 0.697333333 
0.687 26.18 29.18 0.588 34.18 37.18 0.614 42.68 0.629666667 
0.39 22.77 25.77 0.441 29.77 32.77 0.409 36.77 0.413333333 
0.649 21.77 24.77 0.732 28.27 31.27 0.563 35.27 0.648 
0.196 21.77 24.77 0.253 30.27 33.27 0.373 37.77 0.274 
0.456 22.09 25.09 0.372 29.59 32.59 0.33 36.59 0.386 
0.681 22.99 25.99 0.642 28.99 31.99 0.571 36.99 0.631333333 
0.293 116.42 119.42 0.201 123.92 126.92 0.093 131.42 0.195666667 
0.152 34.74 37.74 0.164 43.24 46.24 0.214 50.72 0.176666667 
1.879 22.99 25.99 2.088 30.49 33.49 1.928 37.5 1.965 
0.17 22.15 25.15 0.16 31.15 34.15 0.18 38.15 0.17 
0.37 23.45 26.45 0.29 30.45 33.45 0.37 37.45 0.343333333 
0.32 22.95 25.95 0.33 30.45 33.45 0.22 37.95 0.29 
0.29 23.38 26.38 0.33 31.38 34.38 0.33 38.38 0.316666667 
0.43 25.28 28.28 0.34 32.28 35.28 0.28 38.78 0.35 
0.38 22.89 25.89 0.35 30.39 33.39 0.29 37.89 0.34 
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Add1 T1 T2 Add2 T1 T2 Add3 T1 AddAVG GMaxDecAmp1 
0.332 50.4 53.4 0.373 56.9 59.9 0.533 65.4 0.41267 0.1 
0.427 52.5 55.5 0.515 60.5 63.5 0.606 68.5 0.516 0.04 
0.263 42.5 45.5 0.256 49 52 0.25 55.5 0.25633 0.03 
0.501 43 46 0.453 49.5 52.5 0.448 56.5 0.46733 0.07 
0.314 40.59 43.59 0.33 48.59 51.59     0.322 0.04 
0.283 53.15 56.15 0.232 61.65 64.65 0.272 69.65 0.26233 0.06 
0.356 48.25 51.25 0.426 57.25 60.25 0.314 64.75 0.36533 0.14 
0.311 50.75 53.75 0.349 58.75 61.75 0.348 66.75 0.336 0.03 
0.378 49.5 52.5 0.703 56.5 59.5 0.547 64.5 0.54267 0.05 
0.175 58.83 61.83 0.152 68.33 71.33 0.168 75.83 0.165 0.04 
0.324 51.59 54.59 0.477 58.59 61.59 0.484 66.09 0.42833 0.03 
0.163 53.36 56.36 0.354 62.86 65.86 0.563 72.86 0.36 0.04 
0.309 50.68 53.68 0.208 58.68 61.68 0.231 66.48 0.24933 0.04 
0.362 51.68 54.68 0.42 59.18 62.18 0.381 66.48 0.38767 0.04 
0.612 50.38 53.38 0.634 58.38 61.38 0.549 65.88 0.59833 0.06 
0.478 49.38 52.38 0.588 56.88 59.88 0.587 63.88 0.551 0.06 
0.331 49.68 52.68 0.255 57.18 60.18 0.371 64.18 0.319   
0.644 47.77 50.77 0.592 55.27 58.27 0.601 62.76 0.61233   
0.471 41.27 44.27 0.443 48.27 51.27 0.276 54.77 0.39667 0.03 
0.429 43.77 46.77 0.5 50.27 53.27 0.593 56.77 0.50733 0.05 
0.829 43.09 46.09 0.953 50.09 53.09 0.996 57.59 0.926 0.05 
1.044 43.99 46.99 0.987 50.99 53.99 1.004 57.99 1.01167 0.08 
0.693 137.9 140.9 0.567 144.9 147.9 0.583 152.5 0.61433 0.03 
0.156 58.25 61.25 0.137 65.24 68.24 0.133 73.74 0.142 0.04 
0.248 45.99 48.99 0.3 52.99 55.99 0.282 60.5 0.27667 0.06 
0.21 45.15 48.15 0.2 52.65 55.65 0.18 60.15 0.19667 0.04378 
0.25 44.45 47.45 0.21 51.45 54.45 0.31 58.95 0.25667 0.04598 
0.54 44.95 47.95 0.66 52.45 55.45 0.64 59.95 0.61333 0.05065 
0.29 45.38 48.38 0.48 52.88 55.88 0.47 59.88 0.41333 0.06411 
0.35 47.28 50.28 0.43 54.28 57.28 0.5 61.78 0.42667 0.02558 
0.23 45.93 48.93 0.21 53.48 56.48 0.15 62.41 0.19667 0.05139 
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GmDecAmp1 AddDecAmp1 GMAscAmp1 GmAscAmp1 AddAscAmp1 GMDecAmp2 
0.06 0.06 0.07 0.07 0.05 0.06 
0.04 0.04 0.04 0.03 0.04 0.06 
0.47 0.47 0.03 0.13 0.04 0.04 
0.09 0.09 0.18 0.09 0.05 0.06 
0.03 0.03 0.09 0.04 0.05 0.04 
0.05 0.05 0.07 0.09 0.06 0.04 
0.12 0.12 0.08 0.07 0.05 0.12 
0.04 0.04 0.05 0.07 0.1 0.04 
0.04 0.04 0.08 0.09 0.06 0.07 
0.07 0.07 0.02 0.03 0.05 0.05 
0.03 0.03 0.04 0.04 0.04 0.03 
0.04 0.04 0.07 0.05 0.07 0.04 
0.03 0.03 0.05 0.04 0.07 0.05 
0.03 0.03 0.08 0.03 0.11 0.04 
0.03 0.03 0.06 0.03 0.06 0.06 
0.04 0.04 0.05 0.05 0.05 0.05 
            
            
0.05 0.05 0.03 0.05 0.07 0.03 
0.05 0.05 0.05 0.05 0.5 0.07 
0.03 0.03 0.05 0.03 0.06 0.05 
0.05 0.05 0.08 0.05 0.015 0.07 
0.06 0.06 0.03 0.06 0.17 0.04 
0.05 0.05 0.04 0.05 0.12 0.04 
0.04 0.04 0.06 0.04 0.06 0.06 
0.03126 0.03126 0.04298 0.03171 0.09713 0.04857 
0.04852 0.04852 0.04588 0.04856 0.08147 0.04327 
0.05612 0.05612 0.05058 0.05623 0.08286 0.04936 
0.08532 0.08532 0.06391 0.08647 0.10334 0.06213 
0.05875 0.05875 0.02462 0.05577 0.06336 0.02808 
0.11185 0.11185 0.05249 0.11192 0.009565 0.04807 
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GmDecAmp2 AddDecAmp2 GMAscAmp2 GmAscAmp2 AddAscAmp2 GMDecAmp3 
0.07 0.05 0.05 0.08 0.06 0.05 
0.04 0.04 0.06 0.04 0.07 0.05 
0.69 0.69 0.04 1.11 0.07 0.04 
0.07 0.07 0.15 0.07 0.05 0.07 
0.03 0.03 0.08 0.03 0.06 0.03 
0.08 0.08 0.08 0.1 0.07 0.04 
0.11 0.11 0.09 0.09 0.05 0.12 
0.05 0.05 0.05 0.08 0.09 0.04 
0.04 0.04 0.08 0.09 0.06 0.06 
0.06 0.06 0.03 0.05 0.05 0.04 
0.05 0.05 0.04 0.04 0.04 0.03 
0.05 0.05 0.08 0.06 0.07 0.04 
0.04 0.04 0.06 0.04 0.07 0.05 
0.03 0.03 0.09 0.03 0.09 0.04 
0.4 0.04 0.06 0.04 0.06 0.06 
0.05 0.05 0.05 0.06 0.05 0.03 
            
            
0.05 0.05 0.03 0.05 0.06 0.04 
0.06 0.06 0.07 0.06 0.05 0.06 
0.04 0.04 0.05 0.04 0.05 0.05 
0.06 0.06 0.07 0.06 0.018 0.08 
0.06 0.06 0.04 0.06 0.19 0.04 
0.04 0.04 0.04 0.04 0.11 0.05 
0.06 0.06 0.06 0.07 0.07 0.07 
0.04258 0.04258 0.04829 0.04214 0.11685 0.04992 
0.04948 0.04948 0.04342 0.04923 0.08965 0.04115 
0.05217 0.05217 0.04961 0.05216 0.08979 0.05329 
0.09892 0.09892 0.06211 0.09839 0.11926 0.06444 
0.05995 0.05995 0.02785 0.05898 0.06287 0.02653 
0.11058 0.11058 0.04679 0.11034 0.08518 0.05407 
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GmDecAmp3 AddDecAmp3 GMAscAmp3 GmAscAmp3 AddAscAmp3 GMDecAmp4 
0.07 0.07 0.04 0.07 0.05 0.07 
0.05 0.05 0.05 0.06 0.07 0.05 
0.14 0.14 0.05 0.17 0.05 0.03 
0.08 0.08 0.2 0.09 0.06 0.06 
0.06 0.06 0.09 0.07 0.08 0.04 
0.08 0.08 0.09 0.1 0.07 0.06 
0.1 0.1 0.08 0.07 0.05 0.15 
0.06 0.06 0.04 0.08 0.1 0.04 
0.04 0.04 0.09 0.08 0.06 0.06 
0.07 0.7 0.03 0.04 0.05 0.06 
0.04 0.04 0.05 0.05 0.04 0.04 
0.06 0.06 0.08 0.06 0.07 0.04 
0.04 0.04 0.05 0.04 0.06 0.04 
0.03 0.03 0.1 0.03 0.09 0.04 
0.04 0.04 0.06 0.03 0.07 0.05 
0.05 0.05 0.06 0.08 0.05 0.03 
            
            
0.05 0.05 0.04 0.05 0.07 0.04 
0.05 0.05 0.06 0.05 0.06 0.07 
0.05 0.05 0.05 0.05 0.06 0.05 
0.05 0.05 0.08 0.05 0.16 0.07 
0.05 0.05 0.04 0.05 0.17 0.04 
0.05 0.05 0.05 0.05 0.17 0.05 
0.07 0.07 0.07 0.07 0.06 0.1 
0.03516 0.03516 0.05011 0.0353 0.08845 0.07649 
0.0478 0.0478 0.04102 0.04759 0.07969 0.04368 
0.06444 0.06444 0.06265 0.06459 0.08658 0.05538 
0.09866 0.09866 0.06403 0.09936 0.12706 0.06453 
0.05682 0.05682 0.0263 0.05709 0.06567 0.02872 
0.11078 0.11078 0.05418 0.11088 0.09993 0.05769 
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GmDecAmp4 AddDecAmp4 GMAscAmp4 GmAscAmp4 AddAscAmp4 GMDecAmp5 
0.07 0.07 0.05 0.06 0.06 0.09 
0.05 0.05 0.06 0.05 0.08 0.07 
0.3 0.3 0.04 0.43 0.06 0.04 
0.09 0.09 0.17 0.08 0.05 0.06 
0.04 0.04 0.08 0.05 0.06 0.05 
0.08 0.08 0.08 0.12 0.06 0.05 
0.12 0.12 0.08 0.07 0.04 0.1 
0.05 0.05 0.05 0.08 0.11 0.04 
0.05 0.05 0.07 0.08 0.06 0.06 
0.08 0.08 0.03 0.04 0.05 0.5 
0.05 0.05 0.05 0.05 0.04 0.04 
0.05 0.05 0.09 0.07 0.09 0.05 
0.04 0.04 0.06 0.04 0.06 0.04 
0.02 0.02 0.1 0.03 0.11 0.04 
0.03 0.03 0.05 0.08 0.07 0.05 
0.04 0.04 0.06 0.07 0.05 0.03 
            
            
0.05 0.05 0.03 0.04 0.07 0.04 
0.05 0.05 0.07 0.05 0.06 0.08 
0.05 0.05 0.05 0.05 0.07 0.05 
0.06 0.06 0.07 0.05 0.17 0.06 
0.05 0.05 0.04 0.05 0.18 0.04 
0.06 0.06 0.05 0.06 0.15 0.05 
0.09 0.09 0.1 0.09 0.07 0.07 
0.05763 0.05736 0.08034 0.05718 0.09661 0.0598 
0.04582 0.04582 0.04309 0.04507 0.08115 0.04533 
0.06387 0.06387 0.05597 0.06564 0.083 0.06581 
0.10838 0.10832 0.06465 0.10746 0.011638 0.06866 
0.05742 0.05742 0.02901 0.05846 0.07349 0.02581 
0.11272 0.11272 0.05533 0.11293 0.09435 0.04425 
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GmDAmp5 AddDAmp5 GMAAmp5 GmAAmp5 AddAAmp5 GMDAmpAVG 
0.06 0.06 0.08 0.06 0.05 0.074 
0.04 0.04 0.07 0.05 0.07 0.054 
0.14 0.14 0.04 0.16 0.05 0.036 
0.09 0.09 0.19 0.09 0.05 0.064 
0.04 0.4 0.06 0.04 0.05 0.04 
0.09 0.09 0.09 0.09 0.06 0.05 
0.12 0.12 0.08 0.06 0.04 0.126 
0.07 0.07 0.04 0.11 0.12 0.038 
0.04 0.04 0.07 0.06 0.06 0.06 
0.06 0.06 0.04 0.05 0.05 0.138 
0.05 0.05 0.04 0.04 0.04 0.034 
0.07 0.07 0.1 0.07 0.08 0.042 
0.04 0.04 0.08 0.04 0.06 0.044 
0.02 0.02 0.1 0.03 0.1 0.04 
0.03 0.03 0.05 0.08 0.07 0.056 
0.05 0.05 0.05 0.05 0.06 0.04 
          0 
          0 
0.05 0.05 0.04 0.05 0.06 0.036 
0.05 0.05 0.08 0.05 0.05 0.066 
0.05 0.05 0.05 0.06 0.06 0.05 
0.05 0.05 0.06 0.05 0.16 0.072 
0.06 0.06 0.04 0.06 0.2 0.038 
0.05 0.05 0.05 0.05 0.13 0.046 
0.06 0.06 0.07 0.06 0.07 0.072 
0.0408 0.0408 0.05934 0.04108 0.08328 0.055712 
0.05675 0.05675 0.04539 0.05607 0.08619 0.043882 
0.05994 0.05994 0.0667 0.0619 0.08267 0.054898 
0.11466 0.11466 0.06867 0.11413 0.1045 0.064774 
0.05647 0.05647 0.02589 0.05688 0.07069 0.026944 
0.10953 0.10953 0.04372 0.10998 0.8704 0.051094 
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GMDesAmpNorm GmDesAmpAVG GmDesAmpNorm ADesAmpAVG ADesAmpNorm 
10.16018307 0.066 12.23733004 0.062 15.02423263 
10.84337349 0.044 8.014571949 0.044 8.527131783 
2.922077922 0.348 44.12510566 0.348 135.7607282 
5.143316368 0.084 10.9375 0.084 17.9743224 
19.26163724 0.04 14.25178147 0.112 34.7826087 
7.974481659 0.076 20.84095064 0.076 28.9707751 
14.42748092 0.114 20.91743119 0.114 31.20437956 
4.69328942 0.054 6.666666667 0.054 16.07142857 
6.149641271 0.042 12.13872832 0.042 7.73955774 
55.27369826 0.068 26.77165354 0.194 117.5757576 
3.920061491 0.044 4.401467156 0.044 10.27237354 
6.572769953 0.054 9.648600357 0.054 15 
9.698750918 0.038 7.687120701 0.038 15.24064171 
6.191950464 0.026 13.40206186 0.026 6.706792777 
5.669929126 0.106 21.12956811 0.034 5.682451253 
6.841505131 0.046 6.596558317 0.046 8.34845735 
0 0 0 0 0 
0 0 0 0 0 
2.673267327 0.05 7.716049383 0.05 12.60504202 
12.03647416 0.052 18.97810219 0.052 10.24967148 
9.096422074 0.044 11.39896373 0.044 4.75161987 
11.67567568 0.054 8.553326294 0.054 5.337726524 
4.479371316 0.056 28.62010221 0.056 9.115572436 
12.70718232 0.05 28.30188679 0.05 35.21126761 
4.746209624 0.064 3.256997455 0.064 23.13253012 
22.2848 0.041486 24.40352941 0.041432 21.06711864 
20.25323077 0.049674 14.46815534 0.049674 19.35350649 
14.32121739 0.059308 20.45103448 0.059308 9.669782609 
11.36385965 0.101188 31.95410526 0.101176 24.47806452 
10.104 0.057882 16.53771429 0.057882 13.56609375 
12.06944882 0.111092 32.67411765 0.111092 56.48745763 
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GMAscAmpAVG GMAscAmpNorm GmAscAmpAVG GmAscAmpNorm AddAAmpAVG 
0.058 7.963386728 0.068 12.60815822 0.054 
0.056 11.24497992 0.046 8.378870674 0.066 
0.04 3.246753247 0.4 50.71851226 0.054 
0.178 14.30484865 0.084 10.9375 0.052 
0.08 38.52327448 0.046 16.38954869 0.06 
0.082 13.07814992 0.1 27.42230347 0.064 
0.082 9.389312977 0.072 13.21100917 0.046 
0.046 5.68135035 0.084 10.37037037 0.104 
0.078 7.994533652 0.08 23.12138728 0.06 
0.03 12.01602136 0.042 16.53543307 0.05 
0.044 5.073020753 0.044 4.401467156 0.04 
0.084 13.14553991 0.062 11.07802263 0.076 
0.06 13.22556943 0.04 8.091706001 0.064 
0.094 14.55108359 0.03 15.46391753 0.1 
0.056 5.669929126 0.052 10.3654485 0.066 
0.054 9.236031927 0.062 8.891013384 0.052 
0 0 0 0 0 
0 0 0 0 0 
0.034 2.524752475 0.048 7.407407407 0.066 
0.066 12.03647416 0.052 18.97810219 0.144 
0.05 9.096422074 0.046 11.91709845 0.06 
0.072 11.67567568 0.052 8.236536431 0.1046 
0.038 4.479371316 0.056 28.62010221 0.182 
0.046 12.70718232 0.05 28.30188679 0.136 
0.072 4.746209624 0.066 3.358778626 0.066 
0.056212 22.4848 0.041482 24.40117647 0.096464 
0.04376 20.19692308 0.049304 14.36038835 0.08363 
0.057102 14.89617391 0.060104 20.72551724 0.08498 
0.064674 11.34631579 0.101162 31.94589474 0.0931596 
0.026734 10.02525 0.057436 16.41028571 0.067216 
0.050502 11.9296063 0.11121 32.70882353 0.231885 
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AddAscAmpNorm GMaxDecAmp1board GMedDecAmp1board AddDecAmp1board 
13.08562197       
12.79069767       
21.0663199       
11.12696148       
18.63354037       
24.39644219       
12.59124088       
30.95238095       
11.05651106       
30.3030303       
9.338521401       
21.11111111       
25.6684492       
25.79535684       
11.03064067       
9.43738657       
0       
0 0.06 0.07 0.07 
16.63865546 0.03 0.05 0.05 
28.38370565 0.06 0.05 0.05 
6.479481641 0.05 0.03 0.03 
10.33937397 0.06 0.06 0.06 
29.62561042 0.04 0.04 0.04 
95.77464789 0.04 0.04 0.04 
23.85542169 0.09 0.09 0.09 
49.04949153 0.04033 0.03527 0.03527 
32.58311688 0.04026 0.05816 0.05816 
13.85543478 0.05102 0.05213 0.05213 
22.5386129 0.08254 0.07655 0.07655 
15.75375 0.02713 0.05337 0.05337 
117.9076271 0.03356 0.1032 0.1032 
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GMaxAscAmp1board GmedAscAmp1board AddAscAmp1board GMaxDecAmp2board 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
0.06 0.06 0.09 0.07 
0.03 0.05 0.06 0.03 
0.06 0.05 0.05 0.09 
0.05 0.03 0.05 0.04 
0.05 0.06 0.17 0.05 
0.04 0.04 0.11 0.04 
0.05 0.07 0.11 0.05 
0.09 0.09 0.07 0.05 
0.04059 0.03548 0.08776 0.04304 
0.03981 0.05612 0.06958 0.0385 
0.05158 0.05162 0.08114 0.05037 
0.08306 0.07663 0.09325 0.08231 
0.10029 0.11744 0.11024 0.02447 
0.05893 0.10929 0.11087 0.03253 
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GMedDecAmp2board AddDecAmp2board GMaxAscAmp2board GmedAscAmp2board 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
0.06 0.06 0.07 0.06 
0.04 0.04 0.03 0.04 
0.05 0.05 0.09 0.05 
0.03 0.03 0.04 0.03 
0.04 0.04 0.05 0.06 
0.05 0.05 0.04 0.05 
0.04 0.04 0.05 0.07 
0.04 0.04 0.06 0.04 
0.0412 0.0412 0.04315 0.04224 
0.04213 0.04213 0.0377 0.04273 
0.05418 0.05418 0.05254 0.05248 
0.07551 0.07551 0.08221 0.07471 
0.0456 0.0456 0.09466 0.14922 
0.10295 0.10295 0.07195 0.11029 
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AddAscAmp2board GMaxDecAmp3board GMedDecAmp3board AddDecAmp3board 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
0.11 0.08 0.08 0.08 
0.06 0.03 0.05 0.05 
0.05 0.07 0.05 0.05 
0.06 0.05 0.04 0.04 
0.16 0.05 0.04 0.04 
0.11 0.04 0.05 0.05 
0.1 0.05 0.06 0.06 
0.07 0.06 0.07 0.07 
0.08517 0.03964 0.03314 0.03314 
0.08318 0.03782 0.04375 0.04375 
0.08426 0.05036 0.05712 0.05712 
0.08877 0.08067 0.09252 0.09252 
0.10953 0.02599 0.0934 0.0934 
0.10861 0.03789 0.1044 0.1044 
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GMaxAscAmp3board GmedAscAmp3board AddAscAmp3board GMaxDecAmp4board 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
0.07 0.07 0.1 0.07 
0.03 0.04 0.07 0.04 
0.07 0.05 0.05 0.07 
0.05 0.03 0.06 0.04 
0.05 0.04 0.17 0.06 
0.04 0.05 0.11 0.05 
0.05 0.09 0.13 0.06 
0.06 0.07 0.06 0.05 
0.03976 0.03346 0.0985 0.04706 
0.03758 0.04288 0.07859 0.04223 
0.05073 0.05704 0.07964 0.05012 
0.08054 0.09386 0.09584 0.07995 
0.08698 0.07034 0.12315 0.03011 
0.0573 0.11398 0.1271 0.0361 
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GMedDecAmp4board AddDecAmp4board GMaxAscAmp4board GmedAscAmp4board 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
0.08 0.08 0.07 0.07 
0.05 0.05 0.04 0.04 
0.05 0.05 0.07 0.05 
0.05 0.05 0.04 0.05 
0.05 0.05 0.06 0.05 
0.05 0.05 0.05 0.05 
0.05 0.05 0.05 0.04 
0.04 0.04 0.05 0.04 
0.03675 0.03675 0.04728 0.03642 
0.04386 0.04386 0.04208 0.04374 
0.0612 0.0612 0.05077 0.06178 
0.10412 0.10412 0.07993 0.10381 
0.06504 0.06504 0.09777 0.17195 
0.10571 0.10571 0.05177 0.11099 
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AddAscAmp4board GMaxDecAmp5board GMedDecAmp5board AddDecAmp5board 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
0.1 0.09 0.09 0.09 
0.06 0.04 0.05 0.05 
0.05 0.08 0.05 0.05 
0.06 0.04 0.04 0.04 
0.17 0.05 0.04 0.04 
0.11 0.04 0.06 0.06 
0.1 0.07 0.09 0.09 
0.07 0.04 0.04 0.04 
0.09227 0.03685 0.03567 0.03567 
0.0738 0.04285 0.05165 0.05165 
0.0855 0.05551 0.0675 0.0675 
0.11181 0.08049 0.09635 0.09635 
0.12495 0.02556 0.06581 0.06581 
0.10791 0.03357 0.10842 0.10842 
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GMaxAscAmp5board GmedAscAmp5board AddAscAmp5board GMaxDesAmpboardAVG 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
      0 
0.09 0.09 0.11 0.074 
0.04 0.05 0.06 0.034 
0.08 0.05 0.05 0.074 
0.04 0.04 0.06 0.044 
0.05 0.04 0.19 0.054 
0.04 0.06 0.12 0.042 
0.05 0.07 0.12 0.054 
0.04 0.04 0.06 0.058 
0.03668 0.03598 0.08394 0.041384 
0.04304 0.05108 0.07584 0.040332 
0.05568 0.06892 0.08807 0.051476 
0.08086 0.09831 0.10614 0.081192 
0.10143 0.14447 0.14844 0.026652 
0.09279 0.11802 0.12539 0.03473 
 
 162 
 
GMaxDesAmpboardNorm GMedDesAmpboardAVG GMedDesAmpboardNorm 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
13.90977444 0.076 18.38709677 
2.524752475 0.048 7.407407407 
13.49544073 0.05 18.24817518 
8.004851425 0.038 9.844559585 
8.756756757 0.046 7.286166843 
4.950884086 0.05 25.55366269 
14.91712707 0.056 31.69811321 
3.823335531 0.056 2.849872774 
16.5536 0.036406 21.41529412 
18.61476923 0.04791 13.95436893 
13.42852174 0.058426 20.14689655 
14.24421053 0.08901 28.10842105 
9.9945 0.064644 18.46971429 
8.203937008 0.104936 30.86352941 
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AddDesAmpboardAVG AddDesAmpboardNorm GMaxAscAmpboardAVG 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0.076 12.41154056 0.072 
0.048 12.10084034 0.034 
0.05 9.855453351 0.074 
0.038 4.103671706 0.044 
0.046 4.546952224 0.052 
0.05 8.138903961 0.042 
0.056 39.43661972 0.05 
0.056 20.24096386 0.06 
0.036406 18.51152542 0.041492 
0.04791 18.66623377 0.040042 
0.058426 9.525978261 0.05226 
0.08901 21.53467742 0.08132 
0.064644 15.1509375 0.096226 
0.104936 53.35728814 0.066548 
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GMaxAscAmpboardNorm GMedAscAmpboardAVG GMedAscAmpboardNorm 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
13.53383459 0.07 16.93548387 
2.524752475 0.044 6.790123457 
13.49544073 0.05 18.24817518 
8.004851425 0.036 9.32642487 
8.432432432 0.05 7.919746568 
4.950884086 0.05 25.55366269 
13.8121547 0.068 38.49056604 
3.955174687 0.056 2.849872774 
16.5968 0.036716 21.59764706 
18.48092308 0.04731 13.77961165 
13.63304348 0.058368 20.12689655 
14.26666667 0.089464 28.25178947 
36.08475 0.130684 37.33828571 
15.72 0.112514 33.09235294 
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AddAscAmpboardAVG AddAscAmpboardNorm ERConPkTq ERConPkTqNorm 
0 0 31.7667 0.32415 
0 0 32.1 0.324242424 
0 0 30.067 0.455560606 
0 0 24.733 0.313075949 
0 0 16.267 0.275711864 
0 0 13.167 0.243833333 
0 0 18.467 0.302737705 
0 0 20.633 0.322390625 
0 0 19.933 0.36912963 
0 0 17.467 0.226844156 
0 0 21.467 0.271734177 
0 0 12.067 0.188546875 
0 0 20.933 0.486813953 
0 0 31 0.360465116 
0 0 16.633 0.281915254 
0 0 17.733 0.268681818 
0 0 25.767 0.34356 
0.102 16.6575939 17.533 0.28742623 
0.062 15.6302521 19.567 0.320770492 
0.05 9.855453351 20.7 0.339344262 
0.058 6.26349892 13.933 0.258018519 
0.172 17.00164745 32.767 0.511984375 
0.112 18.23114487 2.0333 0.033332787 
0.112 78.87323944 12.567 0.206016393 
0.066 23.85542169 31.367 0.429684932 
0.089528 45.52271186 6.8 0.119298246 
0.076198 29.68753247 14.5 0.172619048 
0.083722 13.65032609 8.0667 0.136723729 
0.099162 23.99080645 21.633 0.273835443 
0.123262 28.88953125 37.2 0.442857143 
0.115976 58.97084746 17.4 0.271875 
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ERConAngPkTq ERConTmPkTq EREccPkTq EREccPkTqNorm EREccAngPkTq 
14 3 56.9 0.580612245 13.6667 
15 1.3333 60.733 0.613464646 15 
14.667 2.6667 53.6 0.812121212 14.667 
15 2.6667 51.9 0.656962025 15 
15 1.6667 18.767 0.318084746 14.667 
15 1.6667 26.7 0.494444444 14.667 
12 2.6667 40.333 0.661196721 12 
14 3.6667 48.267 0.754171875 14 
15 3 31 0.574074074 15 
15 5.3333 32.767 0.425545455 15 
12.667 6.3333 58.7 0.743037975 14 
13.667 4 35 0.546875 14.333 
15 1.3333 34.4 0.8 14 
12 6.3333 33.167 0.385662791 13.667 
14.667 2.3333 39.733 0.673440678 14.333 
13 5.3333 35.6 0.539393939 13.333 
14 3.6667 53.167 0.708893333 14.333 
15 1 39.8 0.652459016 15 
14.333 2 42.167 0.691262295 12.667 
13.667 3.6667 30.333 0.497262295 13 
14.667 3.3333 34.567 0.64012963 13 
13 3 13.067 0.204171875 13.333 
14.667 3.6667 24.933 0.408737705 15 
15 1.6667 29.233 0.479229508 15 
14.333 3.6667 55.2 0.756164384 15 
13.667 4 27.633 0.484789474 14.667 
9 1.3333 42.467 0.505559524 9 
10.667 8 12.067 0.204525424 12.667 
13.667 2.6667 45.733 0.578898734 14 
6 1 94.333 1.123011905 4.6667 
14.333 2.6667 36.467 0.569796875 14 
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EREccTmPkTq IRConPkTq IRConPkTqNorm IRConAngPkTq IRConTmPkTq 
4.3333 30.067 0.306806122 1 2 
2.6667 89.3 0.902020202 6 1.6667 
2.3333 85.1 1.289393939 5 1.6667 
2.3333 55.3 0.7 5 3.3333 
6 24.167 0.409610169 5 1.6667 
4.3333 52.367 0.969759259 6 2.3333 
2.6667 31.433 0.515295082 2 4 
2 74.867 1.169796875 5 1.3333 
1 49.733 0.920981481 3 3.3333 
3.3333 37.333 0.484844156 5 1 
4 49.233 0.623202532 5 1 
2.6667 57.667 0.901046875 4 1.3333 
  54.3 1.262790698 5 3 
4 51.067 0.593802326 5 1 
2.6667 47.533 0.805644068 5 2.3333 
4.6667 53.033 0.803530303 5 3.6667 
2.6667 78 1.04 5 4.3333 
1.3333 52.7 0.863934426 5 3.3333 
4.6667 62.9 1.031147541 5 2 
5.6667 40.8 0.668852459 5 1 
6.6667 33.567 0.621611111 6 3.6667 
2.6667 65.133 1.017703125 5 2 
2 57.1 0.936065574 4 4.6667 
1.6667 26.4 0.432786885 5 2 
2 84.933 1.163465753 5 3.3333 
1.6667 50.767 0.890649123 5 4 
1.3333 70.1 0.83452381 5 4.3333 
5.3333 39.4 0.66779661 5 3.3333 
1.3333 44.4 0.562025316 4 3 
3.3333 66.133 0.787297619 5 5.3333 
4 49.8 0.778125 5 3 
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IREcPkTq IREcPkTqNorm IREcAngPkTq IREcTmPkTq ExtCoPkTq ExtCoPkTqNorm 
26.367 0.26905102 1 3.3333 81.867 0.835377551 
63.333 0.639727273 6 1 204.7 2.067676768 
50.067 0.758590909 5 1.3333 79.433 1.203530303 
29 0.367088608 5   88.067 1.114772152 
17.2 0.291525424 5 1 69.867 1.184186441 
29.567 0.547537037 6 3 78.833 1.45987037 
14.867 0.243721311 2 4.6667 38.967 0.638803279 
35.567 0.555734375 5 4 135.97 2.12453125 
31.6 0.585185185 3 2.6667 113.07 2.093888889 
23.733 0.308220779 5 4.6667 54.767 0.71125974 
25.7 0.325316456 5 2 120.33 1.523164557 
23.8 0.371875 4 1.3333 95.867 1.497921875 
31.6 0.734883721 4.6667 3.6667 37.867 0.880627907 
10.167 0.11822093 5 4.3333 129.2 1.502325581 
26.2 0.444067797 5 3 26.433 0.448016949 
28.733 0.435348485 5   55.333 0.838378788 
41.533 0.553773333 5 1.3333 124.4 1.658666667 
25.267 0.414213115 5 4 85.867 1.407655738 
38.3 0.627868852 5 1.6667 40.167 0.65847541 
27.4 0.449180328 5 5 75.967 1.245360656 
18.833 0.348759259 6 1.3333 54.933 1.017277778 
43.133 0.673953125 5 2 100.43 1.56921875 
9.7 0.159016393 3 8.6667 51.767 0.848639344 
6.3 0.103278689 5 2 110.3 1.808196721 
56.9 0.779452055 5 1 134.9 1.847945205 
22.533 0.395315789 5 2 49.633 0.870754386 
32.7 0.389285714 5 1 114.47 1.362738095 
23.667 0.401135593 5 3 60.767 1.029949153 
19.5 0.246835443 4 5 47.533 0.601683544 
45 0.535714286 5 2.3333 154.33 1.837261905 
29.8 0.465625 5 1 84.233 1.316140625 
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ExCoAngPkTq ExCoTmPkTq ExEcPkTq ExEcPkTqNorm ExEcAngPkTq ExEcTmPkTq 
39 2.6667 62.7 0.639795918 39 2 
0 4.3333 126 1.272727273 0 1 
0.66667 3.3333 49.033 0.742924242 0 1 
40 4 38.967 0.493253165 40 3.6667 
1.6667 3.6667 54.467 0.923169492 1.3333 3.6667 
-1 4.6667 39.833 0.737648148 1 1.6667 
1.6667 4 32.2 0.527868852 0 1 
0 2.3333 18.6 0.290625 0.33333 4 
0 3.3333 101.77 1.88462963 0 4.3333 
0 3 21.767 0.282688312 0 1 
0 4.6667 92.8 1.174683544 0 1 
40 6.6667 43.067 0.672921875 40 1 
1 3 56 1.302325581 0.33333 2 
39 6 48.867 0.56822093 39 1 
1.6667 9.3333 53.567 0.907915254 0.66667 6.3333 
2.6667 5.3333 28.967 0.438893939 3.6667 7 
3.3333 6 63.433 0.845773333 0 1 
2 5.6667 44.9 0.736065574 0.66667 2.3333 
40 6.6667 81.1 1.329508197 40 4.3333 
31 3 47.967 0.786344262 31 1 
39 4.6667 41.6 0.77037037 39 3 
0.33333 6.3333 56.067 0.876046875 0.33333 4.3333 
1 2 61.9 1.014754098 1 1.6667 
40 3.3333 33.967 0.556836066 40 3.3333 
2 4 88.4 1.210958904 2 3 
40 6.6667 17.733 0.311105263 40 8.3333 
1 6 42.267 0.503178571 1 3 
2 6 9.8 0.166101695 0   
4 6.6667 31.867 0.403379747 1 1 
40.333 3.3333 81.3 0.967857143 39.667 4.6667 
0 4.3333 37.867 0.591671875 0 3 
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AbCoPkTq AbCoPkTqNorm AbCoAngPkTq AbCoTmPkTq AbEcPkTq AbEcPkTqNorm 
54.3667 0.554762245 0 3.3333 45.1667 0.460884694 
38.9 0.392929293 0 1 41.933 0.423565657 
35.833 0.542924242 0 1 56.5 0.856060606 
37.8 0.478481013 0 1 41.767 0.528696203 
21.1 0.357627119 0 1 7.1667 0.121469492 
32.1 0.594444444 0 1.6667 39.067 0.723462963 
20.267 0.332245902 0 1 8.1667 0.133880328 
39.733 0.620828125 0 1 64.2 1.003125 
23.967 0.443833333 0 1 30.6 0.566666667 
18.033 0.234194805 0 1 27.3 0.354545455 
52.667 0.666670886 0 1 56.5 0.715189873 
11.567 0.180734375 0 1 36.6 0.571875 
28.033 0.651930233 0 1 24.233 0.56355814 
4.6667 0.054263953 0 1 38.633 0.44922093 
25.933 0.439542373 0 1 2.9333 0.049716949 
21.533 0.326257576 0 1 15 0.227272727 
43.467 0.57956 0 1 66.733 0.889773333 
32.967 0.540442623 0 1 47.667 0.78142623 
32.467 0.532245902 0 1 42.033 0.689065574 
30.667 0.502737705 -1 1 37.7 0.618032787 
16.533 0.306166667 -1 1 18.933 0.350611111 
25.167 0.393234375 0 2.6667 37.1 0.5796875 
9.8667 0.16174918 0 1 6.9667 0.114208197 
14.767 0.242081967 -1 1 50.833 0.833327869 
27.467 0.376260274 -1.6667 3 36.033 0.49360274 
7.2333 0.1269 -0.66667 2.6667 28.4 0.498245614 
26.3 0.313095238 -1 1 53.8 0.64047619 
14.333 0.242932203 0 1.3333 24.667 0.418084746 
13 0.164556962 -1 1.3333 9.2667 0.1173 
38.233 0.455154762 -0.33333 2 43.7 0.520238095 
13.933 0.217703125 -1 2.6667 23.2 0.3625 
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AbEccAngPkTq AbEccTmPkTq 
0 2.3333 
0 1 
-1.6667 4 
0 2 
0 3.6667 
0 1.3333 
0 3.6667 
0 2.3333 
0 2.6667 
-0.33333 2 
0 2.6667 
0 1 
-1.3333 4.3333 
0 1 
-0.66667 6 
-0.33333 2 
-0.66667 4.3333 
-0.66667 4 
-1.6667 4 
-2 3.6667 
-1.6667 4 
0 2.6667 
-0.66667 4.3333 
-2 4 
-1 1 
-1.6667 5 
-2.6667 4.6667 
0 1.6667 
-1 2.6667 
0 1.6667 
-1.3333 3.6667 
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General Linear Model 
 
Within-Subjects Factors
Measure: MEASURE_1
GastAVG
SolAVG
muscle
1
2
Dependent
Variable
 
Between-Subjects Factors
Normal 14
Valgus 14
1.0000
2.0000
Group
Value Label N
 
Descriptive Statistics
17.880952 7.9255156 14
13.428571 7.8451123 14
15.654762 8.0632694 28
19.857143 8.3724357 14
19.880952 8.3692632 14
19.869048 8.2143803 28
Group
Normal
Valgus
Total
Normal
Valgus
Total
GastAVG
SolAVG
Mean Std. Deviation N
 
Multivariate Testsc
.704 61.695b 1.000 26.000 .000 .704 61.695 1.000
.296 61.695b 1.000 26.000 .000 .704 61.695 1.000
2.373 61.695b 1.000 26.000 .000 .704 61.695 1.000
2.373 61.695b 1.000 26.000 .000 .704 61.695 1.000
.401 17.400b 1.000 26.000 .000 .401 17.400 .980
.599 17.400b 1.000 26.000 .000 .401 17.400 .980
.669 17.400b 1.000 26.000 .000 .401 17.400 .980
.669 17.400b 1.000 26.000 .000 .401 17.400 .980
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
muscle
muscle * Group
Value F Hypothesis df Error df Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Exact statisticb. 
Design: Intercept+Group 
Within Subjects Design: muscle
c. 
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Mauchly's Test of Sphericityb
Measure: MEASURE_1
1.000 .000 0 . 1.000 1.000 1.000
Within Subjects Effect
muscle
Mauchly's W
Approx.
Chi-Square df Sig.
Greenhous
e-Geisser Huynh-Feldt Lower-bound
Epsilon
a
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is
proportional to an identity matrix.
May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed in
the Tests of Within-Subjects Effects table.
a. 
Design: Intercept+Group 
Within Subjects Design: muscle
b. 
 
Tests of Within-Subjects Effects
Measure: MEASURE_1
248.643 1 248.643 61.695 .000 .704 61.695 1.000
248.643 1.000 248.643 61.695 .000 .704 61.695 1.000
248.643 1.000 248.643 61.695 .000 .704 61.695 1.000
248.643 1.000 248.643 61.695 .000 .704 61.695 1.000
70.127 1 70.127 17.400 .000 .401 17.400 .980
70.127 1.000 70.127 17.400 .000 .401 17.400 .980
70.127 1.000 70.127 17.400 .000 .401 17.400 .980
70.127 1.000 70.127 17.400 .000 .401 17.400 .980
104.786 26 4.030
104.786 26.000 4.030
104.786 26.000 4.030
104.786 26.000 4.030
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
muscle
muscle * Group
Error(muscle)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Tests of Within-Subjects Contrasts
Measure: MEASURE_1
248.643 1 248.643 61.695 .000 .704 61.695 1.000
70.127 1 70.127 17.400 .000 .401 17.400 .980
104.786 26 4.030
muscle
Linear
Linear
Linear
Source
muscle
muscle * Group
Error(muscle)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Tests of Between-Subjects Effects
Measure: MEASURE_1
Transformed Variable: Average
17667.175 1 17667.175 137.787 .000 .841 137.787 1.000
68.643 1 68.643 .535 .471 .020 .535 .109
3333.738 26 128.221
Source
Intercept
Group
Error
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Estimated Marginal Means 
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1. Grand Mean
Measure: MEASURE_1
17.762 1.513 14.652 20.872
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
2. Group
Measure: MEASURE_1
18.869 2.140 14.470 23.268
16.655 2.140 12.256 21.053
Group
Normal
Valgus
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
3. muscle
Measure: MEASURE_1
15.655 1.490 12.592 18.718
19.869 1.582 16.617 23.121
muscle
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
4. Group * muscle
Measure: MEASURE_1
17.881 2.107 13.549 22.213
19.857 2.237 15.259 24.456
13.429 2.107 9.097 17.761
19.881 2.237 15.282 24.480
muscle
1
2
1
2
Group
Normal
Valgus
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
Oneway 
 
Descriptives
1773.921569 17.51448984.2478877 64.916449 82.926688 42.6667 107.0000
1474.428571 7.01698621.8753684 70.377084 78.480059 63.3333 86.0000
3174.150538 13.60169892.4429372 69.161394 79.139681 42.6667 107.0000
1736.882353 5.33846261.2947674 34.137569 39.627137 24.3333 45.0000
1435.285714 3.96966521.0609376 32.993698 37.577731 31.3333 44.6667
3136.161290 4.7624076 .8553536 34.414425 37.908156 24.3333 45.0000
Normal
Valgus
Total
Normal
Valgus
Total
HipERAVG
HipABAVG
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
95% Confidence Interval for
Mean
Minimum Maximum
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ANOVA
1.973 1 1.973 .010 .920
5548.213 29 191.318
5550.186 30
19.572 1 19.572 .859 .362
660.844 29 22.788
680.416 30
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
HipERAVG
HipABAVG
Sum of
Squares df Mean Square F Sig.
 
T-Test 
 
Group Statistics
17 36.882353 5.3384626 1.2947674
14 35.285714 3.9696652 1.0609376
17 73.921569 17.5144898 4.2478877
14 74.428571 7.0169862 1.8753684
14 17.880952 7.9255156 2.1181831
14 13.428571 7.8451123 2.0966945
14 19.857143 8.3724357 2.2376276
14 19.880952 8.3692632 2.2367797
Group
Normal
Valgus
Normal
Valgus
Normal
Valgus
Normal
Valgus
HipABAVG
HipERAVG
GastAVG
SolAVG
N Mean Std. Deviation
Std. Error
Mean
 
Independent Samples Test
1.031 .318 .927 29 .362 1.5966387 1.7228318 -1.926955.1202252
.954 28.748 .348 1.5966387 1.6739209 -1.828225.0214957
6.408 .017 -.102 29 .920 -.5070028 4.9919466 -10.71679.7026743
-.109 21.824 .914 -.5070028 4.6434424 -10.14149.1274008
.093 .763 1.494 26 .147 4.4523810 2.9804073 -1.67393 10.57870
1.494 25.997 .147 4.4523810 2.9804073 -1.67396 10.57873
.399 .533 -.008 26 .994 -.0238095 3.1638838 -6.527276.4796467
-.008 26.000 .994 -.0238095 3.1638838 -6.527276.4796467
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
HipABAVG
HipERAVG
GastAVG
SolAVG
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
 
T-Test 
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Paired Samples Statistics
13.428571 14 7.8451123 2.0966945
19.880952 14 8.3692632 2.2367797
GastAVG
SolAVG
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
Paired Samples Correlations
14 .930 .000GastAVG & SolAVGPair 1
N Correlation Sig.
 
Paired Samples Test
-6.45238 3.0734795 .8214219 -8.22696 -4.67781 -7.855 13 .000GastAVG - SolAVGPair 1
Mean Std. Deviation
Std. Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df Sig. (2-tailed)
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Oneway 
 
Descriptives
17 .315258 .0753943 .0182858 .276494 .354023 .1885 .4868
14 .271699 .1335344 .0356886 .194599 .348799 .0333 .5120
31 .295586 .1060385 .0190451 .256691 .334482 .0333 .5120
17 .605175 .1431187 .0347114 .531590 .678760 .3181 .8121
14 .556857 .2291982 .0612558 .424522 .689192 .2042 1.1230
31 .583354 .1851635 .0332563 .515436 .651273 .2042 1.1230
17 .805796 .2927646 .0710058 .655270 .956321 .3068 1.2894
14 .803999 .2006404 .0536234 .688153 .919845 .4328 1.1635
31 .804984 .2513124 .0451370 .712802 .897166 .3068 1.2894
17 .444110 .1804319 .0437612 .351340 .536879 .1182 .7586
14 .427831 .1876576 .0501536 .319481 .536181 .1033 .7795
31 .436758 .1808061 .0324737 .370438 .503078 .1033 .7795
17 1.281353 .5213672 .1264501 1.013291 1.549415 .4480 2.1245
14 1.244378 .4238226 .1132714 .999670 1.489086 .6017 1.8479
31 1.264655 .4723985 .0848453 1.091378 1.437932 .4480 2.1245
17 .806239 .4145150 .1005347 .593115 1.019363 .2827 1.8846
14 .730298 .3345796 .0894202 .537118 .923479 .1661 1.3295
31 .771943 .3763289 .0675907 .633905 .909982 .1661 1.8846
17 .438308 .1749017 .0424199 .348381 .528234 .0543 .6667
14 .326804 .1420702 .0379699 .244775 .408833 .1269 .5404
31 .387951 .1680570 .0301839 .326308 .449595 .0543 .6667
17 .508174 .2769238 .0671639 .365793 .650555 .0497 1.0031
14 .501200 .2165695 .0578806 .376157 .626244 .1142 .8333
31 .505025 .2474600 .0444451 .414256 .595794 .0497 1.0031
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
ERConPkTqNorm
EREccPkTqNorm
IRConPkTqNorm
IREccPkTqNorm
ExtConPkTqNorm
ExtEccPkTqNorm
AbConPkTqNorm
AbEccPkTqNorm
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
95% Confidence Interval for
Mean
Minimum Maximum
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ANOVA
.015 1 .015 1.309 .262
.323 29 .011
.337 30
.018 1 .018 .514 .479
1.011 29 .035
1.029 30
.000 1 .000 .000 .985
1.895 29 .065
1.895 30
.002 1 .002 .060 .808
.979 29 .034
.981 30
.010 1 .010 .046 .833
6.684 29 .230
6.695 30
.044 1 .044 .305 .585
4.204 29 .145
4.249 30
.095 1 .095 3.682 .065
.752 29 .026
.847 30
.000 1 .000 .006 .939
1.837 29 .063
1.837 30
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
ERConPkTqNorm
EREccPkTqNorm
IRConPkTqNorm
IREccPkTqNorm
ExtConPkTqNorm
ExtEccPkTqNorm
AbConPkTqNorm
AbEccPkTqNorm
Sum of
Squares df Mean Square F Sig.
 
Oneway 
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Descriptives
17 3.352941 1.6349808 .3965411 2.512312 4.193571 1.3333 6.3333
14 2.976200 1.7805440 .4758704 1.948144 4.004256 1.0000 8.0000
31 3.182800 1.6839899 .3024535 2.565107 3.800493 1.0000 8.0000
16 3.229169 1.2395829 .3098957 2.568642 3.889696 1.0000 6.0000
14 3.119050 1.8332602 .4899594 2.060557 4.177543 1.3333 6.6667
30 3.177780 1.5180521 .2771571 2.610930 3.744630 1.0000 6.6667
17 2.294112 1.1110650 .2694729 1.722855 2.865369 1.0000 4.3333
14 3.214279 1.1810949 .3156609 2.532335 3.896222 1.0000 5.3333
31 2.709671 1.2163714 .2184668 2.263502 3.155840 1.0000 5.3333
15 2.755553 1.3479478 .3480386 2.009085 3.502022 1.0000 4.6667
14 2.857143 2.1630790 .5781072 1.608218 4.106068 1.0000 8.6667
29 2.804597 1.7559904 .3260792 2.136654 3.472540 1.0000 8.6667
17 4.490194 1.7642959 .4279046 3.583077 5.397311 2.3333 9.3333
14 4.904764 1.5821169 .4228385 3.991277 5.818251 2.0000 6.6667
31 4.677419 1.6699658 .2999347 4.064871 5.289968 2.0000 9.3333
17 2.509806 1.9759540 .4792392 1.493864 3.525748 1.0000 7.0000
13 3.307685 1.9122394 .5303598 2.152130 4.463239 1.0000 8.3333
30 2.855553 1.9567736 .3572563 2.124882 3.586225 1.0000 8.3333
17 1.176471 .5787576 .1403693 .878901 1.474040 1.0000 3.3333
14 1.619050 .7937605 .2121414 1.160746 2.077354 1.0000 3.0000
31 1.376345 .7083765 .1272282 1.116511 1.636180 1.0000 3.3333
17 2.725488 1.4153696 .3432775 1.997772 3.453204 1.0000 6.0000
14 3.357157 1.2227414 .3267914 2.651167 4.063147 1.0000 5.0000
31 3.010758 1.3484797 .2421941 2.516132 3.505384 1.0000 6.0000
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
Normal
Valgus
Total
ERConTmPkTq
EREccTmPkTq
IRConTmPkTq
IREccTmPkTq
ExtConTmPkTq
ExtEccTmPkTq
AbConTmPkTq
AbEccTmPkTq
N Mean Std. DeviationStd. Error Lower BoundUpper Bound
95% Confidence Interval for
Mean
Minimum Maximum
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ANOVA
1.090 1 1.090 .376 .544
83.985 29 2.896
85.075 30
.091 1 .091 .038 .847
66.739 28 2.384
66.830 29
6.501 1 6.501 4.976 .034
37.886 29 1.306
44.387 30
.075 1 .075 .023 .880
86.263 27 3.195
86.338 28
1.320 1 1.320 .465 .501
82.344 29 2.839
83.664 30
4.690 1 4.690 1.235 .276
106.350 28 3.798
111.040 29
1.504 1 1.504 3.218 .083
13.550 29 .467
15.054 30
3.063 1 3.063 1.725 .199
51.489 29 1.775
54.552 30
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
ERConTmPkTq
EREccTmPkTq
IRConTmPkTq
IREccTmPkTq
ExtConTmPkTq
ExtEccTmPkTq
AbConTmPkTq
AbEccTmPkTq
Sum of
Squares df Mean Square F Sig.
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General Linear Model 
 
Within-Subjects Factors
Measure: MEASURE_1
GMaxDes
AmpNorm
GMaxAsc
AmpNorm
phase
1
2
Dependent
Variable
 
Between-Subjects Factors
Normal 16
Valgus 13
1.0000
2.0000
Group
Value Label N
 
Descriptive Statistics
10.984009 12.5250030 16
11.370089 5.6519150 13
11.157080 9.8878250 29
11.521487 8.0315153 16
11.395781 5.7234116 13
11.465136 6.9713218 29
Group
Normal
Valgus
Total
Normal
Valgus
Total
GMaxDesAmpNorm
GMaxAscAmpNorm
Mean Std. Deviation N
 
Multivariate Testsc
.001 .024b 1.000 27.000 .877 .001 .024 .053
.999 .024b 1.000 27.000 .877 .001 .024 .053
.001 .024b 1.000 27.000 .877 .001 .024 .053
.001 .024b 1.000 27.000 .877 .001 .024 .053
.001 .020b 1.000 27.000 .888 .001 .020 .052
.999 .020b 1.000 27.000 .888 .001 .020 .052
.001 .020b 1.000 27.000 .888 .001 .020 .052
.001 .020b 1.000 27.000 .888 .001 .020 .052
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
phase
phase * Group
Value F Hypothesis df Error df Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Exact statisticb. 
Design: Intercept+Group 
Within Subjects Design: phase
c. 
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Mauchly's Test of Sphericityb
Measure: MEASURE_1
1.000 .000 0 . 1.000 1.000 1.000
Within Subjects Effect
phase
Mauchly's W
Approx.
Chi-Square df Sig.
Greenhous
e-Geisser Huynh-Feldt Lower-bound
Epsilon
a
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is
proportional to an identity matrix.
May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed in
the Tests of Within-Subjects Effects table.
a. 
Design: Intercept+Group 
Within Subjects Design: phase
b. 
 
Tests of Within-Subjects Effects
Measure: MEASURE_1
1.137 1 1.137 .024 .877 .001 .024 .053
1.137 1.000 1.137 .024 .877 .001 .024 .053
1.137 1.000 1.137 .024 .877 .001 .024 .053
1.137 1.000 1.137 .024 .877 .001 .024 .053
.939 1 .939 .020 .888 .001 .020 .052
.939 1.000 .939 .020 .888 .001 .020 .052
.939 1.000 .939 .020 .888 .001 .020 .052
.939 1.000 .939 .020 .888 .001 .020 .052
1257.722 27 46.582
1257.722 27.000 46.582
1257.722 27.000 46.582
1257.722 27.000 46.582
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
phase
phase * Group
Error(phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Tests of Within-Subjects Contrasts
Measure: MEASURE_1
1.137 1 1.137 .024 .877 .001 .024 .053
.939 1 .939 .020 .888 .001 .020 .052
1257.722 27 46.582
phase
Linear
Linear
Linear
Source
phase
phase * Group
Error(phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
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Tests of Between-Subjects Effects
Measure: MEASURE_1
Transformed Variable: Average
7349.919 1 7349.919 69.890 .000 .721 69.890 1.000
.243 1 .243 .002 .962 .000 .002 .050
2839.411 27 105.163
Source
Intercept
Group
Error
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Estimated Marginal Means 
 
1. Grand Mean
Measure: MEASURE_1
11.318 1.354 8.540 14.096
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
2. Group
Measure: MEASURE_1
11.253 1.813 7.533 14.972
11.383 2.011 7.256 15.509
Group
Normal
Valgus
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
3. phase
Measure: MEASURE_1
11.177 1.880 7.321 15.034
11.459 1.325 8.739 14.178
phase
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
4. Group * phase
Measure: MEASURE_1
10.984 2.517 5.820 16.148
11.521 1.775 7.880 15.163
11.370 2.792 5.641 17.099
11.396 1.969 7.356 15.436
phase
1
2
1
2
Group
Normal
Valgus
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
General Linear Model 
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Within-Subjects Factors
Measure: MEASURE_1
GMedDes
AmpNorm
GMedAsc
AmpNorm
phase
1
2
Dependent
Variable
 
Between-Subjects Factors
Normal 16
Valgus 13
1.0000
2.0000
Group
Value Label N
 
Descriptive Statistics
14.985443 10.0408630 16
19.024160 9.7204132 13
16.795903 9.9339103 29
15.499042 11.0197818 16
19.028615 9.7469128 13
17.081264 10.4384500 29
Group
Normal
Valgus
Total
Normal
Valgus
Total
GMedDesAmpNorm
GMedAscAmpNorm
Mean Std. Deviation N
 
Multivariate Testsc
.004 .101b 1.000 27.000 .753 .004 .101 .061
.996 .101b 1.000 27.000 .753 .004 .101 .061
.004 .101b 1.000 27.000 .753 .004 .101 .061
.004 .101b 1.000 27.000 .753 .004 .101 .061
.004 .098b 1.000 27.000 .757 .004 .098 .060
.996 .098b 1.000 27.000 .757 .004 .098 .060
.004 .098b 1.000 27.000 .757 .004 .098 .060
.004 .098b 1.000 27.000 .757 .004 .098 .060
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
phase
phase * Group
Value F Hypothesis df Error df Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Exact statisticb. 
Design: Intercept+Group 
Within Subjects Design: phase
c. 
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Mauchly's Test of Sphericityb
Measure: MEASURE_1
1.000 .000 0 . 1.000 1.000 1.000
Within Subjects Effect
phase
Mauchly's W
Approx.
Chi-Square df Sig.
Greenhous
e-Geisser Huynh-Feldt Lower-bound
Epsilon
a
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is
proportional to an identity matrix.
May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed in
the Tests of Within-Subjects Effects table.
a. 
Design: Intercept+Group 
Within Subjects Design: phase
b. 
 
Tests of Within-Subjects Effects
Measure: MEASURE_1
.962 1 .962 .101 .753 .004 .101 .061
.962 1.000 .962 .101 .753 .004 .101 .061
.962 1.000 .962 .101 .753 .004 .101 .061
.962 1.000 .962 .101 .753 .004 .101 .061
.930 1 .930 .098 .757 .004 .098 .060
.930 1.000 .930 .098 .757 .004 .098 .060
.930 1.000 .930 .098 .757 .004 .098 .060
.930 1.000 .930 .098 .757 .004 .098 .060
257.040 27 9.520
257.040 27.000 9.520
257.040 27.000 9.520
257.040 27.000 9.520
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
phase
phase * Group
Error(phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Tests of Within-Subjects Contrasts
Measure: MEASURE_1
.962 1 .962 .101 .753 .004 .101 .061
.930 1 .930 .098 .757 .004 .098 .060
257.040 27 9.520
phase
Linear
Linear
Linear
Source
phase
phase * Group
Error(phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
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Tests of Between-Subjects Effects
Measure: MEASURE_1
Transformed Variable: Average
16845.691 1 16845.691 85.005 .000 .759 85.005 1.000
205.414 1 205.414 1.037 .318 .037 1.037 .166
5350.643 27 198.172
Source
Intercept
Group
Error
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Estimated Marginal Means 
 
1. Grand Mean
Measure: MEASURE_1
17.134 1.858 13.321 20.947
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
2. Group
Measure: MEASURE_1
15.242 2.489 10.136 20.348
19.026 2.761 13.362 24.691
Group
Normal
Valgus
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
3. phase
Measure: MEASURE_1
17.005 1.848 13.213 20.797
17.264 1.955 13.252 21.276
phase
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
4. Group * phase
Measure: MEASURE_1
14.985 2.475 9.907 20.064
15.499 2.618 10.127 20.871
19.024 2.746 13.390 24.658
19.029 2.905 13.069 24.989
phase
1
2
1
2
Group
Normal
Valgus
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
General Linear Model 
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Within-Subjects Factors
Measure: MEASURE_1
AddDes
AmpNorm
AddAsc
AmpNorm
phase
1
2
Dependent
Variable
 
Between-Subjects Factors
Normal 16
Valgus 13
1.0000
2.0000
Group
Value Label N
 
Descriptive Statistics
29.680102 39.0152292 16
18.848112 14.2616026 13
24.824383 30.5398423 29
18.024013 7.6244966 16
35.598841 33.7813601 13
25.902384 24.4814316 29
Group
Normal
Valgus
Total
Normal
Valgus
Total
AddDesAmpNorm
AddAscAmpNorm
Mean Std. Deviation N
 
Multivariate Testsc
.007 .196b 1.000 27.000 .661 .007 .196 .071
.993 .196b 1.000 27.000 .661 .007 .196 .071
.007 .196b 1.000 27.000 .661 .007 .196 .071
.007 .196b 1.000 27.000 .661 .007 .196 .071
.184 6.095b 1.000 27.000 .020 .184 6.095 .663
.816 6.095b 1.000 27.000 .020 .184 6.095 .663
.226 6.095b 1.000 27.000 .020 .184 6.095 .663
.226 6.095b 1.000 27.000 .020 .184 6.095 .663
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
phase
phase * Group
Value F Hypothesis df Error df Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Exact statisticb. 
Design: Intercept+Group 
Within Subjects Design: phase
c. 
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Mauchly's Test of Sphericityb
Measure: MEASURE_1
1.000 .000 0 . 1.000 1.000 1.000
Within Subjects Effect
phase
Mauchly's W
Approx.
Chi-Square df Sig.
Greenhous
e-Geisser Huynh-Feldt Lower-bound
Epsilon
a
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is
proportional to an identity matrix.
May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed in
the Tests of Within-Subjects Effects table.
a. 
Design: Intercept+Group 
Within Subjects Design: phase
b. 
 
Tests of Within-Subjects Effects
Measure: MEASURE_1
93.081 1 93.081 .196 .661 .007 .196 .071
93.081 1.000 93.081 .196 .661 .007 .196 .071
93.081 1.000 93.081 .196 .661 .007 .196 .071
93.081 1.000 93.081 .196 .661 .007 .196 .071
2893.880 1 2893.880 6.095 .020 .184 6.095 .663
2893.880 1.000 2893.880 6.095 .020 .184 6.095 .663
2893.880 1.000 2893.880 6.095 .020 .184 6.095 .663
2893.880 1.000 2893.880 6.095 .020 .184 6.095 .663
12819.595 27 474.800
12819.595 27.000 474.800
12819.595 27.000 474.800
12819.595 27.000 474.800
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
phase
phase * Group
Error(phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Tests of Within-Subjects Contrasts
Measure: MEASURE_1
93.081 1 93.081 .196 .661 .007 .196 .071
2893.880 1 2893.880 6.095 .020 .184 6.095 .663
12819.595 27 474.800
phase
Linear
Linear
Linear
Source
phase
phase * Group
Error(phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
 
Tests of Between-Subjects Effects
Measure: MEASURE_1
Transformed Variable: Average
37421.498 1 37421.498 37.394 .000 .581 37.394 1.000
163.050 1 163.050 .163 .690 .006 .163 .068
27020.104 27 1000.745
Source
Intercept
Group
Error
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
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Estimated Marginal Means 
 
1. Grand Mean
Measure: MEASURE_1
25.538 4.176 16.969 34.107
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
2. Group
Measure: MEASURE_1
23.852 5.592 12.378 35.326
27.223 6.204 14.494 39.953
Group
Normal
Valgus
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
3. phase
Measure: MEASURE_1
24.264 5.712 12.544 35.984
26.811 4.336 17.914 35.709
phase
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
 
4. Group * phase
Measure: MEASURE_1
29.680 7.649 13.986 45.374
18.024 5.807 6.110 29.938
18.848 8.486 1.437 36.259
35.599 6.442 22.381 48.817
phase
1
2
1
2
Group
Normal
Valgus
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
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General Linear Model 
 
Within-Subjects Factors
Measure: MEASURE_1
GMaxDes
AmpNorm
GMaxAsc
AmpNorm
GMaxDes
Ampboard
Norm
GMaxAsc
Ampboard
Norm
phase
1
2
1
2
board
1
2
Dependent
Variable
 
Group = Valgus 
 
Multivariate Testsb,c
.011 .134a 1.000 12.000 .721
.989 .134a 1.000 12.000 .721
.011 .134a 1.000 12.000 .721
.011 .134a 1.000 12.000 .721
.113 1.525a 1.000 12.000 .241
.887 1.525a 1.000 12.000 .241
.127 1.525a 1.000 12.000 .241
.127 1.525a 1.000 12.000 .241
.106 1.430a 1.000 12.000 .255
.894 1.430a 1.000 12.000 .255
.119 1.430a 1.000 12.000 .255
.119 1.430a 1.000 12.000 .255
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
board
phase
board * phase
Value F Hypothesis df Error df Sig.
Exact statistica. 
Design: Intercept 
Within Subjects Design: board+phase+board*phase
b. 
Group = Valgusc. 
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Mauchly's Test of Sphericityb,c
Measure: MEASURE_1
1.000 .000 0 . 1.000 1.000 1.000
1.000 .000 0 . 1.000 1.000 1.000
1.000 .000 0 . 1.000 1.000 1.000
Within Subjects Effect
board
phase
board * phase
Mauchly's W
Approx.
Chi-Square df Sig.
Greenhous
e-Geisser Huynh-Feldt Lower-bound
Epsilon
a
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is
proportional to an identity matrix.
May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed in
the Tests of Within-Subjects Effects table.
a. 
Design: Intercept 
Within Subjects Design: board+phase+board*phase
b. 
Group = Valgusc. 
 
Tests of Within-Subjects Effectsa
Measure: MEASURE_1
2.550 1 2.550 .134 .721
2.550 1.000 2.550 .134 .721
2.550 1.000 2.550 .134 .721
2.550 1.000 2.550 .134 .721
228.463 12 19.039
228.463 12.000 19.039
228.463 12.000 19.039
228.463 12.000 19.039
20.663 1 20.663 1.525 .241
20.663 1.000 20.663 1.525 .241
20.663 1.000 20.663 1.525 .241
20.663 1.000 20.663 1.525 .241
162.606 12 13.550
162.606 12.000 13.550
162.606 12.000 13.550
162.606 12.000 13.550
19.829 1 19.829 1.430 .255
19.829 1.000 19.829 1.430 .255
19.829 1.000 19.829 1.430 .255
19.829 1.000 19.829 1.430 .255
166.412 12 13.868
166.412 12.000 13.868
166.412 12.000 13.868
166.412 12.000 13.868
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
board
Error(board)
phase
Error(phase)
board * phase
Error(board*phase)
Type III Sum
of Squares df Mean Square F Sig.
Group = Valgusa. 
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Tests of Within-Subjects Contrastsa
Measure: MEASURE_1
2.550 1 2.550 .134 .721
228.463 12 19.039
20.663 1 20.663 1.525 .241
162.606 12 13.550
19.829 1 19.829 1.430 .255
166.412 12 13.868
phase
Linear
Linear
Linear
Linear
board
Linear
Linear
Linear
Linear
Source
board
Error(board)
phase
Error(phase)
board * phase
Error(board*phase)
Type III Sum
of Squares df Mean Square F Sig.
Group = Valgusa. 
 
Tests of Between-Subjects Effectsa
Measure: MEASURE_1
Transformed Variable: Average
7002.385 1 7002.385 59.407 .000
1414.464 12 117.872
Source
Intercept
Error
Type III Sum
of Squares df Mean Square F Sig.
Group = Valgusa. 
 
Estimated Marginal Means 
 
1. Grand Meana
Measure: MEASURE_1
11.604 1.506 8.324 14.885
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
 
2. boarda
Measure: MEASURE_1
11.383 1.577 7.946 14.820
11.826 1.667 8.194 15.457
board
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
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3. phasea
Measure: MEASURE_1
10.974 1.450 7.815 14.133
12.235 1.718 8.491 15.978
phase
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
 
4. board * phasea
Measure: MEASURE_1
11.370 1.568 7.955 14.786
11.396 1.587 7.937 14.854
10.578 1.403 7.520 13.636
13.074 2.386 7.875 18.273
phase
1
2
1
2
board
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
 
 
 
General Linear Model 
 
Within-Subjects Factors
Measure: MEASURE_1
GMedDes
AmpNorm
GMedAsc
AmpNorm
GMedDes
Ampboard
Norm
GMedAsc
Ampboard
Norm
phase
1
2
1
2
board
1
2
Dependent
Variable
 
Group = Valgus 
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Descriptive Statisticsa
19.024160 9.7204132 13
19.028615 9.7469128 13
18.142014 9.4341316 13
20.258858 11.8490756 13
GMedDesAmpNorm
GMedAscAmpNorm
GMedDesAmpboard
Norm
GMedAscAmpboardNorm
Mean Std. Deviation N
Group = Valgusa. 
 
Multivariate Testsc,d
.002 .022b 1.000 12.000 .885 .002 .022 .052
.998 .022b 1.000 12.000 .885 .002 .022 .052
.002 .022b 1.000 12.000 .885 .002 .022 .052
.002 .022b 1.000 12.000 .885 .002 .022 .052
.145 2.034b 1.000 12.000 .179 .145 2.034 .259
.855 2.034b 1.000 12.000 .179 .145 2.034 .259
.169 2.034b 1.000 12.000 .179 .145 2.034 .259
.169 2.034b 1.000 12.000 .179 .145 2.034 .259
.140 1.955b 1.000 12.000 .187 .140 1.955 .251
.860 1.955b 1.000 12.000 .187 .140 1.955 .251
.163 1.955b 1.000 12.000 .187 .140 1.955 .251
.163 1.955b 1.000 12.000 .187 .140 1.955 .251
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
board
phase
board * phase
Value F Hypothesis df Error df Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Exact statisticb. 
Design: Intercept 
Within Subjects Design: board+phase+board*phase
c. 
Group = Valgusd. 
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Mauchly's Test of Sphericityb,c
Measure: MEASURE_1
1.000 .000 0 . 1.000 1.000 1.000
1.000 .000 0 . 1.000 1.000 1.000
1.000 .000 0 . 1.000 1.000 1.000
Within Subjects Effect
board
phase
board * phase
Mauchly's W
Approx.
Chi-Square df Sig.
Greenhous
e-Geisser Huynh-FeldtLower-bound
Epsilon
a
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is
proportional to an identity matrix.
May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed in
the Tests of Within-Subjects Effects table.
a. 
Design: Intercept 
Within Subjects Design: board+phase+board*phase
b. 
Group = Valgusc. 
 
Tests of Within-Subjects Effectsb
Measure: MEASURE_1
.394 1 .394 .022 .885 .002 .022 .052
.394 1.000 .394 .022 .885 .002 .022 .052
.394 1.000 .394 .022 .885 .002 .022 .052
.394 1.000 .394 .022 .885 .002 .022 .052
215.282 12 17.940
215.282 12.000 17.940
215.282 12.000 17.940
215.282 12.000 17.940
14.625 1 14.625 2.034 .179 .145 2.034 .259
14.625 1.000 14.625 2.034 .179 .145 2.034 .259
14.625 1.000 14.625 2.034 .179 .145 2.034 .259
14.625 1.000 14.625 2.034 .179 .145 2.034 .259
86.289 12 7.191
86.289 12.000 7.191
86.289 12.000 7.191
86.289 12.000 7.191
14.502 1 14.502 1.955 .187 .140 1.955 .251
14.502 1.000 14.502 1.955 .187 .140 1.955 .251
14.502 1.000 14.502 1.955 .187 .140 1.955 .251
14.502 1.000 14.502 1.955 .187 .140 1.955 .251
89.006 12 7.417
89.006 12.000 7.417
89.006 12.000 7.417
89.006 12.000 7.417
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
board
Error(board)
phase
Error(phase)
board * phase
Error(board*phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Group = Valgusb. 
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Tests of Within-Subjects Contrastsb
Measure: MEASURE_1
.394 1 .394 .022 .885 .002 .022 .052
215.282 12 17.940
14.625 1 14.625 2.034 .179 .145 2.034 .259
86.289 12 7.191
14.502 1 14.502 1.955 .187 .140 1.955 .251
89.006 12 7.417
phase
Linear
Linear
Linear
Linear
board
Linear
Linear
Linear
Linear
Source
board
Error(board)
phase
Error(phase)
board * phase
Error(board*phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Group = Valgusb. 
 
Tests of Between-Subjects Effectsb
Measure: MEASURE_1
Transformed Variable: Average
18996.771 1 18996.771 49.171 .000 .804 49.171 1.000
4636.130 12 386.344
Source
Intercept
Error
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Group = Valgusb. 
 
Estimated Marginal Means 
 
1. Grand Meana
Measure: MEASURE_1
19.113 2.726 13.175 25.052
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
 
2. boarda
Measure: MEASURE_1
19.026 2.699 13.145 24.908
19.200 2.874 12.938 25.463
board
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
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3. phasea
Measure: MEASURE_1
18.583 2.642 12.826 24.340
19.644 2.855 13.422 25.865
phase
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
 
4. board * phasea
Measure: MEASURE_1
19.024 2.696 13.150 24.898
19.029 2.703 13.139 24.919
18.142 2.617 12.441 23.843
20.259 3.286 13.099 27.419
phase
1
2
1
2
board
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
 
General Linear Model 
 
Within-Subjects Factors
Measure: MEASURE_1
AddDes
AmpNorm
AddAsc
AmpNorm
AddDes
Ampboard
Norm
AddAsc
Ampboard
Norm
phase
1
2
1
2
board
1
2
Dependent
Variable
 
Group = Valgus 
 
Descriptive Statisticsa
18.848112 14.2616026 13
35.598841 33.7813601 13
18.090004 14.0836079 13
28.494032 20.9464810 13
AddDesAmpNorm
AddAscAmpNorm
AddDesAmpboardNorm
AddAscAmpboardNorm
Mean Std. Deviation N
Group = Valgusa. 
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Multivariate Testsc,d
.166 2.390b 1.000 12.000 .148 .166 2.390 .296
.834 2.390b 1.000 12.000 .148 .166 2.390 .296
.199 2.390b 1.000 12.000 .148 .166 2.390 .296
.199 2.390b 1.000 12.000 .148 .166 2.390 .296
.477 10.951b 1.000 12.000 .006 .477 10.951 .859
.523 10.951b 1.000 12.000 .006 .477 10.951 .859
.913 10.951b 1.000 12.000 .006 .477 10.951 .859
.913 10.951b 1.000 12.000 .006 .477 10.951 .859
.124 1.700b 1.000 12.000 .217 .124 1.700 .225
.876 1.700b 1.000 12.000 .217 .124 1.700 .225
.142 1.700b 1.000 12.000 .217 .124 1.700 .225
.142 1.700b 1.000 12.000 .217 .124 1.700 .225
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
board
phase
board * phase
Value F Hypothesis df Error df Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Exact statisticb. 
Design: Intercept 
Within Subjects Design: board+phase+board*phase
c. 
Group = Valgusd. 
 
Mauchly's Test of Sphericityb,c
Measure: MEASURE_1
1.000 .000 0 . 1.000 1.000 1.000
1.000 .000 0 . 1.000 1.000 1.000
1.000 .000 0 . 1.000 1.000 1.000
Within Subjects Effect
board
phase
board * phase
Mauchly's W
Approx.
Chi-Square df Sig.
Greenhous
e-Geisser Huynh-FeldtLower-bound
Epsilon
a
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is
proportional to an identity matrix.
May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed in
the Tests of Within-Subjects Effects table.
a. 
Design: Intercept 
Within Subjects Design: board+phase+board*phase
b. 
Group = Valgusc. 
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Tests of Within-Subjects Effectsb
Measure: MEASURE_1
200.933 1 200.933 2.390 .148 .166 2.390 .296
200.933 1.000 200.933 2.390 .148 .166 2.390 .296
200.933 1.000 200.933 2.390 .148 .166 2.390 .296
200.933 1.000 200.933 2.390 .148 .166 2.390 .296
1008.777 12 84.065
1008.777 12.000 84.065
1008.777 12.000 84.065
1008.777 12.000 84.065
2396.488 1 2396.488 10.951 .006 .477 10.951 .859
2396.488 1.000 2396.488 10.951 .006 .477 10.951 .859
2396.488 1.000 2396.488 10.951 .006 .477 10.951 .859
2396.488 1.000 2396.488 10.951 .006 .477 10.951 .859
2626.032 12 218.836
2626.032 12.000 218.836
2626.032 12.000 218.836
2626.032 12.000 218.836
130.912 1 130.912 1.700 .217 .124 1.700 .225
130.912 1.000 130.912 1.700 .217 .124 1.700 .225
130.912 1.000 130.912 1.700 .217 .124 1.700 .225
130.912 1.000 130.912 1.700 .217 .124 1.700 .225
924.341 12 77.028
924.341 12.000 77.028
924.341 12.000 77.028
924.341 12.000 77.028
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
board
Error(board)
phase
Error(phase)
board * phase
Error(board*phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Group = Valgusb. 
 
Tests of Within-Subjects Contrastsb
Measure: MEASURE_1
200.933 1 200.933 2.390 .148 .166 2.390 .296
1008.777 12 84.065
2396.488 1 2396.488 10.951 .006 .477 10.951 .859
2626.032 12 218.836
130.912 1 130.912 1.700 .217 .124 1.700 .225
924.341 12 77.028
phase
Linear
Linear
Linear
Linear
board
Linear
Linear
Linear
Linear
Source
board
Error(board)
phase
Error(phase)
board * phase
Error(board*phase)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Group = Valgusb. 
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Tests of Between-Subjects Effectsb
Measure: MEASURE_1
Transformed Variable: Average
33173.597 1 33173.597 20.711 .001 .633 20.711 .986
19220.971 12 1601.748
Source
Intercept
Error
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power
a
Computed using alpha = .05a. 
Group = Valgusb. 
 
Estimated Marginal Means 
 
1. Grand Meana
Measure: MEASURE_1
25.258 5.550 13.165 37.350
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
 
2. boarda
Measure: MEASURE_1
27.223 6.541 12.972 41.475
23.292 4.696 13.060 33.524
board
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
 
3. phasea
Measure: MEASURE_1
18.469 3.921 9.926 27.012
32.046 7.393 15.939 48.153
phase
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
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4. board * phasea
Measure: MEASURE_1
18.848 3.955 10.230 27.466
35.599 9.369 15.185 56.013
18.090 3.906 9.579 26.601
28.494 5.810 15.836 41.152
phase
1
2
1
2
board
1
2
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
Group = Valgusa. 
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